  ('OV_4655','Bovine herpesvirus','BHV-1','DNA','Herpesviridae','None','No','Virus in combination with 5-AZa (2mg/kg) intraperitoneal single dose','No','NA','NA','NA','NA','NA','NA','NA','NA','CR mice xenograft for LCRT cells (5.0E+5)','5.0E+6 pfu for 5 days','NA','Combination therapy results in 3/8 animals with delayed growth','Intratumoral','NA','Induce antitumor immune response','NA','27119103'),
  ('OV_4656','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','CAL27','NA','NA','Statistical analysis','0.001 MOI','82% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4657','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','CAL27','NA','NA','Statistical analysis','0.005 MOI','42% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4658','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','CAL27','NA','NA','Statistical analysis','0.01 MOI','38% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4659','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','CAL27','NA','NA','Statistical analysis','0.05 MOI','30% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4660','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','CAL27','NA','NA','Statistical analysis','0.1 MOI','30% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4661','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','CAL27','NA','NA','Statistical analysis','0.5 MOI','30% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4662','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','CAL27','NA','NA','Statistical analysis','1 MOI','30% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4663','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-47','NA','NA','Statistical analysis','0.001 MOI','82% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4664','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-47','NA','NA','Statistical analysis','0.005 MOI','60% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4665','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-47','NA','NA','Statistical analysis','0.01 MOI','55% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4666','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-47','NA','NA','Statistical analysis','0.05 MOI','40% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4667','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-47','NA','NA','Statistical analysis','0.1 MOI','38% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4668','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-47','NA','NA','Statistical analysis','0.5 MOI','38% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4669','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-47','NA','NA','Statistical analysis','1 MOI','30% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4670','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UD-SCC-2','NA','NA','Statistical analysis','0.001 MOI','100% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4671','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UD-SCC-2','NA','NA','Statistical analysis','0.005 MOI','95% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4672','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UD-SCC-2','NA','NA','Statistical analysis','0.01 MOI','90% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4673','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UD-SCC-2','NA','NA','Statistical analysis','0.05 MOI','40% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4674','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UD-SCC-2','NA','NA','Statistical analysis','0.1 MOI','25% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4675','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UD-SCC-2','NA','NA','Statistical analysis','0.5 MOI','22% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4676','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UD-SCC-2','NA','NA','Statistical analysis','1 MOI','20% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4677','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-74A','NA','NA','Statistical analysis','0.001 MOI','90% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4678','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-74A','NA','NA','Statistical analysis','0.005 MOI','70% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4679','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-74A','NA','NA','Statistical analysis','0.01 MOI','65% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4680','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-74A','NA','NA','Statistical analysis','0.05 MOI','50% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4681','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-74A','NA','NA','Statistical analysis','0.1 MOI','40% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4682','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-74A','NA','NA','Statistical analysis','0.5 MOI','38% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4683','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-74A','NA','NA','Statistical analysis','1 MOI','38% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4684','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-1','NA','NA','Statistical analysis','0.001 MOI','90% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4685','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-1','NA','NA','Statistical analysis','0.005 MOI','82% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4686','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-1','NA','NA','Statistical analysis','0.01 MOI','60% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4687','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-1','NA','NA','Statistical analysis','0.05 MOI','60% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4688','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-1','NA','NA','Statistical analysis','0.1 MOI','50% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4689','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-1','NA','NA','Statistical analysis','0.5 MOI','40% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4690','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-1','NA','NA','Statistical analysis','1 MOI','38% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4691','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-11A','NA','NA','Statistical analysis','0.001 MOI','90% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4692','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-11A','NA','NA','Statistical analysis','0.005 MOI','82% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4693','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-11A','NA','NA','Statistical analysis','0.01 MOI','76% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4694','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-11A','NA','NA','Statistical analysis','0.05 MOI','62% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4695','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-11A','NA','NA','Statistical analysis','0.1 MOI','62% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4696','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-11A','NA','NA','Statistical analysis','0.5 MOI','50% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4697','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','Human squamous cell carcinoma cell line','UM-SCC-11A','NA','NA','Statistical analysis','1 MOI','40% cell viability after 2 days','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4698','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic nude mice subcutaneous xenograft for CAL27 (1.5E+7)','2.0E+6 pfu on day 7 and 16','NA','Mice treated with virus shows delayed tumor growth compared to control, one shows complete tumor regression','Intratumoral','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4699','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','No','Virus combination with ATN-224 (8 micromolar/litre) an copper chelator show synergy','No','NA','Human squamous cell carcinoma cell line','SCC-74A','NA','NA','Crystal violet staining','0.5 MOI','38% cell viability','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4700','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','No','Virus combination with ATN-224 (8 micromolar/litre) an copper chelator show synergy','No','NA','Human squamous cell carcinoma cell line','CAL27','NA','NA','Crystal violet staining','0.5 MOI','42% cell viability','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4701','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','No','Virus combination with ATN-224 (8 micromolar/litre) an copper chelator show synergy','No','NA','Human squamous cell carcinoma cell line','SCC-1','NA','NA','Crystal violet staining','0.5 MOI','40% cell viability','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4702','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','No','Virus combination with ATN-224 (8 micromolar/litre) an copper chelator show synergy','No','NA','Human squamous cell carcinoma cell line','SCC-2','NA','NA','Crystal violet staining','0.5 MOI','45% cell viability','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4703','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','No','Virus combination with ATN-224 (8 micromolar/litre) an copper chelator show synergy','No','NA','Human squamous cell carcinoma cell line','SCC-11A','NA','NA','Crystal violet staining','0.5 MOI','38% cell viability','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4704','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','No','Virus combination with ATN-224 (0.7 mg/kg/day) an copper chelator showing synergistic effect','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic nude mice xenograft for UM-SCC-74A (1.5E+7)','2.0E+6 pfu on day 7','NA','Increased in survival time and reduction in tumor volume to below 200 cubic mm comapred to control 700 cubic mm','Intratumoral','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4705','Herpes simplex virus','RAMBO','DNA','Herpesviridae','Antiangiogenic Vstat120 expressing virus','No','Virus combination with ATN-224 (0.7 mg/kg/day) an copper chelator showing synergistic effect','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic nude mice xenograft for CAL27 (1.5E+7)','2.0E+6 pfu on day 7','NA','Increased in survival time and reduction in tumor volume to below 500 cubic mm comapred to control 2000 cubic mm','Intratumoral','NA','Induce antitumor immune response','NA','27119105'),
  ('OV_4706','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.001 MOI','100% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4707','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.01 MOI','98% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4708','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.1 MOI','100% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4709','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','1 MOI','75% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4710','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','40% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4711','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.001 MOI','100% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4712','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.01 MOI','100% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4713','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.1 MOI','100% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4714','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','1 MOI','100% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4715','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','50% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4716','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.001 MOI','100% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4717','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.01 MOI','100% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4718','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.1 MOI','100% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4719','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','5000 cells per well','NA','Cell titer Glo luminiscent assay','1 MOI','75% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4720','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','50% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4721','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.001 MOI','100% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4722','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.01 MOI','100% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4723','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.1 MOI','100% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4724','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','1 MOI','50% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4725','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','25% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4726','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.001 MOI','100% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4727','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.01 MOI','100% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4728','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.1 MOI','100% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4729','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','1 MOI','75% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4730','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','65% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4731','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.001 MOI','100% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4732','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.01 MOI','100% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4733','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.1 MOI','100% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4734','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','5000 cells per well','NA','Cell titer Glo luminiscent assay','1 MOI','40% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4735','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','20% cell viability','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4736','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.001 MOI','1% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4737','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.01 MOI','100% cell death','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4738','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.1 MOI','100% cell death','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4739','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','1 MOI','100% cell death','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4740','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell death','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4741','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.001 MOI','5% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4742','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.01 MOI','4% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4743','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.1 MOI','3% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4744','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','1 MOI','3% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4745','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','1% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4746','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.001 MOI','1% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4747','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.01 MOI','1% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4748','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','5000 cells per well','NA','Cell titer Glo luminiscent assay','0.1 MOI','1% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4749','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','5000 cells per well','NA','Cell titer Glo luminiscent assay','1 MOI','1% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4750','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','1% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4751','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','0.01 MOI','100% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4752','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','0.1 MOI','100% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4753','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','1 MOI','100% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4754','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4755','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','0.01 MOI','100% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4756','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','0.1 MOI','100% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4757','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','1 MOI','100% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4758','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4759','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','50000 cells per well','NA','Cell titer Glo luminiscent assay','0.01 MOI','100% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4760','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','50000 cells per well','NA','Cell titer Glo luminiscent assay','0.1 MOI','100% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4761','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','50000 cells per well','NA','Cell titer Glo luminiscent assay','1 MOI','100% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4762','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4763','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','0.01 MOI','90% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4764','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','0.1 MOI','90% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4765','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','1 MOI','75% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4766','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','65% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4767','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','0.01 MOI','100% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4768','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','0.1 MOI','100% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4769','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','1 MOI','75% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4770','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','75% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4771','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','50000 cells per well','NA','Cell titer Glo luminiscent assay','0.01 MOI','100% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4772','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','50000 cells per well','NA','Cell titer Glo luminiscent assay','0.1 MOI','75% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4773','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','50000 cells per well','NA','Cell titer Glo luminiscent assay','1 MOI','50% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4774','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','25% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4775','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','0.01 MOI','25% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4776','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','0.1 MOI','20% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4777','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','1 MOI','15% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4778','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','10% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4779','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','0.01 MOI','30% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4780','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','0.1 MOI','15% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4781','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','1 MOI','15% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4782','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','15% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4783','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','50000 cells per well','NA','Cell titer Glo luminiscent assay','0.01 MOI','100% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4784','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','50000 cells per well','NA','Cell titer Glo luminiscent assay','0.1 MOI','80% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4785','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','50000 cells per well','NA','Cell titer Glo luminiscent assay','1 MOI','80% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4786','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','50% cell survival','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4787','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4788','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4789','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','18% cell viability after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4790','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','90% cell viability after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4791','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','80% cell viability after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4792','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','10% cell viability after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4793','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','60% cell viability after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4794','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','50% cell viability after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4795','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','5% cell viability after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4796','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','40% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4797','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','20% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4798','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','1% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4799','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','30% cell viability after 5 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4800','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','2% cell viability after 5 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4801','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','2% cell viability after 5 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4802','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4803','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4804','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','60% cell viability after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4805','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','80% cell viability after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4806','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','70% cell viability after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4807','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','20% cell viability after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4808','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','60% cell viability after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4809','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','40% cell viability after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4810','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','10% cell viability after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4811','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','60% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4812','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','20% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4813','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','1% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4814','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','50% cell viability after 5 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4815','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','2% cell viability after 5 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4816','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','2% cell viability after 5 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4817','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4818','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','90% cell viability after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4819','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','10% cell viability after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4820','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4821','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','40% cell viability after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4822','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','1% cell viability after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4823','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','50% cell viability after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4824','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','10% cell viability after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4825','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','1% cell viability after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4826','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','30% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4827','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','10% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4828','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','1% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4829','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','20% cell viability after 5 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4830','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','1% cell viability after 5 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4831','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','5000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','1% cell viability after 5 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4832','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4833','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4834','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','60% cell viability after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4835','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4836','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','80% cell viability after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4837','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','10% cell viability after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4838','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4839','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','70% cell viability after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4840','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','5% cell viability after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4841','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','90% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4842','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','50% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4843','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','1% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4844','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','70% cell viability after 5 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4845','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','20% cell viability after 5 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4846','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','HEYA8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','1% cell viability after 5 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4847','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4848','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4849','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','80% cell viability after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4850','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4851','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4852','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','40% cell viability after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4853','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4854','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','90% cell viability after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4855','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','10% cell viability after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4856','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4857','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','70% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4858','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','20% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4859','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 5 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4860','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','60% cell viability after 5 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4861','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','SKOV3','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','20% cell viability after 5 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4862','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4863','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4864','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4865','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4866','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','60% cell viability after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4867','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','70% cell viability after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4868','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','90% cell viability after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4869','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','40% cell viability after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4870','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','30% cell viability after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4871','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4872','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','30% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4873','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','25% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4874','Myxoma virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','100% cell viability after 5 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4875','Vaccinia virus','vvDD','DNA','Poxviridae','Deletion of TK gene and vaccinia growth factor','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','25% cell viability after 5 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4876','Maraba virus','wild type','RNA','Rhabdoviridae','None','Yes','No','No','NA','Human ovarian cancer cell line','OVCAR8','50000 cells per well','NA','Cell titer Glo luminiscent assay','10 MOI','25% cell viability after 5 days','No','No','NA','No response','NA','NA','NA','NA','27119108'),
  ('OV_4877','Adenovirus','Ad-deltaB','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human hepatocellular carcinoma','Hep3B','70% confluence on 24 well plate','NA','MTT assay','5 MOI','100% cell viability after 48 hours','No','No','NA','No response','NA','Combination therapy and alone promotes apoptosis','Activation of caspase-3 and 8 and upregulation of IFN-gamma','NA','27154307'),
  ('OV_4878','Adenovirus','Ad-deltaB','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human hepatocellular carcinoma','Hep3B','70% confluence on 24 well plate','NA','MTT assay','10 MOI','90% cell viability after 48 hours','No','No','NA','No response','NA','Combination therapy and alone promotes apoptosis','Activation of caspase-3 and 8 and upregulation of IFN-gamma','NA','27154307'),
  ('OV_4879','Adenovirus','Ad-deltaB','DNA','Adenoviridae','Expressing TRAIL and IL-12 gene in under CMV promoter in deleted E3 region of virus backbone','Yes','No','Virus expressing IL12 gene','ATCC','Human hepatocellular carcinoma','Hep3B','70% confluence on 24 well plate','NA','MTT assay','10 MOI','50% cell viability after 48 hours','No','No','NA','No response','NA','Combination therapy and alone promotes apoptosis','Activation of caspase-3 and 8 and upregulation of IFN-gamma','NA','27154307'),
  ('OV_4880','Adenovirus','Ad-deltaB','DNA','Adenoviridae','Expressing TRAIL and IL-12 gene in under CMV promoter in deleted E3 region of virus backbone','Yes','No','Virus expressing IL12 gene','ATCC','Human hepatocellular carcinoma','Hep3B','70% confluence on 24 well plate','NA','MTT assay','20 MOI','40% cell viability after 48 hours','No','No','NA','No response','NA','Combination therapy and alone promotes apoptosis','Activation of caspase-3 and 8 and upregulation of IFN-gamma','NA','27154307'),
  ('OV_4881','Adenovirus','Ad-deltaB','DNA','Adenoviridae','None','Yes','No','No','JCRB gene bank japan','Human hepatocellular carcinoma','Huh-7','70% confluence on 24 well plate','NA','MTT assay','5 MOI','80% cell viability after 48 hours','No','No','NA','No response','NA','Combination therapy and alone promotes apoptosis','Activation of caspase-3 and 8 and upregulation of IFN-gamma','NA','27154307'),
  ('OV_4882','Adenovirus','Ad-deltaB','DNA','Adenoviridae','None','Yes','No','No','JCRB gene bank japan','Human hepatocellular carcinoma','Huh-7','70% confluence on 24 well plate','NA','MTT assay','10 MOI','60% cell viability after 48 hours','No','No','NA','No response','NA','Combination therapy and alone promotes apoptosis','Activation of caspase-3 and 8 and upregulation of IFN-gamma','NA','27154307'),
  ('OV_4883','Adenovirus','Ad-deltaB','DNA','Adenoviridae','Expressing TRAIL and IL-12 gene in under CMV promoter in deleted E3 region of virus backbone','Yes','No','Virus expressing IL12 gene','JCRB gene bank japan','Human hepatocellular carcinoma','Huh-7','70% confluence on 24 well plate','NA','MTT assay','10 MOI','20% cell viability after 48 hours','No','No','NA','No response','NA','Combination therapy and alone promotes apoptosis','Activation of caspase-3 and 8 and upregulation of IFN-gamma','NA','27154307'),
  ('OV_4884','Adenovirus','Ad-deltaB','DNA','Adenoviridae','Expressing TRAIL and IL-12 gene in under CMV promoter in deleted E3 region of virus backbone','Yes','No','Virus expressing IL12 gene','JCRB gene bank japan','Human hepatocellular carcinoma','Huh-7','70% confluence on 24 well plate','NA','MTT assay','20 MOI','10% cell viability after 48 hours','No','No','NA','No response','NA','Combination therapy and alone promotes apoptosis','Activation of caspase-3 and 8 and upregulation of IFN-gamma','NA','27154307'),
  ('OV_4885','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human cervix epithelial adenocarcinoma cell line','HeLa','1 million cells per well','NA','MTT assay','0.1 MOI','100% cell viability after 7 days','No','No','Slightly toxic to HeLa as measured by LDH assay','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4886','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human cervix epithelial adenocarcinoma cell line','HeLa','1 million cells per well','NA','MTT assay','1 MOI','98% cell viability after 7 days','No','No','Slightly toxic to HeLa as measured by LDH assay','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4887','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human cervix epithelial adenocarcinoma cell line','HeLa','1 million cells per well','NA','MTT assay','10 MOI','88% cell viability after 7 days','No','No','Slightly toxic to HeLa as measured by LDH assay','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4888','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human cervix epithelial adenocarcinoma cell line','HeLa','1 million cells per well','NA','MTT assay','50 MOI','88% cell viability after 7 days','No','No','Slightly toxic to HeLa as measured by LDH assay','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4889','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 gene in virus genome','Yes','No','Virus expressing IL-21 gene','ATCC','Human cervix epithelial adenocarcinoma cell line','HeLa','1 million cells per well','NA','MTT assay','0.1 MOI','90% cell viability after 7 days','No','No','Slightly toxic to HeLa as measured by LDH assay','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4890','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 gene in virus genome','Yes','No','Virus expressing IL-21 gene','ATCC','Human cervix epithelial adenocarcinoma cell line','HeLa','1 million cells per well','NA','MTT assay','1 MOI','50% cell viability after 7 days','No','No','Slightly toxic to HeLa as measured by LDH assay','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4891','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 gene in virus genome','Yes','No','Virus expressing IL-21 gene','ATCC','Human cervix epithelial adenocarcinoma cell line','HeLa','1 million cells per well','NA','MTT assay','10 MOI','10% cell viability after 7 days','No','No','Slightly toxic to HeLa as measured by LDH assay','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4892','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 gene in virus genome','Yes','No','Virus expressing IL-21 gene','ATCC','Human cervix epithelial adenocarcinoma cell line','HeLa','1 million cells per well','NA','MTT assay','50 MOI','100% cell killing aftwr 7 days','No','No','Slightly toxic to HeLa as measured by LDH assay','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4893','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 and CCL21gene in virus genome','Yes','No','Virus expressing IL-21 and CCL21 gene','ATCC','Human cervix epithelial adenocarcinoma cell line','HeLa','1 million cells per well','NA','MTT assay','0.1 MOI','80% cell viability after 7 days','No','No','Slightly toxic to HeLa as measured by LDH assay','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4894','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 and CCL21gene in virus genome','Yes','No','Virus expressing IL-21 and CCL21 gene','ATCC','Human cervix epithelial adenocarcinoma cell line','HeLa','1 million cells per well','NA','MTT assay','1 MOI','20% cell viability after 7 days','No','No','Slightly toxic to HeLa as measured by LDH assay','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4895','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 and CCL21gene in virus genome','Yes','No','Virus expressing IL-21 and CCL21 gene','ATCC','Human cervix epithelial adenocarcinoma cell line','HeLa','1 million cells per well','NA','MTT assay','10 MOI','10% cell viability after 7 days','No','No','Slightly toxic to HeLa as measured by LDH assay','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4896','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 and CCL21gene in virus genome','Yes','No','Virus expressing IL-21 and CCL21 gene','ATCC','Human cervix epithelial adenocarcinoma cell line','HeLa','1 million cells per well','NA','MTT assay','50 MOI','100% cell killing aftwr 7 days','No','No','Slightly toxic to HeLa as measured by LDH assay','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4897','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human colon carcinoma cell line','CaCo-2','1 million cells per well','NA','MTT assay','0.1 MOI','100% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4898','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human colon carcinoma cell line','CaCo-2','1 million cells per well','NA','MTT assay','1 MOI','100% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4899','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human colon carcinoma cell line','CaCo-2','1 million cells per well','NA','MTT assay','10 MOI','90% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4900','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human colon carcinoma cell line','CaCo-2','1 million cells per well','NA','MTT assay','50 MOI','90% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4901','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 gene in virus genome','Yes','No','Virus expressing IL-21 gene','ATCC','Human colon carcinoma cell line','CaCo-2','1 million cells per well','NA','MTT assay','0.1 MOI','90% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4902','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 gene in virus genome','Yes','No','Virus expressing IL-21 gene','ATCC','Human colon carcinoma cell line','CaCo-2','1 million cells per well','NA','MTT assay','1 MOI','80% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4903','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 gene in virus genome','Yes','No','Virus expressing IL-21 gene','ATCC','Human colon carcinoma cell line','CaCo-2','1 million cells per well','NA','MTT assay','10 MOI','30% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4904','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 gene in virus genome','Yes','No','Virus expressing IL-21 gene','ATCC','Human colon carcinoma cell line','CaCo-2','1 million cells per well','NA','MTT assay','50 MOI','10% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4905','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 and CCL21gene in virus genome','Yes','No','Virus expressing IL-21 and CCL21 gene','ATCC','Human colon carcinoma cell line','CaCo-2','1 million cells per well','NA','MTT assay','0.1 MOI','90% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4906','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 and CCL21gene in virus genome','Yes','No','Virus expressing IL-21 and CCL21 gene','ATCC','Human colon carcinoma cell line','CaCo-2','1 million cells per well','NA','MTT assay','1 MOI','60% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4907','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 and CCL21gene in virus genome','Yes','No','Virus expressing IL-21 and CCL21 gene','ATCC','Human colon carcinoma cell line','CaCo-2','1 million cells per well','NA','MTT assay','10 MOI','20% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4908','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 and CCL21gene in virus genome','Yes','No','Virus expressing IL-21 and CCL21 gene','ATCC','Human colon carcinoma cell line','CaCo-2','1 million cells per well','NA','MTT assay','50 MOI','10% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4909','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','Jilin University china','Human prostate cancer cell line','PC-3M','1 million cells per well','NA','MTT assay','0.1 MOI','100% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4910','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','Jilin University china','Human prostate cancer cell line','PC-3M','1 million cells per well','NA','MTT assay','1 MOI','100% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4911','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','Jilin University china','Human prostate cancer cell line','PC-3M','1 million cells per well','NA','MTT assay','10 MOI','100% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4912','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','Jilin University china','Human prostate cancer cell line','PC-3M','1 million cells per well','NA','MTT assay','50 MOI','100% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4913','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 gene in virus genome','Yes','No','Virus expressing IL-21 gene','Jilin University china','Human prostate cancer cell line','PC-3M','1 million cells per well','NA','MTT assay','0.1 MOI','100% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4914','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 gene in virus genome','Yes','No','Virus expressing IL-21 gene','Jilin University china','Human prostate cancer cell line','PC-3M','1 million cells per well','NA','MTT assay','1 MOI','90% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4915','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 gene in virus genome','Yes','No','Virus expressing IL-21 gene','Jilin University china','Human prostate cancer cell line','PC-3M','1 million cells per well','NA','MTT assay','10 MOI','30% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4916','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 gene in virus genome','Yes','No','Virus expressing IL-21 gene','Jilin University china','Human prostate cancer cell line','PC-3M','1 million cells per well','NA','MTT assay','50 MOI','15% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4917','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 and CCL21gene in virus genome','Yes','No','Virus expressing IL-21 and CCL21 gene','Jilin University china','Human prostate cancer cell line','PC-3M','1 million cells per well','NA','MTT assay','0.1 MOI','70% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4918','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 and CCL21gene in virus genome','Yes','No','Virus expressing IL-21 and CCL21 gene','Jilin University china','Human prostate cancer cell line','PC-3M','1 million cells per well','NA','MTT assay','1 MOI','40% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4919','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 and CCL21gene in virus genome','Yes','No','Virus expressing IL-21 and CCL21 gene','Jilin University china','Human prostate cancer cell line','PC-3M','1 million cells per well','NA','MTT assay','10 MOI','15% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4920','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 and CCL21gene in virus genome','Yes','No','Virus expressing IL-21 and CCL21 gene','Jilin University china','Human prostate cancer cell line','PC-3M','1 million cells per well','NA','MTT assay','50 MOI','15% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4921','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human colorectal adenocarcinoma cell line','LS180','1 million cells per well','NA','MTT assay','0.1 MOI','100% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4922','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human colorectal adenocarcinoma cell line','LS180','1 million cells per well','NA','MTT assay','1 MOI','100% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4923','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human colorectal adenocarcinoma cell line','LS180','1 million cells per well','NA','MTT assay','10 MOI','100% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4924','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human colorectal adenocarcinoma cell line','LS180','1 million cells per well','NA','MTT assay','50 MOI','100% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4925','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 gene in virus genome','Yes','No','Virus expressing IL-21 gene','ATCC','Human colorectal adenocarcinoma cell line','LS180','1 million cells per well','NA','MTT assay','0.1 MOI','90% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4926','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 gene in virus genome','Yes','No','Virus expressing IL-21 gene','ATCC','Human colorectal adenocarcinoma cell line','LS180','1 million cells per well','NA','MTT assay','1 MOI','70% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4927','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 gene in virus genome','Yes','No','Virus expressing IL-21 gene','ATCC','Human colorectal adenocarcinoma cell line','LS180','1 million cells per well','NA','MTT assay','10 MOI','30% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4928','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 gene in virus genome','Yes','No','Virus expressing IL-21 gene','ATCC','Human colorectal adenocarcinoma cell line','LS180','1 million cells per well','NA','MTT assay','50 MOI','15% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4929','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 and CCL21gene in virus genome','Yes','No','Virus expressing IL-21 and CCL21 gene','ATCC','Human colorectal adenocarcinoma cell line','LS180','1 million cells per well','NA','MTT assay','0.1 MOI','60% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4930','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 and CCL21gene in virus genome','Yes','No','Virus expressing IL-21 and CCL21 gene','ATCC','Human colorectal adenocarcinoma cell line','LS180','1 million cells per well','NA','MTT assay','1 MOI','50% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4931','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 and CCL21gene in virus genome','Yes','No','Virus expressing IL-21 and CCL21 gene','ATCC','Human colorectal adenocarcinoma cell line','LS180','1 million cells per well','NA','MTT assay','10 MOI','22% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4932','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 and CCL21gene in virus genome','Yes','No','Virus expressing IL-21 and CCL21 gene','ATCC','Human colorectal adenocarcinoma cell line','LS180','1 million cells per well','NA','MTT assay','50 MOI','15% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4933','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human osteosarcoma cell line','U2OS','1 million cells per well','NA','MTT assay','0.1 MOI','100% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4934','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human osteosarcoma cell line','U2OS','1 million cells per well','NA','MTT assay','1 MOI','100% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4935','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human osteosarcoma cell line','U2OS','1 million cells per well','NA','MTT assay','10 MOI','100% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4936','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human osteosarcoma cell line','U2OS','1 million cells per well','NA','MTT assay','50 MOI','100% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4937','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 gene in virus genome','Yes','No','Virus expressing IL-21 gene','ATCC','Human osteosarcoma cell line','U2OS','1 million cells per well','NA','MTT assay','0.1 MOI','90% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4938','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 gene in virus genome','Yes','No','Virus expressing IL-21 gene','ATCC','Human osteosarcoma cell line','U2OS','1 million cells per well','NA','MTT assay','1 MOI','90% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4939','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 gene in virus genome','Yes','No','Virus expressing IL-21 gene','ATCC','Human osteosarcoma cell line','U2OS','1 million cells per well','NA','MTT assay','10 MOI','90% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4940','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 gene in virus genome','Yes','No','Virus expressing IL-21 gene','ATCC','Human osteosarcoma cell line','U2OS','1 million cells per well','NA','MTT assay','50 MOI','90% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4941','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 and CCL21gene in virus genome','Yes','No','Virus expressing IL-21 and CCL21 gene','ATCC','Human osteosarcoma cell line','U2OS','1 million cells per well','NA','MTT assay','0.1 MOI','90% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4942','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 and CCL21gene in virus genome','Yes','No','Virus expressing IL-21 and CCL21 gene','ATCC','Human osteosarcoma cell line','U2OS','1 million cells per well','NA','MTT assay','1 MOI','90% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4943','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 and CCL21gene in virus genome','Yes','No','Virus expressing IL-21 and CCL21 gene','ATCC','Human osteosarcoma cell line','U2OS','1 million cells per well','NA','MTT assay','10 MOI','90% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4944','Adenovirus','wild type','DNA','Adenoviridae','Addition of IL21 and CCL21gene in virus genome','Yes','No','Virus expressing IL-21 and CCL21 gene','ATCC','Human osteosarcoma cell line','U2OS','1 million cells per well','NA','MTT assay','50 MOI','90% cell viability after 7 days','No','No','NA','No response','NA','NA','Activate proloferation of B-cell and Naive T-cell','NA','27157859'),
  ('OV_4945','Newcastle disease virus','NDV/Anh','RNA','Paramyxoviridae','None','Yes','No','No','Harbin phamaceutical group bioengineering','NA','NA','NA','NA','NA','NA','NA','Nude mice xenograft for H22 cell line (1.0E+5 cells)','1.0E+7 pfu every other day for four times','NA','Average volume in control mice was 3401.25 cubic mm and decreased to 1489.97 cubuc mm in treated mice','Intratumoral','NA','Activate T cells','NA','27174862'),
  ('OV_4946','Newcastle disease virus','NDV/Anh-IL2','RNA','Paramyxoviridae','Insertion of IL-2 gene between HN and L gene of pAnh-wt','Yes','No','Expressing Il-2 gene','Harbin phamaceutical group bioengineering','NA','NA','NA','NA','NA','NA','NA','Nude mice xenograft for H22 cell line (1.0E+5 cells)','1.0E+7 pfu every other day for four times','NA','Average volume in control mice was 3401.25 cubic mm and decreased to 420.67 cubuc mm in treated mice, while 3 out of 6 complete regressed tumor volume','Intratumoral','NA','Activate T cells','NA','27174862'),
  ('OV_4947','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','Shanghai cell collection','Human lung cancer cell line','H-1299','NA','NA','MTT assay','10 MOI','20% cell viability','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4948','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','Shanghai cell collection','Human lung cancer cell line','H-1299','NA','NA','MTT assay','1 MOI','30% cell viability','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4949','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','Shanghai cell collection','Human lung cancer cell line','H-1299','NA','NA','MTT assay','0.1 MOI','50% cell viability','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4950','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','Shanghai cell collection','Human lung cancer cell line','H-1299','NA','NA','MTT assay','0.01 MOI','70% cell viability','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4951','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','Shanghai cell collection','Human lung cancer cell line','A549','NA','NA','MTT assay','10 MOI','20% cell viability','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4952','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','Shanghai cell collection','Human lung cancer cell line','A549','NA','NA','MTT assay','1 MOI','25% cell viability','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4953','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','Shanghai cell collection','Human lung cancer cell line','A549','NA','NA','MTT assay','0.1 MOI','40% cell viability','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4954','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','Shanghai cell collection','Human lung cancer cell line','A549','NA','NA','MTT assay','0.01 MOI','60% cell viability','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4955','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','Shanghai cell collection','Human lung cancer cell line','A549','NA','NA','MTT assay','10 MOI','40% cell viability after 24 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4956','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','Shanghai cell collection','Human lung cancer cell line','A549','NA','NA','MTT assay','1 MOI','60% cell viability after 24 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4957','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','Shanghai cell collection','Human lung cancer cell line','A549','NA','NA','MTT assay','0.1 MOI','70% cell viability after 24 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4958','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','Shanghai cell collection','Human lung cancer cell line','A549','NA','NA','MTT assay','0.01 MOI','80% cell viability after 24 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4959','Vaccinia virus','wild type','DNA','Poxviridae','None','Yes','No','No','Shanghai cell collection','Human lung cancer cell line','A549','NA','NA','MTT assay','10 MOI','70% cell viability after 24 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4960','Vaccinia virus','wild type','DNA','Poxviridae','None','Yes','No','No','Shanghai cell collection','Human lung cancer cell line','A549','NA','NA','MTT assay','1 MOI','80% cell viability after 24 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4961','Vaccinia virus','wild type','DNA','Poxviridae','None','Yes','No','No','Shanghai cell collection','Human lung cancer cell line','A549','NA','NA','MTT assay','0.1 MOI','90% cell viability after 24 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4962','Vaccinia virus','wild type','DNA','Poxviridae','None','Yes','No','No','Shanghai cell collection','Human lung cancer cell line','A549','NA','NA','MTT assay','0.01 MOI','90% cell viability after 24 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4963','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','Shanghai cell collection','Human lung cancer cell line','A549','NA','NA','MTT assay','10 MOI','20% cell viability after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4964','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','Shanghai cell collection','Human lung cancer cell line','A549','NA','NA','MTT assay','1 MOI','50% cell viability after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4965','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','Shanghai cell collection','Human lung cancer cell line','A549','NA','NA','MTT assay','0.1 MOI','60% cell viability after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4966','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','Shanghai cell collection','Human lung cancer cell line','A549','NA','NA','MTT assay','0.01 MOI','80% cell viability after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4967','Vaccinia virus','wild type','DNA','Poxviridae','None','Yes','No','No','Shanghai cell collection','Human lung cancer cell line','A549','NA','NA','MTT assay','10 MOI','60% cell viability after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4968','Vaccinia virus','wild type','DNA','Poxviridae','None','Yes','No','No','Shanghai cell collection','Human lung cancer cell line','A549','NA','NA','MTT assay','1 MOI','70% cell viability after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4969','Vaccinia virus','wild type','DNA','Poxviridae','None','Yes','No','No','Shanghai cell collection','Human lung cancer cell line','A549','NA','NA','MTT assay','0.1 MOI','100% cell viability after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4970','Vaccinia virus','wild type','DNA','Poxviridae','None','Yes','No','No','Shanghai cell collection','Human lung cancer cell line','A549','NA','NA','MTT assay','0.01 MOI','100% cell viability after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4971','Vaccinia virus','wild type','DNA','Poxviridae','None','Yes','No','No','Shanghai cell collection','Lewis lung cancer cell line','LLC','NA','NA','MTT assay','2 MOI','60% cell viability after 24 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4972','Vaccinia virus','wild type','DNA','Poxviridae','None','Yes','No','No','Shanghai cell collection','Lewis lung cancer cell line','LLC','NA','NA','MTT assay','5 MOI','40% cell viability after 24 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4973','Vaccinia virus','wild type','DNA','Poxviridae','None','Yes','No','No','Shanghai cell collection','Lewis lung cancer cell line','LLC','NA','NA','MTT assay','2 MOI','20% cell viability after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4974','Vaccinia virus','wild type','DNA','Poxviridae','None','Yes','No','No','Shanghai cell collection','Lewis lung cancer cell line','LLC','NA','NA','MTT assay','5 MOI','5% cell viability after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4975','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','Shanghai cell collection','Lewis lung cancer cell line','LLC','NA','NA','MTT assay','2 MOI','44% cell viability after 24 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4976','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','Shanghai cell collection','Lewis lung cancer cell line','LLC','NA','NA','MTT assay','5 MOI','35% cell viability after 24 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4977','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','Shanghai cell collection','Lewis lung cancer cell line','LLC','NA','NA','MTT assay','2 MOI','20% cell viability after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4978','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','Shanghai cell collection','Lewis lung cancer cell line','LLC','NA','NA','MTT assay','5 MOI','2% cell viability after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4979','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','NA','NA','NA','NA','NA','NA','NA','NA','C54BL/6 mice xenograft for A549 cell line (5.0E+6)','1.0E+7 pfu','NA','Reduction in tumor volume to 1000 cubic mm compared to control 2200 cubic mm after 27 days','Intratumoral','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4980','Vaccinia virus','vv-IL-24','DNA','Poxviridae','Insertion of IL-24 gene in tk locus','Yes','No','Virus expressing IL-24 gene','NA','NA','NA','NA','NA','NA','NA','NA','Immunocompetant mice xenograft for LLC','1.0E+7 pfu','NA','Reduction in tumor volume to 5000 cubic mm compared to control 10000 cubic mm after 15 days','Intratumoral','Induction of apoptosis','NA','NA','27208781'),
  ('OV_4981','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','Yes','No','Virus expressing human GM-CSF gene','DSMZ Germany','Human malignant biphasic mesothelioma cell line','MTSO-211H','1.0E+4 cells per well','NA','MTS assay','10 VP per cell','78% cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_4982','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','No','Virus in combination with drugs pemetrexed 0.0026 mg/ml + cisplatin 0.0625','Virus expressing human GM-CSF gene','DSMZ Germany','Human malignant biphasic mesothelioma cell line','MTSO-211H','1.0E+4 cells per well','NA','MTS assay','10 VP per cell','35% cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_4983','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','No','Virus in combination with drugs pemetrexed 0.0026 mg/ml + carboplatin 0.0625','Virus expressing human GM-CSF gene','DSMZ Germany','Human malignant biphasic mesothelioma cell line','MTSO-211H','1.0E+4 cells per well','NA','MTS assay','10 VP per cell','22% cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_4984','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','Yes','No','Virus expressing human GM-CSF gene','DSMZ Germany','Human epitheliod mesothelioma','H226','1.0E+4 cells per well','NA','MTS assay','10 VP per cell','90% cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_4985','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','No','Virus in combination with drugs pemetrexed 0.0026 mg/ml + cisplatin 0.0625','Virus expressing human GM-CSF gene','DSMZ Germany','Human epitheliod mesothelioma','H226','1.0E+4 cells per well','NA','MTS assay','10 VP per cell','70% cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_4986','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','No','Virus in combination with drugs pemetrexed 0.0026 mg/ml + carboplatin 0.0625','Virus expressing human GM-CSF gene','DSMZ Germany','Human epitheliod mesothelioma','H226','1.0E+4 cells per well','NA','MTS assay','10 VP per cell','72% cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_4987','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','Yes','No','Virus expressing human GM-CSF gene','DSMZ Germany','Human epitheliod mesothelioma','JL-1','1.0E+4 cells per well','NA','MTS assay','10 VP per cell','90% cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_4988','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','No','Virus in combination with drugs pemetrexed 0.0006 mg/ml + cisplatin 0.0019','Virus expressing human GM-CSF gene','DSMZ Germany','Human epitheliod mesothelioma','JL-1','1.0E+4 cells per well','NA','MTS assay','10 VP per cell','60% cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_4989','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','No','Virus in combination with drugs pemetrexed 0.0006 mg/ml + carboplatin 0.083','Virus expressing human GM-CSF gene','DSMZ Germany','Human epitheliod mesothelioma','JL-1','1.0E+4 cells per well','NA','MTS assay','10 VP per cell','70% cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_4990','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','Yes','No','Virus expressing human GM-CSF gene','DSMZ Germany','Human malignant biphasic mesothelioma cell line','MTSO-211H','1.0E+4 cells per well','NA','MTS assay','1 VP per cell','100% cell viability after 3 days','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_4991','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','Yes','No','Virus expressing human GM-CSF gene','DSMZ Germany','Human malignant biphasic mesothelioma cell line','MTSO-211H','1.0E+4 cells per well','NA','MTS assay','10 VP per cell','80% cell viability after 3 days','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_4992','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','Yes','No','Virus expressing human GM-CSF gene','DSMZ Germany','Human malignant biphasic mesothelioma cell line','MTSO-211H','1.0E+4 cells per well','NA','MTS assay','100 VP per cell','60% cell viability after 3 days','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_4993','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','Yes','No','Virus expressing human GM-CSF gene','DSMZ Germany','Human malignant biphasic mesothelioma cell line','MTSO-211H','1.0E+4 cells per well','NA','MTS assay','1000 VP per cell','20% cell viability after 3 days','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_4994','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','Yes','No','Virus expressing human GM-CSF gene','DSMZ Germany','Human epitheliod mesothelioma','H226','1.0E+4 cells per well','NA','MTS assay','1 VP per cell','100% cell viability after 3 days','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_4995','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','Yes','No','Virus expressing human GM-CSF gene','DSMZ Germany','Human epitheliod mesothelioma','H226','1.0E+4 cells per well','NA','MTS assay','10 VP per cell','90% cell viability after 3 days','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_4996','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','Yes','No','Virus expressing human GM-CSF gene','DSMZ Germany','Human epitheliod mesothelioma','H226','1.0E+4 cells per well','NA','MTS assay','100 VP per cell','40% cell viability after 3 days','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_4997','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','Yes','No','Virus expressing human GM-CSF gene','DSMZ Germany','Human epitheliod mesothelioma','H226','1.0E+4 cells per well','NA','MTS assay','1000 VP per cell','20% cell viability after 3 days','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_4998','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','Yes','No','Virus expressing human GM-CSF gene','DSMZ Germany','Human epitheliod mesothelioma','JL-1','1.0E+4 cells per well','NA','MTS assay','1 VP per cell','100% cell viability after 3 days','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_4999','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','Yes','No','Virus expressing human GM-CSF gene','DSMZ Germany','Human epitheliod mesothelioma','JL-1','1.0E+4 cells per well','NA','MTS assay','10 VP per cell','80% cell viability after 3 days','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_5000','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','Yes','No','Virus expressing human GM-CSF gene','DSMZ Germany','Human epitheliod mesothelioma','JL-1','1.0E+4 cells per well','NA','MTS assay','100 VP per cell','40% cell viability after 3 days','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_5001','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','Yes','No','Virus expressing human GM-CSF gene','DSMZ Germany','Human epitheliod mesothelioma','JL-1','1.0E+4 cells per well','NA','MTS assay','1000 VP per cell','20% cell viability after 3 days','No','No','NA','No response','NA','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_5002','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','Yes','No','Virus expressing human GM-CSF gene','NA','NA','NA','NA','NA','NA','NA','NA','Mice xenograft for NCI-H226 (1.0E+6 cells)','5.0E+7 VP per tumor','Tumor volume regressed to 0.40 FTV','','Intratumoral','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_5003','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','No','Virus in combination with Pem 10 mg/kg + cis 1.5 mg/kg intrapertoneal on day 1 and 7','Virus expressing human GM-CSF gene','NA','NA','NA','NA','NA','NA','NA','NA','Mice xenograft for NCI-H226 (1.0E+6 cells)','5.0E+7 VP per tumor','Tumor volume regressed to 0.29 compared to control 0.40 FTV','','Intratumoral','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_5004','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','Yes','Virus priming on day 1 and 7 combine with Prem 10mg/kg on day 4 and day 10 + cis 1.5 mg/kg on day 4 and 10','Virus expressing human GM-CSF gene','NA','NA','NA','NA','NA','NA','NA','NA','Mice xenograft for NCI-H226 (1.0E+6 cells)','5.0E+7 VP per tumor','Tumor volume regressed to 0.290compared to control 0.40 FTV','','Intratumoral','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_5005','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','Yes','Virus in combination with Pem 10 mg/kg + car 8mg/kg intrapertoneal on day 1 and 7','Virus expressing human GM-CSF gene','NA','NA','NA','NA','NA','NA','NA','NA','Mice xenograft for NCI-H226 (1.0E+6 cells)','5.0E+7 VP per tumor','Tumor volume regressed to 0.35 compared to control 0.40 FTV','','Intratumoral','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_5006','Adenovirus','ONCOS-102','DNA','Adenoviridae','Virus having 24 bp deletion in Rb binding site of E1A region and consisting of chmeric capsid protein and Human GM-CSF','Yes','Virus priming on day 1 and 7 combine with Prem 10mg/kg on day 4 and day 10 + cis 8 mg/kg on day 4 and 10','Virus expressing human GM-CSF gene','NA','NA','NA','NA','NA','NA','NA','NA','Mice xenograft for NCI-H226 (1.0E+6 cells)','5.0E+7 VP per tumor','Tumor volume regressed to 0.32 compared to control 0.40 FTV','','Intratumoral','Virus induce apoptosis','NA','NA','27287512'),
  ('OV_5007','Vaccinia virus','VG9','DNA','Poxviridae','None','Yes','No','No','ATCC','Murine melanoma cell line','B16','1.0E+4 cells per well','NA','MTT assay','0.1 MOI','35% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5008','Vaccinia virus','VG9','DNA','Poxviridae','None','Yes','No','No','ATCC','Murine melanoma cell line','B16','1.0E+4 cells per well','NA','MTT assay','1 MOI','22% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5009','Vaccinia virus','VG9','DNA','Poxviridae','None','Yes','No','No','ATCC','Murine melanoma cell line','B16','1.0E+4 cells per well','NA','MTT assay','10 MOI','20% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5010','Vaccinia virus','VG9-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Murine melanoma cell line','B16','1.0E+4 cells per well','NA','MTT assay','0.1 MOI','36% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5011','Vaccinia virus','VG9-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Murine melanoma cell line','B16','1.0E+4 cells per well','NA','MTT assay','1 MOI','24% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5012','Vaccinia virus','VG9-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Murine melanoma cell line','B16','1.0E+4 cells per well','NA','MTT assay','10 MOI','20% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5013','Vaccinia virus','WR-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Murine melanoma cell line','B16','1.0E+4 cells per well','NA','MTT assay','0.1 MOI','35% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5014','Vaccinia virus','WR-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Murine melanoma cell line','B16','1.0E+4 cells per well','NA','MTT assay','1 MOI','22% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5015','Vaccinia virus','WR-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Murine melanoma cell line','B16','1.0E+4 cells per well','NA','MTT assay','10 MOI','18% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5016','Vaccinia virus','VG9','DNA','Poxviridae','None','Yes','No','No','ATCC','Human lung cancer cell line','A549','1.0E+4 cells per well','NA','MTT assay','0.1 MOI','55% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5017','Vaccinia virus','VG9','DNA','Poxviridae','None','Yes','No','No','ATCC','Human lung cancer cell line','A549','1.0E+4 cells per well','NA','MTT assay','1 MOI','42% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5018','Vaccinia virus','VG9','DNA','Poxviridae','None','Yes','No','No','ATCC','Human lung cancer cell line','A549','1.0E+4 cells per well','NA','MTT assay','10 MOI','30% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5019','Vaccinia virus','VG9-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human lung cancer cell line','A549','1.0E+4 cells per well','NA','MTT assay','0.1 MOI','58% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5020','Vaccinia virus','VG9-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human lung cancer cell line','A549','1.0E+4 cells per well','NA','MTT assay','1 MOI','44% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5021','Vaccinia virus','VG9-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human lung cancer cell line','A549','1.0E+4 cells per well','NA','MTT assay','10 MOI','40% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5022','Vaccinia virus','WR-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human lung cancer cell line','A549','1.0E+4 cells per well','NA','MTT assay','0.1 MOI','58% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5023','Vaccinia virus','WR-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human lung cancer cell line','A549','1.0E+4 cells per well','NA','MTT assay','1 MOI','46% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5024','Vaccinia virus','WR-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human lung cancer cell line','A549','1.0E+4 cells per well','NA','MTT assay','10 MOI','40% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5025','Vaccinia virus','VG9','DNA','Poxviridae','None','Yes','No','No','ATCC','Human gastric carcinoma cell line','SCG-7901','1.0E+4 cells per well','NA','MTT assay','0.1 MOI','68% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5026','Vaccinia virus','VG9','DNA','Poxviridae','None','Yes','No','No','ATCC','Human gastric carcinoma cell line','SCG-7901','1.0E+4 cells per well','NA','MTT assay','1 MOI','36% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5027','Vaccinia virus','VG9','DNA','Poxviridae','None','Yes','No','No','ATCC','Human gastric carcinoma cell line','SCG-7901','1.0E+4 cells per well','NA','MTT assay','10 MOI','26% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5028','Vaccinia virus','VG9-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human gastric carcinoma cell line','SCG-7901','1.0E+4 cells per well','NA','MTT assay','0.1 MOI','68% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5029','Vaccinia virus','VG9-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human gastric carcinoma cell line','SCG-7901','1.0E+4 cells per well','NA','MTT assay','1 MOI','40% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5030','Vaccinia virus','VG9-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human gastric carcinoma cell line','SCG-7901','1.0E+4 cells per well','NA','MTT assay','10 MOI','20% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5031','Vaccinia virus','WR-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human gastric carcinoma cell line','SCG-7901','1.0E+4 cells per well','NA','MTT assay','0.1 MOI','65% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5032','Vaccinia virus','WR-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human gastric carcinoma cell line','SCG-7901','1.0E+4 cells per well','NA','MTT assay','1 MOI','36% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5033','Vaccinia virus','WR-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human gastric carcinoma cell line','SCG-7901','1.0E+4 cells per well','NA','MTT assay','10 MOI','22% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5034','Vaccinia virus','VG9','DNA','Poxviridae','None','Yes','No','No','ATCC','Murine hepatoma cell line','Hepal-6','1.0E+4 cells per well','NA','MTT assay','0.1 MOI','50% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5035','Vaccinia virus','VG9','DNA','Poxviridae','None','Yes','No','No','ATCC','Murine hepatoma cell line','Hepal-6','1.0E+4 cells per well','NA','MTT assay','1 MOI','40% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5036','Vaccinia virus','VG9','DNA','Poxviridae','None','Yes','No','No','ATCC','Murine hepatoma cell line','Hepal-6','1.0E+4 cells per well','NA','MTT assay','10 MOI','25% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5037','Vaccinia virus','VG9-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Murine hepatoma cell line','Hepal-6','1.0E+4 cells per well','NA','MTT assay','0.1 MOI','52% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5038','Vaccinia virus','VG9-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Murine hepatoma cell line','Hepal-6','1.0E+4 cells per well','NA','MTT assay','1 MOI','38% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5039','Vaccinia virus','VG9-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Murine hepatoma cell line','Hepal-6','1.0E+4 cells per well','NA','MTT assay','10 MOI','25% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5040','Vaccinia virus','WR-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Murine hepatoma cell line','Hepal-6','1.0E+4 cells per well','NA','MTT assay','0.1 MOI','51% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5041','Vaccinia virus','WR-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Murine hepatoma cell line','Hepal-6','1.0E+4 cells per well','NA','MTT assay','1 MOI','38% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5042','Vaccinia virus','WR-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Murine hepatoma cell line','Hepal-6','1.0E+4 cells per well','NA','MTT assay','10 MOI','21% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5043','Vaccinia virus','VG9','DNA','Poxviridae','None','Yes','No','No','ATCC','Human breast adenocarcinoma cell line','MDA-MB-231','1.0E+4 cells per well','NA','MTT assay','0.1 MOI','40% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5044','Vaccinia virus','VG9','DNA','Poxviridae','None','Yes','No','No','ATCC','Human breast adenocarcinoma cell line','MDA-MB-231','1.0E+4 cells per well','NA','MTT assay','1 MOI','30% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5045','Vaccinia virus','VG9','DNA','Poxviridae','None','Yes','No','No','ATCC','Human breast adenocarcinoma cell line','MDA-MB-231','1.0E+4 cells per well','NA','MTT assay','10 MOI','20% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5046','Vaccinia virus','VG9-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human breast adenocarcinoma cell line','MDA-MB-231','1.0E+4 cells per well','NA','MTT assay','0.1 MOI','30% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5047','Vaccinia virus','VG9-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human breast adenocarcinoma cell line','MDA-MB-231','1.0E+4 cells per well','NA','MTT assay','1 MOI','30% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5048','Vaccinia virus','VG9-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human breast adenocarcinoma cell line','MDA-MB-231','1.0E+4 cells per well','NA','MTT assay','10 MOI','20% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5049','Vaccinia virus','WR-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human breast adenocarcinoma cell line','MDA-MB-231','1.0E+4 cells per well','NA','MTT assay','0.1 MOI','30% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5050','Vaccinia virus','WR-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human breast adenocarcinoma cell line','MDA-MB-231','1.0E+4 cells per well','NA','MTT assay','1 MOI','30% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5051','Vaccinia virus','WR-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human breast adenocarcinoma cell line','MDA-MB-231','1.0E+4 cells per well','NA','MTT assay','10 MOI','20% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5052','Vaccinia virus','VG9','DNA','Poxviridae','None','Yes','No','No','ATCC','Human hepatocellular carcinoma cell line','SMMC7721','1.0E+4 cells per well','NA','MTT assay','0.1 MOI','50% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5053','Vaccinia virus','VG9','DNA','Poxviridae','None','Yes','No','No','ATCC','Human hepatocellular carcinoma cell line','SMMC7721','1.0E+4 cells per well','NA','MTT assay','1 MOI','35% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5054','Vaccinia virus','VG9','DNA','Poxviridae','None','Yes','No','No','ATCC','Human hepatocellular carcinoma cell line','SMMC7721','1.0E+4 cells per well','NA','MTT assay','10 MOI','20% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5055','Vaccinia virus','VG9-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human hepatocellular carcinoma cell line','SMMC7721','1.0E+4 cells per well','NA','MTT assay','0.1 MOI','50% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5056','Vaccinia virus','VG9-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human hepatocellular carcinoma cell line','SMMC7721','1.0E+4 cells per well','NA','MTT assay','1 MOI','35% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5057','Vaccinia virus','VG9-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human hepatocellular carcinoma cell line','SMMC7721','1.0E+4 cells per well','NA','MTT assay','10 MOI','22% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5058','Vaccinia virus','WR-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human hepatocellular carcinoma cell line','SMMC7721','1.0E+4 cells per well','NA','MTT assay','0.1 MOI','50% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5059','Vaccinia virus','WR-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human hepatocellular carcinoma cell line','SMMC7721','1.0E+4 cells per well','NA','MTT assay','1 MOI','35% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5060','Vaccinia virus','WR-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','ATCC','Human hepatocellular carcinoma cell line','SMMC7721','1.0E+4 cells per well','NA','MTT assay','10 MOI','21% cell viability after 3 days','No','No','NA','No response','NA','NA','NA','NA','28465492'),
  ('OV_5061','Vaccinia virus','VG9-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','C56BL/6 mice xenograft for SMMC-7721 (1.0E+6 cells )','1.0E+7 pfu','NA','Prolongs the survival time','Intratumoral','NA','NA','NA','28465492'),
  ('OV_5062','Vaccinia virus','WR-EGFP','DNA','Poxviridae','Addition of EGFP gene in tk locus','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','C56BL/6 mice xenograft for SMMC-7721 (1.0E+6 cells )','1.0E+7 pfu','NA','Prolongs the survival time','Intratumoral','NA','NA','NA','28465492'),
  ('OV_5063','Avian orthoreovirus','ARV-PB1','RNA','Reoviridae','None','Yes','No','No','ATCC','Murine lymphocytic leukemia cell line','L1210','1.0E+3 cells per well','NA','Crystal violet staining','10 MOI','96% cell viability after 96 hours','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28441762'),
  ('OV_5064','Avian orthoreovirus','ARV-PB1','RNA','Reoviridae','None','Yes','No','No','ATCC','Murine ovarian cell line','ID8','1.0E+3 cells per well','NA','Crystal violet staining','10 MOI','100% cell viability after 96 hours','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28441762'),
  ('OV_5065','Avian orthoreovirus','ARV-PB1','RNA','Reoviridae','None','Yes','No','No','ATCC','Human pancreatic cancer cell line','PC-3','1.0E+3 cells per well','NA','Crystal violet staining','10 MOI','80% cell viability after 96 hours','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28441762'),
  ('OV_5066','Avian orthoreovirus','ARV-PB1','RNA','Reoviridae','None','Yes','No','No','ATCC','Human cervical cancer cell line','HeLa','1.0E+3 cells per well','NA','Crystal violet staining','10 MOI','50% cell viability after 96 hours','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28441762'),
  ('OV_5067','Avian orthoreovirus','ARV-PB1','RNA','Reoviridae','None','Yes','No','No','ATCC','Mycobacterium tubeculosis cell line','22RV1','1.0E+3 cells per well','NA','Crystal violet staining','10 MOI','40% cell viability after 96 hours','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28441762'),
  ('OV_5068','Avian orthoreovirus','ARV-PB1','RNA','Reoviridae','None','Yes','No','No','ATCC','Human prostate cancer cell line','Du145','1.0E+3 cells per well','NA','Crystal violet staining','10 MOI','70% cell viability after 96 hours','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28441762'),
  ('OV_5069','Avian orthoreovirus','ARV-PB1','RNA','Reoviridae','None','Yes','No','No','ATCC','Human colorectal cancer cell line','HCT-116','1.0E+3 cells per well','NA','Crystal violet staining','10 MOI','100% cell viability after 96 hours','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28441762'),
  ('OV_5070','Avian orthoreovirus','ARV-PB1','RNA','Reoviridae','None','Yes','No','No','ATCC','Human lung carcinoma cell line','A549','1.0E+3 cells per well','NA','Crystal violet staining','10 MOI','80% cell viability after 96 hours','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28441762'),
  ('OV_5071','Avian orthoreovirus','ARV-PB1','RNA','Reoviridae','None','Yes','No','No','ATCC','Human epithelial ovarian carcinoma','SKOV3','1.0E+3 cells per well','NA','Crystal violet staining','10 MOI','70% cell viability after 96 hours','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28441762'),
  ('OV_5072','Adenovirus','ZD-55-TRAIl-IETD-smac','DNA','Adenoviridae','Addition of TRAIL and smac gene via IETD linker','Yes','No','Virus expressing TRAIL gene','Shanghai cell collection','Human pancreatic cancer cell line','BxPC-3','1.0E+4 cells per well','NA','MTT assay','1 MOI','100% cell viability','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28440486'),
  ('OV_5073','Adenovirus','ZD-55-TRAIl-IETD-smac','DNA','Adenoviridae','Addition of TRAIL and smac gene via IETD linker','Yes','No','Virus expressing TRAIL gene','Shanghai cell collection','Human pancreatic cancer cell line','BxPC-3','1.0E+4 cells per well','NA','MTT assay','2 MOI','98% cell viability','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28440486'),
  ('OV_5074','Adenovirus','ZD-55-TRAIl-IETD-smac','DNA','Adenoviridae','Addition of TRAIL and smac gene via IETD linker','Yes','No','Virus expressing TRAIL gene','Shanghai cell collection','Human pancreatic cancer cell line','BxPC-3','1.0E+4 cells per well','NA','MTT assay','4 MOI','70% cell viability','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28440486'),
  ('OV_5075','Adenovirus','ZD-55-TRAIl-IETD-smac','DNA','Adenoviridae','Addition of TRAIL and smac gene via IETD linker','Yes','No','Virus expressing TRAIL gene','Shanghai cell collection','Human pancreatic cancer cell line','BxPC-3','1.0E+4 cells per well','NA','MTT assay','8 MOI','60% cell viability','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28440486'),
  ('OV_5076','Adenovirus','ZD-55-TRAIl-IETD-smac','DNA','Adenoviridae','Addition of TRAIL and smac gene via IETD linker','Yes','No','Virus expressing TRAIL gene','Shanghai cell collection','Human pancreatic cancer cell line','BxPC-3','1.0E+4 cells per well','NA','MTT assay','16 MOI','55% cell viability','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28440486'),
  ('OV_5077','Adenovirus','ZD-55-TRAIl-IETD-smac','DNA','Adenoviridae','Addition of TRAIL and smac gene via IETD linker','Yes','Virus in combination with SNS032 5ng/ml','Virus expressing TRAIL gene','Shanghai cell collection','Human pancreatic cancer cell line','BxPC-3','1.0E+4 cells per well','NA','MTT assay','1 MOI','55% cell viability','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28440486'),
  ('OV_5078','Adenovirus','ZD-55-TRAIl-IETD-smac','DNA','Adenoviridae','Addition of TRAIL and smac gene via IETD linker','Yes','Virus in combination with SNS032 10ng/ml','Virus expressing TRAIL gene','Shanghai cell collection','Human pancreatic cancer cell line','BxPC-3','1.0E+4 cells per well','NA','MTT assay','2 MOI','45% cell viability','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28440486'),
  ('OV_5079','Adenovirus','ZD-55-TRAIl-IETD-smac','DNA','Adenoviridae','Addition of TRAIL and smac gene via IETD linker','Yes','Virus in combination with SNS032 20ng/ml','Virus expressing TRAIL gene','Shanghai cell collection','Human pancreatic cancer cell line','BxPC-3','1.0E+4 cells per well','NA','MTT assay','4 MOI','30% cell viability','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28440486'),
  ('OV_5080','Adenovirus','ZD-55-TRAIl-IETD-smac','DNA','Adenoviridae','Addition of TRAIL and smac gene via IETD linker','Yes','Virus in combination with SNS032 40ng/ml','Virus expressing TRAIL gene','Shanghai cell collection','Human pancreatic cancer cell line','BxPC-3','1.0E+4 cells per well','NA','MTT assay','8 MOI','20% cell viability','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28440486'),
  ('OV_5081','Adenovirus','ZD-55-TRAIl-IETD-smac','DNA','Adenoviridae','Addition of TRAIL and smac gene via IETD linker','Yes','Virus in combination with SNS032 80ng/ml','Virus expressing TRAIL gene','Shanghai cell collection','Human pancreatic cancer cell line','BxPC-3','1.0E+4 cells per well','NA','MTT assay','16 MOI','10% cell viability','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28440486'),
  ('OV_5082','Adenovirus','ZD-55-TRAIl-IETD-smac','DNA','Adenoviridae','Addition of TRAIL and smac gene via IETD linker','Yes','No','Virus expressing TRAIL gene','Shanghai cell collection','Human pancreatic cancer cell line','PANC-1','1.0E+4 cells per well','NA','MTT assay','1 MOI','100% cell viability','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28440486'),
  ('OV_5083','Adenovirus','ZD-55-TRAIl-IETD-smac','DNA','Adenoviridae','Addition of TRAIL and smac gene via IETD linker','Yes','No','Virus expressing TRAIL gene','Shanghai cell collection','Human pancreatic cancer cell line','PANC-1','1.0E+4 cells per well','NA','MTT assay','2 MOI','80% cell viability','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28440486'),
  ('OV_5084','Adenovirus','ZD-55-TRAIl-IETD-smac','DNA','Adenoviridae','Addition of TRAIL and smac gene via IETD linker','Yes','No','Virus expressing TRAIL gene','Shanghai cell collection','Human pancreatic cancer cell line','PANC-1','1.0E+4 cells per well','NA','MTT assay','4 MOI','70% cell viability','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28440486'),
  ('OV_5085','Adenovirus','ZD-55-TRAIl-IETD-smac','DNA','Adenoviridae','Addition of TRAIL and smac gene via IETD linker','Yes','No','Virus expressing TRAIL gene','Shanghai cell collection','Human pancreatic cancer cell line','PANC-1','1.0E+4 cells per well','NA','MTT assay','8 MOI','60% cell viability','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28440486'),
  ('OV_5086','Adenovirus','ZD-55-TRAIl-IETD-smac','DNA','Adenoviridae','Addition of TRAIL and smac gene via IETD linker','Yes','No','Virus expressing TRAIL gene','Shanghai cell collection','Human pancreatic cancer cell line','PANC-1','1.0E+4 cells per well','NA','MTT assay','16 MOI','60% cell viability','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28440486'),
  ('OV_5087','Adenovirus','ZD-55-TRAIl-IETD-smac','DNA','Adenoviridae','Addition of TRAIL and smac gene via IETD linker','Yes','Virus in combination with SNS032 5ng/ml','Virus expressing TRAIL gene','Shanghai cell collection','Human pancreatic cancer cell line','PANC-1','1.0E+4 cells per well','NA','MTT assay','1 MOI','70% cell viability','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28440486'),
  ('OV_5088','Adenovirus','ZD-55-TRAIl-IETD-smac','DNA','Adenoviridae','Addition of TRAIL and smac gene via IETD linker','Yes','Virus in combination with SNS032 10ng/ml','Virus expressing TRAIL gene','Shanghai cell collection','Human pancreatic cancer cell line','PANC-1','1.0E+4 cells per well','NA','MTT assay','2 MOI','60% cell viability','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28440486'),
  ('OV_5089','Adenovirus','ZD-55-TRAIl-IETD-smac','DNA','Adenoviridae','Addition of TRAIL and smac gene via IETD linker','Yes','Virus in combination with SNS032 20ng/ml','Virus expressing TRAIL gene','Shanghai cell collection','Human pancreatic cancer cell line','PANC-1','1.0E+4 cells per well','NA','MTT assay','4 MOI','50% cell viability','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28440486'),
  ('OV_5090','Adenovirus','ZD-55-TRAIl-IETD-smac','DNA','Adenoviridae','Addition of TRAIL and smac gene via IETD linker','Yes','Virus in combination with SNS032 40ng/ml','Virus expressing TRAIL gene','Shanghai cell collection','Human pancreatic cancer cell line','PANC-1','1.0E+4 cells per well','NA','MTT assay','8 MOI','40% cell viability','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28440486'),
  ('OV_5091','Adenovirus','ZD-55-TRAIl-IETD-smac','DNA','Adenoviridae','Addition of TRAIL and smac gene via IETD linker','Yes','Virus in combination with SNS032 80ng/ml','Virus expressing TRAIL gene','Shanghai cell collection','Human pancreatic cancer cell line','PANC-1','1.0E+4 cells per well','NA','MTT assay','16 MOI','30% cell viability','No','No','NA','No response','NA','Induction of apoptosis','Induction of Interferon related gene expression','NA','28440486'),
  ('OV_5092','Vaccinia virus','vvdd-tdTomato-hDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of human DAI','Yes','No','Virus expressing human DAI gene','ATCC','Human melanoma cell line','HS294T','1.0E+4 cells per well','NA','MTS assay','0.001 MOI','70% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5093','Vaccinia virus','vvdd-tdTomato-hDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of human DAI','Yes','No','Virus expressing human DAI gene','ATCC','Human melanoma cell line','HS294T','1.0E+4 cells per well','NA','MTS assay','0.01 MOI','50% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5094','Vaccinia virus','vvdd-tdTomato-hDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of human DAI','Yes','No','Virus expressing human DAI gene','ATCC','Human melanoma cell line','HS294T','1.0E+4 cells per well','NA','MTS assay','0.1 MOI','20% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5095','Vaccinia virus','vvdd-tdTomato-hDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of human DAI','Yes','No','Virus expressing human DAI gene','ATCC','Human melanoma cell line','HS294T','1.0E+4 cells per well','NA','MTS assay','1 MOI','10% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5096','Vaccinia virus','vvdd-tdTomato-mDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of murine DAI','Yes','No','Virus expressing murine DAI gene','ATCC','Human melanoma cell line','HS294T','1.0E+4 cells per well','NA','MTS assay','0.001 MOI','70% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5097','Vaccinia virus','vvdd-tdTomato-mDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of murine DAI','Yes','No','Virus expressing murine DAI gene','ATCC','Human melanoma cell line','HS294T','1.0E+4 cells per well','NA','MTS assay','0.01 MOI','60% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5098','Vaccinia virus','vvdd-tdTomato-mDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of murine DAI','Yes','No','Virus expressing murine DAI gene','ATCC','Human melanoma cell line','HS294T','1.0E+4 cells per well','NA','MTS assay','0.1 MOI','40% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5099','Vaccinia virus','vvdd-tdTomato-mDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of murine DAI','Yes','No','Virus expressing murine DAI gene','ATCC','Human melanoma cell line','HS294T','1.0E+4 cells per well','NA','MTS assay','1 MOI','10% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5100','Vaccinia virus','vvdd-tdTomato-hDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of human DAI','Yes','No','Virus expressing human DAI gene','ATCC','Human melanoma cell line','A2058','1.0E+4 cells per well','NA','MTS assay','0.001 MOI','60% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5101','Vaccinia virus','vvdd-tdTomato-hDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of human DAI','Yes','No','Virus expressing human DAI gene','ATCC','Human melanoma cell line','A2058','1.0E+4 cells per well','NA','MTS assay','0.01 MOI','30% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5102','Vaccinia virus','vvdd-tdTomato-hDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of human DAI','Yes','No','Virus expressing human DAI gene','ATCC','Human melanoma cell line','A2058','1.0E+4 cells per well','NA','MTS assay','0.1 MOI','10% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5103','Vaccinia virus','vvdd-tdTomato-hDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of human DAI','Yes','No','Virus expressing human DAI gene','ATCC','Human melanoma cell line','A2058','1.0E+4 cells per well','NA','MTS assay','1 MOI','100% cell killing','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5104','Vaccinia virus','vvdd-tdTomato-mDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of murine DAI','Yes','No','Virus expressing murine DAI gene','ATCC','Human melanoma cell line','A2058','1.0E+4 cells per well','NA','MTS assay','0.001 MOI','80% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5105','Vaccinia virus','vvdd-tdTomato-mDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of murine DAI','Yes','No','Virus expressing murine DAI gene','ATCC','Human melanoma cell line','A2058','1.0E+4 cells per well','NA','MTS assay','0.01 MOI','30% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5106','Vaccinia virus','vvdd-tdTomato-mDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of murine DAI','Yes','No','Virus expressing murine DAI gene','ATCC','Human melanoma cell line','A2058','1.0E+4 cells per well','NA','MTS assay','0.1 MOI','10% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5107','Vaccinia virus','vvdd-tdTomato-mDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of murine DAI','Yes','No','Virus expressing murine DAI gene','ATCC','Human melanoma cell line','A2058','1.0E+4 cells per well','NA','MTS assay','1 MOI','100% cell killing','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5108','Vaccinia virus','vvdd-tdTomato-hDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of human DAI','Yes','No','Virus expressing human DAI gene','ATCC','Human lung cancer cell line','A549','1.0E+4 cells per well','NA','MTS assay','0.001 MOI','100% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5109','Vaccinia virus','vvdd-tdTomato-hDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of human DAI','Yes','No','Virus expressing human DAI gene','ATCC','Human lung cancer cell line','A549','1.0E+4 cells per well','NA','MTS assay','0.01 MOI','80% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5110','Vaccinia virus','vvdd-tdTomato-hDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of human DAI','Yes','No','Virus expressing human DAI gene','ATCC','Human lung cancer cell line','A549','1.0E+4 cells per well','NA','MTS assay','0.1 MOI','50% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5111','Vaccinia virus','vvdd-tdTomato-hDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of human DAI','Yes','No','Virus expressing human DAI gene','ATCC','Human lung cancer cell line','A549','1.0E+4 cells per well','NA','MTS assay','1 MOI','10% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5112','Vaccinia virus','vvdd-tdTomato-mDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of murine DAI','Yes','No','Virus expressing murine DAI gene','ATCC','Human lung cancer cell line','A549','1.0E+4 cells per well','NA','MTS assay','0.001 MOI','100% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5113','Vaccinia virus','vvdd-tdTomato-mDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of murine DAI','Yes','No','Virus expressing murine DAI gene','ATCC','Human lung cancer cell line','A549','1.0E+4 cells per well','NA','MTS assay','0.01 MOI','100% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5114','Vaccinia virus','vvdd-tdTomato-mDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of murine DAI','Yes','No','Virus expressing murine DAI gene','ATCC','Human lung cancer cell line','A549','1.0E+4 cells per well','NA','MTS assay','0.1 MOI','60% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5115','Vaccinia virus','vvdd-tdTomato-mDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of murine DAI','Yes','No','Virus expressing murine DAI gene','ATCC','Human lung cancer cell line','A549','1.0E+4 cells per well','NA','MTS assay','1 MOI','10% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5116','Vaccinia virus','vvdd-tdTomato-hDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of human DAI','Yes','No','Virus expressing human DAI gene','ATCC','Human melanoma cell line','SK-MEL-2','1.0E+4 cells per well','NA','MTS assay','0.001 MOI','60% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5117','Vaccinia virus','vvdd-tdTomato-hDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of human DAI','Yes','No','Virus expressing human DAI gene','ATCC','Human melanoma cell line','SK-MEL-2','1.0E+4 cells per well','NA','MTS assay','0.01 MOI','40% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5118','Vaccinia virus','vvdd-tdTomato-hDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of human DAI','Yes','No','Virus expressing human DAI gene','ATCC','Human melanoma cell line','SK-MEL-2','1.0E+4 cells per well','NA','MTS assay','0.1 MOI','10% cell viability','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5119','Vaccinia virus','vvdd-tdTomato-hDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of human DAI','Yes','No','Virus expressing human DAI gene','ATCC','Human melanoma cell line','SK-MEL-2','1.0E+4 cells per well','NA','MTS assay','1 MOI','100% cell killing','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5120','Vaccinia virus','vvdd-tdTomato-mDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of murine DAI','Yes','No','Virus expressing murine DAI gene','ATCC','Human melanoma cell line','SK-MEL-2','1.0E+4 cells per well','NA','MTS assay','0.001 MOI','90% cell killing','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5121','Vaccinia virus','vvdd-tdTomato-mDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of murine DAI','Yes','No','Virus expressing murine DAI gene','ATCC','Human melanoma cell line','SK-MEL-2','1.0E+4 cells per well','NA','MTS assay','0.01 MOI','70% cell killing','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5122','Vaccinia virus','vvdd-tdTomato-mDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of murine DAI','Yes','No','Virus expressing murine DAI gene','ATCC','Human melanoma cell line','SK-MEL-2','1.0E+4 cells per well','NA','MTS assay','0.1 MOI','20% cell killing','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5123','Vaccinia virus','vvdd-tdTomato-mDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of murine DAI','Yes','No','Virus expressing murine DAI gene','ATCC','Human melanoma cell line','SK-MEL-2','1.0E+4 cells per well','NA','MTS assay','1 MOI','100% cell killing','No','No','NA','No response','NA','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5124','Vaccinia virus','vvdd-tdTomato-hDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of human DAI','Yes','No','Virus expressing human DAI gene','NA','NA','NA','NA','NA','NA','NA','NA','C57BL/6 mice xenograft for B16-OVA (1.0E+5 cells)','3.0E+6 on day 0 and 1.0E+6 on day 2','NA','Reduction in tumor volume to 100 cubic mm compared to control 500 cubic mm after 12 days','Intratumoral','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5125','Vaccinia virus','vvdd-tdTomato-mDAI','DNA','Poxviridae','Deletion of tk gene and vaccinia growth gene and addition of murine DAI','Yes','No','Virus expressing murine DAI gene','NA','NA','NA','NA','NA','NA','NA','NA','C57BL/6 mice xenograft for B16-OVA (1.0E+5 cells)','3.0E+6 on day 0 and 1.0E+6 on day 2','NA','Complete reduction in tumor volumecompared to control 500 cubic mm after 12 days','Intratumoral','NA','Induction of Immunogenic gene such as T cell activation','NA','27626058'),
  ('OV_5126','Semliki forest virus','wild type SFV4','RNA','Alphaviridae','None','Yes','No','No','NA','Murine neuroblastoma cell line','NXS2','20000 cells per well','NA','MTS assay','0.001 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5127','Semliki forest virus','wild type SFV4','RNA','Alphaviridae','None','Yes','No','No','NA','Murine neuroblastoma cell line','NXS2','20000 cells per well','NA','MTS assay','0.01 MOI','80% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5128','Semliki forest virus','wild type SFV4','RNA','Alphaviridae','None','Yes','No','No','NA','Murine neuroblastoma cell line','NXS2','20000 cells per well','NA','MTS assay','0.1 MOI','70% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5129','Semliki forest virus','wild type SFV4','RNA','Alphaviridae','None','Yes','No','No','NA','Murine neuroblastoma cell line','NXS2','20000 cells per well','NA','MTS assay','1 MOI','42% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5130','Semliki forest virus','wild type SFV4','RNA','Alphaviridae','None','Yes','No','No','NA','Murine neuroblastoma cell line','NXS2','20000 cells per well','NA','MTS assay','10 MOI','30% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5131','Semliki forest virus','SFVmiRT','RNA','Alphaviridae','Insertional mutagenesis at 3UTr for miR124, 125 and 134','Yes','No','No','NA','Murine neuroblastoma cell line','NXS2','20000 cells per well','NA','MTS assay','0.001 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5132','Semliki forest virus','SFVmiRT','RNA','Alphaviridae','Insertional mutagenesis at 3UTr for miR124, 125 and 134','Yes','No','No','NA','Murine neuroblastoma cell line','NXS2','20000 cells per well','NA','MTS assay','0.01 MOI','82% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5133','Semliki forest virus','SFVmiRT','RNA','Alphaviridae','Insertional mutagenesis at 3UTr for miR124, 125 and 134','Yes','No','No','NA','Murine neuroblastoma cell line','NXS2','20000 cells per well','NA','MTS assay','0.1 MOI','71% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5134','Semliki forest virus','SFVmiRT','RNA','Alphaviridae','Insertional mutagenesis at 3UTr for miR124, 125 and 134','Yes','No','No','NA','Murine neuroblastoma cell line','NXS2','20000 cells per well','NA','MTS assay','1 MOI','44% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5135','Semliki forest virus','SFVmiRT','RNA','Alphaviridae','Insertional mutagenesis at 3UTr for miR124, 125 and 134','Yes','No','No','NA','Murine neuroblastoma cell line','NXS2','20000 cells per well','NA','MTS assay','10 MOI','30% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5136','Semliki forest virus','wild type SFV4','RNA','Alphaviridae','None','Yes','No','No','NA','Murine glioma cell line','GL261','20000 cells per well','NA','MTS assay','0.001 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5137','Semliki forest virus','wild type SFV4','RNA','Alphaviridae','None','Yes','No','No','NA','Murine glioma cell line','GL261','20000 cells per well','NA','MTS assay','0.01 MOI','90% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5138','Semliki forest virus','wild type SFV4','RNA','Alphaviridae','None','Yes','No','No','NA','Murine glioma cell line','GL261','20000 cells per well','NA','MTS assay','0.1 MOI','88% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5139','Semliki forest virus','wild type SFV4','RNA','Alphaviridae','None','Yes','No','No','NA','Murine glioma cell line','GL261','20000 cells per well','NA','MTS assay','1 MOI','70% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5140','Semliki forest virus','wild type SFV4','RNA','Alphaviridae','None','Yes','No','No','NA','Murine glioma cell line','GL261','20000 cells per well','NA','MTS assay','10 MOI','60% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5141','Semliki forest virus','SFVmiRT','RNA','Alphaviridae','Insertional mutagenesis at 3UTr for miR124, 125 and 134','Yes','No','No','NA','Murine glioma cell line','GL261','20000 cells per well','NA','MTS assay','0.001 MOI','88% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5142','Semliki forest virus','SFVmiRT','RNA','Alphaviridae','Insertional mutagenesis at 3UTr for miR124, 125 and 134','Yes','No','No','NA','Murine glioma cell line','GL261','20000 cells per well','NA','MTS assay','0.01 MOI','80% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5143','Semliki forest virus','SFVmiRT','RNA','Alphaviridae','Insertional mutagenesis at 3UTr for miR124, 125 and 134','Yes','No','No','NA','Murine glioma cell line','GL261','20000 cells per well','NA','MTS assay','0.1 MOI','80% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5144','Semliki forest virus','SFVmiRT','RNA','Alphaviridae','Insertional mutagenesis at 3UTr for miR124, 125 and 134','Yes','No','No','NA','Murine glioma cell line','GL261','20000 cells per well','NA','MTS assay','1 MOI','70% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5145','Semliki forest virus','SFVmiRT','RNA','Alphaviridae','Insertional mutagenesis at 3UTr for miR124, 125 and 134','Yes','No','No','NA','Murine glioma cell line','GL261','20000 cells per well','NA','MTS assay','10 MOI','60% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5146','Semliki forest virus','wild type SFV4','RNA','Alphaviridae','None','Yes','No','No','NA','Murine glioma cell line','CT-2A','20000 cells per well','NA','MTS assay','0.001 MOI','5% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5147','Semliki forest virus','wild type SFV4','RNA','Alphaviridae','None','Yes','No','No','NA','Murine glioma cell line','CT-2A','20000 cells per well','NA','MTS assay','0.01 MOI','5% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5148','Semliki forest virus','wild type SFV4','RNA','Alphaviridae','None','Yes','No','No','NA','Murine glioma cell line','CT-2A','20000 cells per well','NA','MTS assay','0.1 MOI','5% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5149','Semliki forest virus','wild type SFV4','RNA','Alphaviridae','None','Yes','No','No','NA','Murine glioma cell line','CT-2A','20000 cells per well','NA','MTS assay','1 MOI','5% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5150','Semliki forest virus','wild type SFV4','RNA','Alphaviridae','None','Yes','No','No','NA','Murine glioma cell line','CT-2A','20000 cells per well','NA','MTS assay','10 MOI','5% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5151','Semliki forest virus','SFVmiRT','RNA','Alphaviridae','Insertional mutagenesis at 3UTr for miR124, 125 and 134','Yes','No','No','NA','Murine glioma cell line','CT-2A','20000 cells per well','NA','MTS assay','0.001 MOI','5% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5152','Semliki forest virus','SFVmiRT','RNA','Alphaviridae','Insertional mutagenesis at 3UTr for miR124, 125 and 134','Yes','No','No','NA','Murine glioma cell line','CT-2A','20000 cells per well','NA','MTS assay','0.01 MOI','5% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5153','Semliki forest virus','SFVmiRT','RNA','Alphaviridae','Insertional mutagenesis at 3UTr for miR124, 125 and 134','Yes','No','No','NA','Murine glioma cell line','CT-2A','20000 cells per well','NA','MTS assay','0.1 MOI','5% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5154','Semliki forest virus','SFVmiRT','RNA','Alphaviridae','Insertional mutagenesis at 3UTr for miR124, 125 and 134','Yes','No','No','NA','Murine glioma cell line','CT-2A','20000 cells per well','NA','MTS assay','1 MOI','5% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5155','Semliki forest virus','SFVmiRT','RNA','Alphaviridae','Insertional mutagenesis at 3UTr for miR124, 125 and 134','Yes','No','No','NA','Murine glioma cell line','CT-2A','20000 cells per well','NA','MTS assay','10 MOI','5% cell viability after 72 hours','No','No','NA','No response','NA','NA','Induce production of IFN gamma','NA','27637889'),
  ('OV_5156','Adenovirus','Ad-ZD55-miR143','DNA','Adenoviridae','Insertion of miR143 in adenovirus via homologus recombination','Yes','No','No','Chinese academy of science','Human colorectal cancer cell line','SW480','NA','NA','Crystal violet staining','0.01 MOI','100% cell viability','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27725862'),
  ('OV_5157','Adenovirus','Ad-ZD55-miR143','DNA','Adenoviridae','Insertion of miR143 in adenovirus via homologus recombination','Yes','No','No','Chinese academy of science','Human colorectal cancer cell line','SW480','NA','NA','Crystal violet staining','0.5 MOI','50% cell viability','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27725862'),
  ('OV_5158','Adenovirus','Ad-ZD55-miR143','DNA','Adenoviridae','Insertion of miR143 in adenovirus via homologus recombination','Yes','No','No','Chinese academy of science','Human colorectal cancer cell line','SW480','NA','NA','Crystal violet staining','1 MOI','30% cell viability','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27725862'),
  ('OV_5159','Adenovirus','Ad-ZD55-miR143','DNA','Adenoviridae','Insertion of miR143 in adenovirus via homologus recombination','Yes','No','No','Chinese academy of science','Human colorectal cancer cell line','SW480','NA','NA','Crystal violet staining','10 MOI','100% cell killing','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27725862'),
  ('OV_5160','Vesicular stomatitis virus','VSV-deltaGP','RNA','Rhabdoviridae','Virus lacking envelope protein G','Yes','No','No','University of vienna','Human ovarian cancer cell line','A2780','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','40% cell viable after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5161','Vesicular stomatitis virus','VSV-MqdeltaG','RNA','Rhabdoviridae','Attenuated strain with 4 mutation in M protein and lacking G protein','Yes','No','No','University of vienna','Human ovarian cancer cell line','A2780','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','60% cell viable after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5162','Vesicular stomatitis virus','VSV-deltaGP','RNA','Rhabdoviridae','Virus lacking envelope protein G','Yes','No','No','University of vienna','Human ovarian cancer cell line','A2780','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','100% cell killing after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5163','Vesicular stomatitis virus','VSV-MqdeltaG','RNA','Rhabdoviridae','Attenuated strain with 4 mutation in M protein and lacking G protein','Yes','No','No','University of vienna','Human ovarian cancer cell line','A2780','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','100% cell killing after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5164','Vesicular stomatitis virus','VSV-deltaGP','RNA','Rhabdoviridae','Virus lacking envelope protein G','Yes','No','No','University of vienna','Human ovarian cancer cell line','SKOV6','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','70% cell viable after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5165','Vesicular stomatitis virus','VSV-MqdeltaG','RNA','Rhabdoviridae','Attenuated strain with 4 mutation in M protein and lacking G protein','Yes','No','No','University of vienna','Human ovarian cancer cell line','SKOV6','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','70% cell viable after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5166','Vesicular stomatitis virus','VSV-deltaGP','RNA','Rhabdoviridae','Virus lacking envelope protein G','Yes','No','No','University of vienna','Human ovarian cancer cell line','SKOV6','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','30% cell viable after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5167','Vesicular stomatitis virus','VSV-MqdeltaG','RNA','Rhabdoviridae','Attenuated strain with 4 mutation in M protein and lacking G protein','Yes','No','No','University of vienna','Human ovarian cancer cell line','SKOV6','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','20% cell viable after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5168','Vesicular stomatitis virus','VSV-deltaGP','RNA','Rhabdoviridae','Virus lacking envelope protein G','Yes','No','No','University of vienna','Human ovarian cancer cell line','SKOV6','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','10% cell viable after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5169','Vesicular stomatitis virus','VSV-MqdeltaG','RNA','Rhabdoviridae','Attenuated strain with 4 mutation in M protein and lacking G protein','Yes','No','No','University of vienna','Human ovarian cancer cell line','SKOV6','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','15% cell viable after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5170','Vesicular stomatitis virus','VSV-deltaGP','RNA','Rhabdoviridae','Virus lacking envelope protein G','Yes','No','No','University of vienna','Human ovarian cancer cell line','HOC7','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','90% cell viable after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5171','Vesicular stomatitis virus','VSV-MqdeltaG','RNA','Rhabdoviridae','Attenuated strain with 4 mutation in M protein and lacking G protein','Yes','No','No','University of vienna','Human ovarian cancer cell line','HOC7','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','90% cell viable after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5172','Vesicular stomatitis virus','VSV-deltaGP','RNA','Rhabdoviridae','Virus lacking envelope protein G','Yes','No','No','University of vienna','Human ovarian cancer cell line','HOC7','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','60% cell viable after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5173','Vesicular stomatitis virus','VSV-MqdeltaG','RNA','Rhabdoviridae','Attenuated strain with 4 mutation in M protein and lacking G protein','Yes','No','No','University of vienna','Human ovarian cancer cell line','HOC7','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','50% cell viable after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5174','Vesicular stomatitis virus','VSV-deltaGP','RNA','Rhabdoviridae','Virus lacking envelope protein G','Yes','No','No','University of vienna','Human ovarian cancer cell line','HOC7','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','40% cell viable after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5175','Vesicular stomatitis virus','VSV-MqdeltaG','RNA','Rhabdoviridae','Attenuated strain with 4 mutation in M protein and lacking G protein','Yes','No','No','University of vienna','Human ovarian cancer cell line','HOC7','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','40% cell viable after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5176','Vesicular stomatitis virus','VSV-deltaGP','RNA','Rhabdoviridae','Virus lacking envelope protein G','Yes','No','No','ATCC','Human ovarian cancer cell line','OVCAR3','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','100% cell viable after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5177','Vesicular stomatitis virus','VSV-MqdeltaG','RNA','Rhabdoviridae','Attenuated strain with 4 mutation in M protein and lacking G protein','Yes','No','No','ATCC','Human ovarian cancer cell line','OVCAR3','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','100% cell viable after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5178','Vesicular stomatitis virus','VSV-deltaGP','RNA','Rhabdoviridae','Virus lacking envelope protein G','Yes','No','No','ATCC','Human ovarian cancer cell line','OVCAR3','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','100% cell viable after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5179','Vesicular stomatitis virus','VSV-MqdeltaG','RNA','Rhabdoviridae','Attenuated strain with 4 mutation in M protein and lacking G protein','Yes','No','No','ATCC','Human ovarian cancer cell line','OVCAR3','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','20% cell viable after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5180','Vesicular stomatitis virus','VSV-deltaGP','RNA','Rhabdoviridae','Virus lacking envelope protein G','Yes','No','No','ATCC','Human ovarian cancer cell line','OVCAR3','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','80% cell viable after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5181','Vesicular stomatitis virus','VSV-MqdeltaG','RNA','Rhabdoviridae','Attenuated strain with 4 mutation in M protein and lacking G protein','Yes','No','No','ATCC','Human ovarian cancer cell line','OVCAR3','1.0E+5 cells per well','NA','WST-1 assay','1 MOI','10% cell viable after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27738655'),
  ('OV_5182','Vesicular stomatitis virus','VSV-deltaGP','RNA','Rhabdoviridae','Virus lacking envelope protein G','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','SCID mice xenograft for A2780 (5.0E+6 cells)','2.0E+5 pfu','NA','Reduction in tumor volume to 0.1 cubic cm compared to control 0.7 cubic cm','Intratumoral','NA','NA','NA','27738655'),
  ('OV_5183','Vesicular stomatitis virus','VSV-MqdeltaG','RNA','Rhabdoviridae','Attenuated strain with 4 mutation in M protein and lacking G protein','No','Virus in combination with Ruxolinitib 1 micromolar per litre','No','NA','NA','NA','NA','NA','NA','NA','NA','SCID mice xenograft for A2780 (5.0E+6 cells)','2.0E+5 pfu','NA','Reduction in tumor volume to 0.1 cubic cm compared to control 0.7 cubic cm and increase in survival time to beyond 100 days compared to drug and alone','Intratumoral','NA','NA','NA','27738655'),
  ('OV_5184','Tanapoxvirus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic nude mice CrlNU-Foxn1 xenograft for cellosaurus cell line 5.0E+6 cells','5.0E+6 pfu','NA','Reduction in tumor growth 250 compared to 550 after 34 days','Intratumoral','NA','NA','NA','27738905'),
  ('OV_5185','Tanapoxvirus','TPV-delta15L','DNA','Poxviridae','Deletion mutant for 15L gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic nude mice CrlNU-Foxn1 xenograft for cellosaurus cell line 5.0E+6 cells','5.0E+6 pfu','NA','Complete regression in tumor volume compared to 550 after 34 days','Intratumoral','NA','NA','NA','27738905'),
  ('OV_5186','Tanapoxvirus','TPV-delta66R','DNA','Poxviridae','Deletion mutant for tk 66ORF','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic nude mice CrlNU-Foxn1 xenograft for cellosaurus cell line 5.0E+6 cells','5.0E+6 pfu','NA','Reduction in tumor growth 150 compared to 550 after 34 days','Intratumoral','NA','NA','NA','27738905'),
  ('OV_5187','Tanapoxvirus','TPV-delta15Ldelta66R','DNA','Poxviridae','Deletion mutant for 15L gene and tk 66R locus','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic nude mice CrlNU-Foxn1 xenograft for cellosaurus cell line 5.0E+6 cells','5.0E+6 pfu','NA','Reduction in tumor growth 200 compared to 550 after 34 days','Intratumoral','NA','NA','NA','27738905'),
  ('OV_5188','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copis of gamma 34.5 gene','Yes','No','No','ATCC','Human rhabdosarcoma cell line','RD','1.5E+3 cells per well','NA','Alamar blue assay','0.1 PFU','100% cell viable after 72 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27751346'),
  ('OV_5189','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copis of gamma 34.5 gene','Yes','No','No','ATCC','Human rhabdosarcoma cell line','RD','1.5E+3 cells per well','NA','Alamar blue assay','1 PFU','50% cell viable after 72 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27751346'),
  ('OV_5190','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copis of gamma 34.5 gene','Yes','No','No','ATCC','Human rhabdosarcoma cell line','RD','1.5E+3 cells per well','NA','Alamar blue assay','10 PFU','10% cell viable after 72 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27751346'),
  ('OV_5191','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copis of gamma 34.5 gene','Yes','No','No','ATCC','Human rhabdosarcoma cell line','RD','1.5E+3 cells per well','NA','Alamar blue assay','20 PFU','5% cell viable after 72 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27751346'),
  ('OV_5192','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copis of gamma 34.5 gene','Yes','No','No','ATCC','human cellosaurus cell line','SJC RH30','1.5E+3 cells per well','NA','Alamar blue assay','0.1 PFU','90% cell viable after 72 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27751346'),
  ('OV_5193','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copis of gamma 34.5 gene','Yes','No','No','ATCC','human cellosaurus cell line','SJC RH30','1.5E+3 cells per well','NA','Alamar blue assay','1 PFU','90% cell viable after 72 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27751346'),
  ('OV_5194','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copis of gamma 34.5 gene','Yes','No','No','ATCC','human cellosaurus cell line','SJC RH30','1.5E+3 cells per well','NA','Alamar blue assay','10 PFU','30% cell viable after 72 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27751346'),
  ('OV_5195','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copis of gamma 34.5 gene','Yes','No','No','ATCC','human cellosaurus cell line','SJC RH30','1.5E+3 cells per well','NA','Alamar blue assay','20 PFU','22% cell viable after 72 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','NA','27751346'),
  ('OV_5196','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','JCRB cell bank','Human epithelia carcinoma cell line','HeLa','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','100% cell viable after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5197','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','JCRB cell bank','Human epithelia carcinoma cell line','HeLa','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','100% cell viable after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5198','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','JCRB cell bank','Human epithelia carcinoma cell line','HeLa','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','80% cell viable after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5199','Adenovirus','TRAD-shLuc','DNA','Adenoviridae','Virus having shorthairpin RNA for Luciferase gene knockout','Yes','No','No','JCRB cell bank','Human epithelia carcinoma cell line','HeLa','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','100% cell viable after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5200','Adenovirus','TRAD-shLuc','DNA','Adenoviridae','Virus having shorthairpin RNA for Luciferase gene knockout','Yes','No','No','JCRB cell bank','Human epithelia carcinoma cell line','HeLa','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','100% cell viable after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5201','Adenovirus','TRAD-shLuc','DNA','Adenoviridae','Virus having shorthairpin RNA for Luciferase gene knockout','Yes','No','No','JCRB cell bank','Human epithelia carcinoma cell line','HeLa','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','80% cell viable after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5202','Adenovirus','TRAD-shDICER','DNA','Adenoviridae','Virus having shorthairpin RNA for DICER','Yes','No','No','JCRB cell bank','Human epithelia carcinoma cell line','HeLa','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','100% cell viable after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5203','Adenovirus','TRAD-shDICER','DNA','Adenoviridae','Virus having shorthairpin RNA for DICER','Yes','No','No','JCRB cell bank','Human epithelia carcinoma cell line','HeLa','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','60% cell viable after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5204','Adenovirus','TRAD-shDICER','DNA','Adenoviridae','Virus having shorthairpin RNA for DICER','Yes','No','No','JCRB cell bank','Human epithelia carcinoma cell line','HeLa','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','10% cell viable after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5205','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','JCRB cell bank','Human hepatocellular carcinoma cell line','HepG2','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','100% cell viable after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5206','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','JCRB cell bank','Human hepatocellular carcinoma cell line','HepG2','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','100% cell viable after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5207','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','JCRB cell bank','Human hepatocellular carcinoma cell line','HepG2','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','80% cell viable after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5208','Adenovirus','TRAD-shLuc','DNA','Adenoviridae','Virus having shorthairpin RNA for Luciferase gene knockout','Yes','No','No','JCRB cell bank','Human hepatocellular carcinoma cell line','HepG2','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','100% cell viable after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5209','Adenovirus','TRAD-shLuc','DNA','Adenoviridae','Virus having shorthairpin RNA for Luciferase gene knockout','Yes','No','No','JCRB cell bank','Human hepatocellular carcinoma cell line','HepG2','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','100% cell viable after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5210','Adenovirus','TRAD-shLuc','DNA','Adenoviridae','Virus having shorthairpin RNA for Luciferase gene knockout','Yes','No','No','JCRB cell bank','Human hepatocellular carcinoma cell line','HepG2','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','80% cell viable after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5211','Adenovirus','TRAD-shDICER','DNA','Adenoviridae','Virus having shorthairpin RNA for DICER','Yes','No','No','JCRB cell bank','Human hepatocellular carcinoma cell line','HepG2','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','100% cell viable after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5212','Adenovirus','TRAD-shDICER','DNA','Adenoviridae','Virus having shorthairpin RNA for DICER','Yes','No','No','JCRB cell bank','Human hepatocellular carcinoma cell line','HepG2','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','80% cell viable after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5213','Adenovirus','TRAD-shDICER','DNA','Adenoviridae','Virus having shorthairpin RNA for DICER','Yes','No','No','JCRB cell bank','Human hepatocellular carcinoma cell line','HepG2','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','20% cell viable after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5214','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','JCRB cell bank','Human hepatocellular carcinoma cell line','Huh-7','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','100% cell viable after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5215','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','JCRB cell bank','Human hepatocellular carcinoma cell line','Huh-7','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','100% cell viable after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5216','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','JCRB cell bank','Human hepatocellular carcinoma cell line','Huh-7','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','80% cell viable after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5217','Adenovirus','TRAD-shLuc','DNA','Adenoviridae','Virus having shorthairpin RNA for Luciferase gene knockout','Yes','No','No','JCRB cell bank','Human hepatocellular carcinoma cell line','Huh-7','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','100% cell viable after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5218','Adenovirus','TRAD-shLuc','DNA','Adenoviridae','Virus having shorthairpin RNA for Luciferase gene knockout','Yes','No','No','JCRB cell bank','Human hepatocellular carcinoma cell line','Huh-7','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','100% cell viable after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5219','Adenovirus','TRAD-shLuc','DNA','Adenoviridae','Virus having shorthairpin RNA for Luciferase gene knockout','Yes','No','No','JCRB cell bank','Human hepatocellular carcinoma cell line','Huh-7','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','80% cell viable after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5220','Adenovirus','TRAD-shDICER','DNA','Adenoviridae','Virus having shorthairpin RNA for DICER','Yes','No','No','JCRB cell bank','Human hepatocellular carcinoma cell line','Huh-7','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','100% cell viable after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5221','Adenovirus','TRAD-shDICER','DNA','Adenoviridae','Virus having shorthairpin RNA for DICER','Yes','No','No','JCRB cell bank','Human hepatocellular carcinoma cell line','Huh-7','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','80% cell viable after 48 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5222','Adenovirus','TRAD-shDICER','DNA','Adenoviridae','Virus having shorthairpin RNA for DICER','Yes','No','No','JCRB cell bank','Human hepatocellular carcinoma cell line','Huh-7','NA','Toxic to normal human cell line above 10 MOI','Alamar blue assay','2 MOI','20% cell viable after 72 hours','No','No','NA','No response','NA','NA','NA','NA','27760834'),
  ('OV_5223','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice xenograft for H1299 (2.0E+6 cells)','1.0E+7 pfu','NA','No significant reduction in tumor volume compared to control','Intratumoral','NA','NA','NA','27760834'),
  ('OV_5224','Adenovirus','TRAD-shLuc','DNA','Adenoviridae','Virus having shorthairpin RNA for Luciferase gene knockout','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice xenograft for H1299 (2.0E+6 cells)','1.0E+7 pfu','NA','No significant reduction in tumor volume compared to control','Intratumoral','NA','NA','NA','27760834'),
  ('OV_5225','Adenovirus','TRAD-shDICER','DNA','Adenoviridae','Virus having shorthairpin RNA for DICER','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice xenograft for H1299 (2.0E+6 cells)','1.0E+7 pfu','NA','Reduction in tumor volume to 1000 cubic mm after 35 days compared to control 6000 cubic mm','Intratumoral','NA','NA','NA','27760834'),
  ('OV_5226','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice xenograft for SKOV3 (2.0E+6 cells)','1.0E+7 pfu','NA','Reduction in tumor volume to 2500 cubic mm after 45 days compared to control 3500 cubic mm','Intratumoral','NA','NA','NA','27760834'),
  ('OV_5227','Adenovirus','TRAD-shLuc','DNA','Adenoviridae','Virus having shorthairpin RNA for Luciferase gene knockout','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice xenograft for SKOV3 (2.0E+6 cells)','1.0E+7 pfu','NA','Reduction in tumor volume to 2500 cubic mm after 45 days compared to control 3500 cubic mm','Intratumoral','NA','NA','NA','27760834'),
  ('OV_5228','Adenovirus','TRAD-shDICER','DNA','Adenoviridae','Virus having shorthairpin RNA for DICER','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice xenograft for SKOV3 (2.0E+6 cells)','1.0E+7 pfu','NA','Reduction in tumor volume to 800 cubic mm after 45 days compared to control 3500 cubic mm','Intratumoral','NA','NA','NA','27760834'),
  ('OV_5229','Parovirus','wild type','DNA','Paroviridae','None','Yes','No','No','ATCC','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice xenograft for 4T1 (1.0E+5 cells)','NA','NA','Reduction in tumor volume 700 cubic mm compared to control 1700 cubic mm after 33 days','Intratumoral','Induction of apoptosis','Increase production of IFN-gama and IL-2','NA','27776794'),
  ('OV_5230','Parovirus','wild type','DNA','Paroviridae','None','Yes','No','No','ATCC','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice xenograft for 4T1 (1.0E+5 cells)','NA','NA','Reduction in tumor volume 4200 cubic mm compared to control 1700 cubic mm after 33 days','Intratumoral','Induction of apoptosis','Increase production of IFN-gama and IL-2','NA','27776794'),
  ('OV_5231','Parovirus','wild type','DNA','Paroviridae','None','Yes','No','No','ATCC','Human mesothelioma cell line','NCI-H2052','5.0E+3 cells per well','NA','MTS assay','10 VP per cell','90% cell viable','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5232','Parovirus','wild type','DNA','Paroviridae','None','Yes','No','No','ATCC','Human mesothelioma cell line','NCI-H2052','5.0E+3 cells per well','NA','MTS assay','100 VP per cell','80% cell viable','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5233','Parovirus','wild type','DNA','Paroviridae','None','Yes','No','No','ATCC','Human mesothelioma cell line','NCI-H2052','5.0E+3 cells per well','NA','MTS assay','1000 VP per cell','80% cell viable','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5234','Parovirus','wild type','DNA','Paroviridae','None','Yes','No','No','ATCC','Human mesothelioma cell line','NCIH2452','5.0E+3 cells per well','NA','MTS assay','10 VP per cell','90% cell viable','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5235','Parovirus','wild type','DNA','Paroviridae','None','Yes','No','No','ATCC','Human mesothelioma cell line','NCIH2452','5.0E+3 cells per well','NA','MTS assay','100 VP per cell','90% cell viable','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5236','Parovirus','wild type','DNA','Paroviridae','None','Yes','No','No','ATCC','Human mesothelioma cell line','NCIH2452','5.0E+3 cells per well','NA','MTS assay','1000 VP per cell','20% cell viable','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5237','Parovirus','wild type','DNA','Paroviridae','None','Yes','No','No','ATCC','Human mesothelioma cell line','NCI-H226','5.0E+3 cells per well','NA','MTS assay','10 VP per cell','10% cell viable','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5238','Parovirus','wild type','DNA','Paroviridae','None','Yes','No','No','ATCC','Human mesothelioma cell line','NCI-H226','5.0E+3 cells per well','NA','MTS assay','100 VP per cell','2% cell viable','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5239','Parovirus','wild type','DNA','Paroviridae','None','Yes','No','No','ATCC','Human mesothelioma cell line','NCI-H226','5.0E+3 cells per well','NA','MTS assay','1000 VP per cell','100% cell killing','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5240','Parovirus','wild type','DNA','Paroviridae','None','Yes','No','No','ATCC','Human mesothelioma cell line','NCI-H28','5.0E+3 cells per well','NA','MTS assay','10 VP per cell','90% cell viable','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5241','Parovirus','wild type','DNA','Paroviridae','None','Yes','No','No','ATCC','Human mesothelioma cell line','NCI-H28','5.0E+3 cells per well','NA','MTS assay','100 VP per cell','10% cell viable','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5242','Parovirus','wild type','DNA','Paroviridae','None','Yes','No','No','ATCC','Human mesothelioma cell line','NCI-H28','5.0E+3 cells per well','NA','MTS assay','1000 VP per cell','100% cell killing','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5243','Parovirus','Ad5/3VEGFE1-delta','DNA','Paroviridae','Deletion mutant for E1A gene and expressing VEGF gene','Yes','No','No','ATCC','Human mesothelioma cell line','NCI-H2052','5.0E+3 cells per well','NA','MTS assay','10 VP per cell','90% cell viable','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5244','Parovirus','Ad5/3VEGFE1-delta','DNA','Paroviridae','Deletion mutant for E1A gene and expressing VEGF gene','Yes','No','No','ATCC','Human mesothelioma cell line','NCI-H2052','5.0E+3 cells per well','NA','MTS assay','100 VP per cell','90% cell viable','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5245','Parovirus','Ad5/3VEGFE1-delta','DNA','Paroviridae','Deletion mutant for E1A gene and expressing VEGF gene','Yes','No','No','ATCC','Human mesothelioma cell line','NCI-H2052','5.0E+3 cells per well','NA','MTS assay','1000 VP per cell','100% cell killing','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5246','Parovirus','Ad5/3VEGFE1-delta','DNA','Paroviridae','Deletion mutant for E1A gene and expressing VEGF gene','Yes','No','No','ATCC','Human mesothelioma cell line','NCIH2452','5.0E+3 cells per well','NA','MTS assay','10 VP per cell','80% cell viable','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5247','Parovirus','Ad5/3VEGFE1-delta','DNA','Paroviridae','Deletion mutant for E1A gene and expressing VEGF gene','Yes','No','No','ATCC','Human mesothelioma cell line','NCIH2452','5.0E+3 cells per well','NA','MTS assay','100 VP per cell','10% cell viable','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5248','Parovirus','Ad5/3VEGFE1-delta','DNA','Paroviridae','Deletion mutant for E1A gene and expressing VEGF gene','Yes','No','No','ATCC','Human mesothelioma cell line','NCIH2452','5.0E+3 cells per well','NA','MTS assay','1000 VP per cell','100% cell killing','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5249','Parovirus','Ad5/3VEGFE1-delta','DNA','Paroviridae','Deletion mutant for E1A gene and expressing VEGF gene','Yes','No','No','ATCC','Human mesothelioma cell line','NCI-H226','5.0E+3 cells per well','NA','MTS assay','10 VP per cell','10% cell viable','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5250','Parovirus','Ad5/3VEGFE1-delta','DNA','Paroviridae','Deletion mutant for E1A gene and expressing VEGF gene','Yes','No','No','ATCC','Human mesothelioma cell line','NCI-H226','5.0E+3 cells per well','NA','MTS assay','100 VP per cell','5 % cell viable','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5251','Parovirus','Ad5/3VEGFE1-delta','DNA','Paroviridae','Deletion mutant for E1A gene and expressing VEGF gene','Yes','No','No','ATCC','Human mesothelioma cell line','NCI-H226','5.0E+3 cells per well','NA','MTS assay','1000 VP per cell','100% cell killing','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5252','Parovirus','Ad5/3VEGFE1-delta','DNA','Paroviridae','Deletion mutant for E1A gene and expressing VEGF gene','Yes','No','No','ATCC','Human mesothelioma cell line','NCI-H28','5.0E+3 cells per well','NA','MTS assay','10 VP per cell','50% cell viable','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5253','Parovirus','Ad5/3VEGFE1-delta','DNA','Paroviridae','Deletion mutant for E1A gene and expressing VEGF gene','Yes','No','No','ATCC','Human mesothelioma cell line','NCI-H28','5.0E+3 cells per well','NA','MTS assay','100 VP per cell','5% cell viable','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5254','Parovirus','Ad5/3VEGFE1-delta','DNA','Paroviridae','Deletion mutant for E1A gene and expressing VEGF gene','Yes','No','No','ATCC','Human mesothelioma cell line','NCI-H28','5.0E+3 cells per well','NA','MTS assay','1000 VP per cell','100% cell killing','No','No','NA','No response','NA','NA','NA','NA','27783867'),
  ('OV_5255','Parovirus','Ad5/3VEGFE1-delta','DNA','Paroviridae','Deletion mutant for E1A gene and expressing VEGF gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Nude mice xenograft for NCI-H226 cell line (1.0E+7)','1.0E+8 pfu','NA','Improvement in survival time was observed','Intratumoral','NA','NA','NA','27783867'),
  ('OV_5256','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','STOSE','4000 cells per well','NA','Alamar blue assay','0.1 PFU','100% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5257','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','STOSE','4000 cells per well','NA','Alamar blue assay','0.33 PFU','70% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5258','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','STOSE','4000 cells per well','NA','Alamar blue assay','1 PFU','15% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5259','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','STOSE','4000 cells per well','NA','Alamar blue assay','3.3 PFU','5% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5260','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','STOSE','4000 cells per well','NA','Alamar blue assay','10 PFU','7% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5261','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','STOSE','4000 cells per well','NA','Alamar blue assay','33 PFU','1% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5262','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','STOSE','4000 cells per well','NA','Alamar blue assay','100 PFU','100% cell killing','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5263','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','ID8','4000 cells per well','NA','Alamar blue assay','0.1 PFU','100% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5264','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','ID8','4000 cells per well','NA','Alamar blue assay','0.33 PFU','70% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5265','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','ID8','4000 cells per well','NA','Alamar blue assay','1 PFU','50% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5266','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','ID8','4000 cells per well','NA','Alamar blue assay','3.3 PFU','30% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5267','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','ID8','4000 cells per well','NA','Alamar blue assay','10 PFU','10% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5268','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','ID8','4000 cells per well','NA','Alamar blue assay','33 PFU','1% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5269','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','ID8','4000 cells per well','NA','Alamar blue assay','100 PFU','100% cell killing','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5270','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','Ig10','4000 cells per well','NA','Alamar blue assay','0.1 PFU','100% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5271','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','Ig10','4000 cells per well','NA','Alamar blue assay','0.33 PFU','70% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5272','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','Ig10','4000 cells per well','NA','Alamar blue assay','1 PFU','58% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5273','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','Ig10','4000 cells per well','NA','Alamar blue assay','3.3 PFU','30% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5274','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','Ig10','4000 cells per well','NA','Alamar blue assay','10 PFU','15% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5275','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','Ig10','4000 cells per well','NA','Alamar blue assay','33 PFU','1% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5276','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','Ig10','4000 cells per well','NA','Alamar blue assay','100 PFU','100% cell killing','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5277','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','MISIIR','4000 cells per well','NA','Alamar blue assay','0.1 PFU','85% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5278','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','MISIIR','4000 cells per well','NA','Alamar blue assay','0.33 PFU','87% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5279','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','MISIIR','4000 cells per well','NA','Alamar blue assay','1 PFU','87% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5280','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','MISIIR','4000 cells per well','NA','Alamar blue assay','3.3 PFU','78% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5281','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','MISIIR','4000 cells per well','NA','Alamar blue assay','10 PFU','62% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5282','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','MISIIR','4000 cells per well','NA','Alamar blue assay','33 PFU','22% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5283','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing murine IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Murine ovarian adenocarcinoma cell line','MISIIR','4000 cells per well','NA','Alamar blue assay','100 PFU','20% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5284','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','A2780','4000 cells per well','NA','Alamar blue assay','0.1 PFU','85% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5285','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','A2780','4000 cells per well','NA','Alamar blue assay','0.33 PFU','70% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5286','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','A2780','4000 cells per well','NA','Alamar blue assay','1 PFU','42% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5287','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','A2780','4000 cells per well','NA','Alamar blue assay','3.3 PFU','10% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5288','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','A2780','4000 cells per well','NA','Alamar blue assay','10 PFU','5% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5289','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','A2780','4000 cells per well','NA','Alamar blue assay','33 PFU','100% cell killing','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5290','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','A2780','4000 cells per well','NA','Alamar blue assay','100 PFU','100% cell killing','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5291','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','HeyA8','4000 cells per well','NA','Alamar blue assay','0.1 PFU','100% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5292','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','HeyA8','4000 cells per well','NA','Alamar blue assay','0.33 PFU','98% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5293','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','HeyA8','4000 cells per well','NA','Alamar blue assay','1 PFU','95% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5294','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','HeyA8','4000 cells per well','NA','Alamar blue assay','3.3 PFU','77% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5295','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','HeyA8','4000 cells per well','NA','Alamar blue assay','10 PFU','60% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5296','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','HeyA8','4000 cells per well','NA','Alamar blue assay','33 PFU','39% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5297','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','HeyA8','4000 cells per well','NA','Alamar blue assay','100 PFU','22% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5298','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','HEYA8 MDR','4000 cells per well','NA','Alamar blue assay','0.1 PFU','100% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5299','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','HEYA8 MDR','4000 cells per well','NA','Alamar blue assay','0.33 PFU','38% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5300','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','HEYA8 MDR','4000 cells per well','NA','Alamar blue assay','1 PFU','10% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5301','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','HEYA8 MDR','4000 cells per well','NA','Alamar blue assay','3.3 PFU','100% cell killing','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5302','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','HEYA8 MDR','4000 cells per well','NA','Alamar blue assay','10 PFU','100% cell killing','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5303','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','HEYA8 MDR','4000 cells per well','NA','Alamar blue assay','33 PFU','100% cell killing','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5304','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','HEYA8 MDR','4000 cells per well','NA','Alamar blue assay','100 PFU','100% cell killing','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5305','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','SKOV3','4000 cells per well','NA','Alamar blue assay','0.1 PFU','100% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5306','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','SKOV3','4000 cells per well','NA','Alamar blue assay','0.33 PFU','98% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5307','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','SKOV3','4000 cells per well','NA','Alamar blue assay','1 PFU','50% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5308','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','SKOV3','4000 cells per well','NA','Alamar blue assay','3.3 PFU','18% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5309','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','SKOV3','4000 cells per well','NA','Alamar blue assay','10 PFU','15% cell viable','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5310','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','SKOV3','4000 cells per well','NA','Alamar blue assay','33 PFU','100% cell killing','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5311','Herpes simplex virus','M032','DNA','Herpesviridae','Deletion mutant for both copies of gamma 34.5 gene and expressing human IL-12 gene','Yes','No','Virus expressing murine IL-12','NA','Human ovarian cancer cell line','SKOV3','4000 cells per well','NA','Alamar blue assay','100 PFU','100% cell killing','No','No','NA','No response','NA','NA','Tumor specific T cell response induced','NA','27784340'),
  ('OV_5312','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','Yes','No','Virus expressing IL18 gene','NA','Human skin melanoma cell line','A375','NA','NA','MTT assay','0.1 MOI','100% cell viability on day 1','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5313','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','Yes','No','Virus expressing IL18 gene','NA','Human skin melanoma cell line','A375','NA','NA','MTT assay','0.1 MOI','90% cell viability on day 2','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5314','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','Yes','No','Virus expressing IL18 gene','NA','Human skin melanoma cell line','A375','NA','NA','MTT assay','0.1 MOI','87% cell viability on day 3','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5315','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','Yes','No','Virus expressing IL18 gene','NA','Human skin melanoma cell line','A375','NA','NA','MTT assay','0.1 MOI','80% cell viability on day 4','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5316','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','Yes','No','Virus expressing IL18 gene','NA','Human skin melanoma cell line','A375','NA','NA','MTT assay','1 MOI','90% cell viability on day 1','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5317','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','Yes','No','Virus expressing IL18 gene','NA','Human skin melanoma cell line','A375','NA','NA','MTT assay','1 MOI','82% cell viability on day 2','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5318','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','Yes','No','Virus expressing IL18 gene','NA','Human skin melanoma cell line','A375','NA','NA','MTT assay','1 MOI','78% cell viability on day 3','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5319','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','Yes','No','Virus expressing IL18 gene','NA','Human skin melanoma cell line','A375','NA','NA','MTT assay','1 MOI','65% cell viability on day 4','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5320','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','Yes','No','Virus expressing IL18 gene','NA','Human skin melanoma cell line','A375','NA','NA','MTT assay','10 MOI','82% cell viability on day 1','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5321','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','Yes','No','Virus expressing IL18 gene','NA','Human skin melanoma cell line','A375','NA','NA','MTT assay','10 MOI','78% cell viability on day 2','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5322','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','Yes','No','Virus expressing IL18 gene','NA','Human skin melanoma cell line','A375','NA','NA','MTT assay','10 MOI','62% cell viability on day 3','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5323','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','Yes','No','Virus expressing IL18 gene','NA','Human skin melanoma cell line','A375','NA','NA','MTT assay','10 MOI','42% cell viability on day 4','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5324','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','Yes','No','Virus expressing IL18 gene','NA','Human skin melanoma cell line','A375','NA','NA','MTT assay','100 MOI','70% cell viability on day 1','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5325','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','Yes','No','Virus expressing IL18 gene','NA','Human skin melanoma cell line','A375','NA','NA','MTT assay','100 MOI','58% cell viability on day 2','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5326','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','Yes','No','Virus expressing IL18 gene','NA','Human skin melanoma cell line','A375','NA','NA','MTT assay','100 MOI','50% cell viability on day 3','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5327','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','Yes','No','Virus expressing IL18 gene','NA','Human skin melanoma cell line','A375','NA','NA','MTT assay','100 MOI','30% cell viability on day 4','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5328','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','No','Virus in combination with DTIC 200 microgram per ml','Virus expressing IL18 gene','NA','Human skin melanoma cell line','A375','NA','NA','MTT assay','10 MOI','65% cell viability on day 1','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5329','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','No','Virus in combination with DTIC 200 microgram per ml','Virus expressing IL18 gene','NA','Human skin melanoma cell line','A375','NA','NA','MTT assay','10 MOI','52% cell viability on day 2','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5330','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','No','Virus in combination with DTIC 200 microgram per ml','Virus expressing IL18 gene','NA','Human skin melanoma cell line','A375','NA','NA','MTT assay','10 MOI','38% cell viability on day 3','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5331','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','No','Virus in combination with DTIC 200 microgram per ml','Virus expressing IL18 gene','NA','Human skin melanoma cell line','A375','NA','NA','MTT assay','10 MOI','30% cell viability on day 4','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5332','Adenovirus','ZD55-IL18','DNA','Adenoviridae','virus having insertion of IL18 gene','No','Virus in combination with DTIC 100 microgram per ml','Virus expressing IL18 gene','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice xenograft for A375 (2.0E+6)','10 MOI','NA','Reduction in tumor volume to 250 cubic mm after six week compared to control 800 cubic mm','NA','Virus induced apoptosis as measured by TUNEL assay','NA','NA','27895465'),
  ('OV_5333','Herpes simplex virus','HSV2','DNA','Herpesviridae','Deletion mutant for ICP34.5 and ICP47 gene and insertion of GMCSF','Yes','No','Virus expressing GMCSF gene','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice xenograft for CT26 (5.0E+5)','5.0E+6 pfu','NA','Reduction in tumor volume 1200 cubic mm compared to control 2500 cubic mm after 28 days','Intratumoral','Virus induced apoptosis as measured by TUNEL assay','Induce prolifration of tumor specific T cell','NA','28223815'),
  ('OV_5334','Newcastle disease virus','NDV/Anh-TRAIL','RNA','Paramyxoviridae','Virus insertion for TRAIL gene','Yes','No','No','China Xiehe Medical University','Human hepatocellular carcinoma cell line','HepG2','1.0E+4 cells per well','NA','MTT assay','0.01 MOI','56.7% cells remain viable','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','Caspase 3 pathway are activated','NA','28246027'),
  ('OV_5335','Newcastle disease virus','NDV/Anh-TRAIL','RNA','Paramyxoviridae','Virus insertion for TRAIL gene','Yes','No','No','China Xiehe Medical University','Human hepatocellular carcinoma cell line','HepG2','1.0E+4 cells per well','NA','MTT assay','0.1 MOI','43.2% cells remain viable','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','Caspase 3 pathway are activated','NA','28246027'),
  ('OV_5336','Newcastle disease virus','NDV/Anh-TRAIL','RNA','Paramyxoviridae','Virus insertion for TRAIL gene','Yes','No','No','China Xiehe Medical University','Human hepatocellular carcinoma cell line','HepG2','1.0E+4 cells per well','NA','MTT assay','1 MOI','29.6% cells remain viable','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','Caspase 3 pathway are activated','NA','28246027'),
  ('OV_5337','Newcastle disease virus','NDV/Anh-TRAIL','RNA','Paramyxoviridae','Virus insertion for TRAIL gene','Yes','No','No','China Xiehe Medical University','Human hepatocellular carcinoma cell line','HepG2','1.0E+4 cells per well','NA','MTT assay','10 MOI','20.8% cell growth inhibition','No','No','NA','No response','NA','Virus induced apoptosis as measured by TUNEL assay','Caspase 3 pathway are activated','NA','28246027'),
  ('OV_5338','Newcastle disease virus','NDV/Anh-TRAIL','RNA','Paramyxoviridae','Virus insertion for TRAIL gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Kumming mice implanted for 5.0E+5 H22 cells','1.0E+7 pfu','NA','Reduction in tumor volume to 10 cubic mm compared to control 3500 cubic mm after 14 days','Intratumoral','Virus induced apoptosis as measured by TUNEL assay','Caspase 3 pathway are activated','NA','28246027'),
  ('OV_5339','Newcastle disease virus','LaSota','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human nonsmall cell lung carcinoma','A549','5.0E+4 cells per well','NA','MTT assay','0.001 MOI','16% cells remain viable after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis','Induced production of IFN-alpha, IFN-beta, IL-6and IFN-gamma','NA','28293547'),
  ('OV_5340','Newcastle disease virus','LaSota','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human hepatocellular carcinoma cell line','Huh-7','5.0E+4 cells per well','NA','MTT assay','0.001 MOI','37% cells remain viable after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis','Induced production of IFN-alpha, IFN-beta, IL-6and IFN-gamma','NA','28293547'),
  ('OV_5341','Newcastle disease virus','LaSota','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human glioblastoma multiforme','U-87 MG','5.0E+4 cells per well','NA','MTT assay','0.001 MOI','19% cells remain viable after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis','Induced production of IFN-alpha, IFN-beta, IL-6and IFN-gamma','NA','28293547'),
  ('OV_5342','Newcastle disease virus','LaSota','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human mammary gland adenocarcinoma','MDA-MB-453','5.0E+4 cells per well','NA','MTT assay','0.001 MOI','35% cells remain viable after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis','Induced production of IFN-alpha, IFN-beta, IL-6and IFN-gamma','NA','28293547'),
  ('OV_5343','Newcastle disease virus','LaSota','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human glioblastoma multiforme','T98G','5.0E+4 cells per well','NA','MTT assay','0.001 MOI','29% cells remain viable after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis','Induced production of IFN-alpha, IFN-beta, IL-6and IFN-gamma','NA','28293547'),
  ('OV_5344','Newcastle disease virus','LaSota','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human mammary gland adenocarcinoma','MCF-7','5.0E+4 cells per well','NA','MTT assay','0.001 MOI','44% cells remain viable after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis','Induced production of IFN-alpha, IFN-beta, IL-6and IFN-gamma','NA','28293547'),
  ('OV_5345','Adenovirus','YDC002','DNA','Adenoviridae','Virus having insertion mutant for relaxin gene','Yes','No','No','ATCC','Human pancreatic cancer cell line','MIAPaCa-2','5.0E+3 cells per well','NA','MTT assay','1 MOI','78% cell viability after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','28315430'),
  ('OV_5346','Adenovirus','YDC002','DNA','Adenoviridae','Virus having insertion mutant for relaxin gene','Yes','No','No','ATCC','Human pancreatic cancer cell line','MIAPaCa-2','5.0E+3 cells per well','NA','MTT assay','2 MOI','78% cell viability after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','28315430'),
  ('OV_5347','Adenovirus','YDC002','DNA','Adenoviridae','Virus having insertion mutant for relaxin gene','No','Virus in combination with gemcitabine 0.01 micromoar','No','ATCC','Human pancreatic cancer cell line','MIAPaCa-2','5.0E+3 cells per well','NA','MTT assay','1 MOI','60% cells remain viable after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','28315430'),
  ('OV_5348','Adenovirus','YDC002','DNA','Adenoviridae','Virus having insertion mutant for relaxin gene','No','Virus in combination with gemcitabine 0.01 micromoar','No','ATCC','Human pancreatic cancer cell line','MIAPaCa-2','5.0E+3 cells per well','NA','MTT assay','2 MOI','50% cells remain viable after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','28315430'),
  ('OV_5349','Adenovirus','YDC002','DNA','Adenoviridae','Virus having insertion mutant for relaxin gene','No','Virus in combination with gemcitabine 0.05 micromoar','No','ATCC','Human pancreatic cancer cell line','MIAPaCa-2','5.0E+3 cells per well','NA','MTT assay','1 MOI','35% cells remain viable after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','28315430'),
  ('OV_5350','Adenovirus','YDC002','DNA','Adenoviridae','Virus having insertion mutant for relaxin gene','No','Virus in combination with gemcitabine 0.05 micromoar','No','ATCC','Human pancreatic cancer cell line','MIAPaCa-2','5.0E+3 cells per well','NA','MTT assay','2 MOI','30% cells remain viable after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','28315430'),
  ('OV_5351','Adenovirus','YDC002','DNA','Adenoviridae','Virus having insertion mutant for relaxin gene','Yes','No','No','ATCC','Human pancreatic cancer cell line','PANC-1','5.0E+3 cells per well','NA','MTT assay','0.1 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','28315430'),
  ('OV_5352','Adenovirus','YDC002','DNA','Adenoviridae','Virus having insertion mutant for relaxin gene','Yes','No','No','ATCC','Human pancreatic cancer cell line','PANC-1','5.0E+3 cells per well','NA','MTT assay','0.5 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','28315430'),
  ('OV_5353','Adenovirus','YDC002','DNA','Adenoviridae','Virus having insertion mutant for relaxin gene','No','Virus in combination with gemcitabine 0.01 micromoar','No','ATCC','Human pancreatic cancer cell line','PANC-1','5.0E+3 cells per well','NA','MTT assay','0.1 MOI','70% cell viability after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','28315430'),
  ('OV_5354','Adenovirus','YDC002','DNA','Adenoviridae','Virus having insertion mutant for relaxin gene','No','Virus in combination with gemcitabine 0.01 micromoar','No','ATCC','Human pancreatic cancer cell line','PANC-1','5.0E+3 cells per well','NA','MTT assay','0.5 MOI','68% cell viability after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','28315430'),
  ('OV_5355','Adenovirus','YDC002','DNA','Adenoviridae','Virus having insertion mutant for relaxin gene','No','Virus in combination with gemcitabine 0.05 micromoar','No','ATCC','Human pancreatic cancer cell line','PANC-1','5.0E+3 cells per well','NA','MTT assay','0.1 MOI','65% cell viability after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','28315430'),
  ('OV_5356','Adenovirus','YDC002','DNA','Adenoviridae','Virus having insertion mutant for relaxin gene','No','Virus in combination with gemcitabine 0.05 micromoar','No','ATCC','Human pancreatic cancer cell line','PANC-1','5.0E+3 cells per well','NA','MTT assay','0.5 MOI','50% cell viability after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','28315430'),
  ('OV_5357','Adenovirus','YDC002','DNA','Adenoviridae','Virus having insertion mutant for relaxin gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice xenograft for 3.0E+5 MIAPaCa2','2.0E+6 pfu','NA','Reduction in tumor volume to 1700 cubic mm after 60 days compared to 2700 cubic mm','Intratumoral','Virus induced apoptosis','NA','NA','28315430'),
  ('OV_5358','Adenovirus','YDC002','DNA','Adenoviridae','Virus having insertion mutant for relaxin gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice xenograft for 5.0E+5 BxPC3','2.0E+6 pfu','NA','Reduction in tumor volume to 1000 cubic mm after 60 days compared to 2700 cubic mm','Intratumoral','Virus induced apoptosis','NA','NA','28315430'),
  ('OV_5359','Adenovirus','YDC002','DNA','Adenoviridae','Virus having insertion mutant for relaxin gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice xenograft for 5.0E+5 PANC1','2.0E+6 pfu','NA','Reduction in tumor volume to 400 cubic mm after 60 days compared to 1000 cubic mm','Intratumoral','Virus induced apoptosis','NA','NA','28315430'),
  ('OV_5360','Adenovirus','YDC002','DNA','Adenoviridae','Virus having insertion mutant for relaxin gene','No','Virus in combination with Gemcitabine 1.5mg/kg','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice xenograft for 3.0E+5 MIAPaCa2','2.0E+6 pfu','NA','Reduction in tumor volume to 500 cubic mm after 60 days compared to 2700 cubic mm','Intratumoral','Virus induced apoptosis','NA','NA','28315430'),
  ('OV_5361','Adenovirus','YDC002','DNA','Adenoviridae','Virus having insertion mutant for relaxin gene','No','Virus in combination with Gemcitabine 1.5mg/kg','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice xenograft for 5.0E+5 BxPC3','2.0E+6 pfu','NA','Reduction in tumor volume to 400 cubic mm after 60 days compared to 2700 cubic mm','Intratumoral','Virus induced apoptosis','NA','NA','28315430'),
  ('OV_5362','Adenovirus','YDC002','DNA','Adenoviridae','Virus having insertion mutant for relaxin gene','No','Virus in combination with Gemcitabine 1.5mg/kg','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice xenograft for 5.0E+5 PANC1','2.0E+6 pfu','NA','Reduction in tumor volume to 100 cubic mm after 60 days compared to 1000 cubic mm','Intratumoral','Virus induced apoptosis','NA','NA','28315430'),
  ('OV_5363','Herpes simplex virus','HF10','DNA','Herpesviridae','None','Yes','No','No','NCI','Murine colon carcinoma cell line','MC26','4000 cells per well','Slightly toxic to lymphocytes','MTT assay','0.001 MOI','90% cell viability after 6 days','No','No','NA','No response','NA','NA','Stimulation of cytotoxic CD8 T cells','NA','28331843'),
  ('OV_5364','Herpes simplex virus','HF10','DNA','Herpesviridae','None','Yes','No','No','NCI','Murine colon carcinoma cell line','MC26','4000 cells per well','Slightly toxic to lymphocytes','MTT assay','0.01 MOI','60% cell viability after 6 days','No','No','NA','No response','NA','NA','Stimulation of cytotoxic CD8 T cells','NA','28331843'),
  ('OV_5365','Herpes simplex virus','HF10','DNA','Herpesviridae','None','Yes','No','No','NCI','Murine colon carcinoma cell line','MC26','4000 cells per well','Slightly toxic to lymphocytes','MTT assay','0.1 MOI','40% cell viability after 6 days','No','No','NA','No response','NA','NA','Stimulation of cytotoxic CD8 T cells','NA','28331843'),
  ('OV_5366','Herpes simplex virus','HF10','DNA','Herpesviridae','None','Yes','No','No','NCI','Murine colon carcinoma cell line','MC26','4000 cells per well','Slightly toxic to lymphocytes','MTT assay','1 MOI','5% cell viability after 6 days','No','No','NA','No response','NA','NA','Stimulation of cytotoxic CD8 T cells','NA','28331843'),
  ('OV_5367','Herpes simplex virus','HF10','DNA','Herpesviridae','None','Yes','No','No','NCI','Murine colon carcinoma cell line','MC26','4000 cells per well','Slightly toxic to lymphocytes','MTT assay','10 MOI','1% cell viability after 6 days','No','No','NA','No response','NA','NA','Stimulation of cytotoxic CD8 T cells','NA','28331843'),
  ('OV_5368','Herpes simplex virus','HF10','DNA','Herpesviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c mice isograft for 1.0E+6 MC26 cells','1.0E+7 pfu on day 10, 17 and 24','NA','Reduction in tumor volume to 500 mm compared to control 2500 mm after 28 days and increase in survival time','Subcutaneous','NA','Stimulation of cytotoxic CD8 T cells','NA','28331843'),
  ('OV_5369','Maraba virus','MG1','RNA','Rhabdoviridae','None','Yes','No','No','ATCC','Murine triple negative breast cancer cell line','4T1','NA','NA','Coomassie brilinat blue staining','4 micromolar','70% cell killing after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','In clinical trial for various cancer cell line','27503504'),
  ('OV_5370','Maraba virus','MG1','RNA','Rhabdoviridae','None','Yes','No','No','ATCC','Murine triple negative breast cancer cell line','EMT6','NA','NA','Coomassie brilinat blue staining','4 micromolar','!00% cell viability after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','In clinical trial for various cancer cell line','27503504'),
  ('OV_5371','Maraba virus','MG1','RNA','Rhabdoviridae','None','Yes','No','No','ATCC','Murine triple negative breast cancer cell line','E0771','NA','NA','Coomassie brilinat blue staining','4 micromolar','90% cell viability after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','In clinical trial for various cancer cell line','27503504'),
  ('OV_5372','Maraba virus','MG1','RNA','Rhabdoviridae','None','No','Virus in combination with 2 micromolar palcitaxel for 48 hours','No','ATCC','Murine triple negative breast cancer cell line','4T1','NA','NA','Coomassie brilinat blue staining','4 micromolar','10% cell viability after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','Impaired IFN beta production by combination','In clinical trial for various cancer cell line','27503504'),
  ('OV_5373','Maraba virus','MG1','RNA','Rhabdoviridae','None','No','Virus in combination with 2 micromolar palcitaxel for 48 hours','No','ATCC','Murine triple negative breast cancer cell line','EMT6','NA','NA','Coomassie brilinat blue staining','4 micromolar','30% cell viability after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','Impaired IFN beta production by combination','In clinical trial for various cancer cell line','27503504'),
  ('OV_5374','Maraba virus','MG1','RNA','Rhabdoviridae','None','No','Virus in combination with 2 micromolar palcitaxel for 48 hours','No','ATCC','Murine triple negative breast cancer cell line','E0771','NA','NA','Coomassie brilinat blue staining','4 micromolar','20% cell viability after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','Level of IFN beta production does not effected by combination','In clinical trial for various cancer cell line','27503504'),
  ('OV_5375','Maraba virus','MG1','RNA','Rhabdoviridae','None','Yes','No','No','ATCC','Human triple negative breast cancer cell line','Hs578T','NA','NA','Coomassie brilinat blue staining','4 micromolar','100% cell viable after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','In clinical trial for various cancer cell line','27503504'),
  ('OV_5376','Maraba virus','MG1','RNA','Rhabdoviridae','None','Yes','No','No','ATCC','Human triple negative breast cancer cell line','BT-549','NA','NA','Coomassie brilinat blue staining','4 micromolar','80% cell viable after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','In clinical trial for various cancer cell line','27503504'),
  ('OV_5377','Maraba virus','MG1','RNA','Rhabdoviridae','None','Yes','No','No','ATCC','Human triple negative breast cancer cell line','MDA-MB-231','NA','NA','Coomassie brilinat blue staining','4 micromolar','80% cell viable after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','NA','In clinical trial for various cancer cell line','27503504'),
  ('OV_5378','Maraba virus','MG1','RNA','Rhabdoviridae','None','No','Virus in combination with 2 micromolar palcitaxel for 48 hours','No','ATCC','Human triple negative breast cancer cell line','Hs578T','NA','NA','Coomassie brilinat blue staining','4 micromolar','20% cell viability after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','Impaired IFN beta production by combination','In clinical trial for various cancer cell line','27503504'),
  ('OV_5379','Maraba virus','MG1','RNA','Rhabdoviridae','None','No','Virus in combination with 2 micromolar palcitaxel for 48 hours','No','ATCC','Human triple negative breast cancer cell line','BT-549','NA','NA','Coomassie brilinat blue staining','4 micromolar','20% cell viability after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','Impaired IFN beta production by combination','In clinical trial for various cancer cell line','27503504'),
  ('OV_5380','Maraba virus','MG1','RNA','Rhabdoviridae','None','No','Virus in combination with 2 micromolar palcitaxel for 48 hours','No','ATCC','Human triple negative breast cancer cell line','MDA-MB-231','NA','NA','Coomassie brilinat blue staining','4 micromolar','30% cell viability after 48 hours','No','No','NA','No response','NA','Induction of apoptosis','Level of IFN beta production does not effected by combination','In clinical trial for various cancer cell line','27503504'),
  ('OV_5381','Maraba virus','MG1','RNA','Rhabdoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c mice isograft for 2.0E+5 4T1 cells','No','NA','Reduction in tumor volume to 400 cubic mm compared to control 800 cubic mm after 25 days and increase in survival time to 45 days compared to 40 days control','Intratumoral','Induction of apoptosis','Level of IFN beta production does not effected by combination','In clinical trial for various cancer cell line','27503504'),
  ('OV_5382','Maraba virus','MG1','RNA','Rhabdoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c mice isograft for 2.0E+5 EMT6 cells','No','NA','Reduction in tumor volume to 800 cubic mm compared to control 1000 cubic mm after 18 days and increase in survival time to 30 days compared to 25 days control','Intratumoral','Induction of apoptosis','Level of IFN beta production does not effected by combination','In clinical trial for various cancer cell line','27503504'),
  ('OV_5383','Maraba virus','MG1','RNA','Rhabdoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','C57/Bl6 mice isograft for 1.0E+6 EO771 cells','No','NA','Reduction in tumor volume to 500 cubic mm compared to control 1200 cubic mm after 30 days and increase in survival time to 45 days compared to 32 days control','Intratumoral','Induction of apoptosis','Level of IFN beta production does not effected by combination','In clinical trial for various cancer cell line','27503504'),
  ('OV_5384','Maraba virus','MG1','RNA','Rhabdoviridae','None','No','Virus in combination with 2mg/kg micromolar palcitaxel for 48 hours','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c mice isograft for 2.0E+5 4T1 cells','No','NA','Reduction in tumor volume to 200 cubic mm compared to control 800 cubic mm after 25 days and increase in survival time to 60 days compared to 40 days control','Intratumoral','Induction of apoptosis','Level of IFN beta production does not effected by combination','In clinical trial for various cancer cell line','27503504'),
  ('OV_5385','Maraba virus','MG1','RNA','Rhabdoviridae','None','No','Virus in combination with 10mg/kg micromolar palcitaxel for 48 hours','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c mice isograft for 2.0E+5 EMT6 cells','No','NA','Reduction in tumor volume to 400 cubic mm compared to control 1000 cubic mm after 18 days and increase in survival time to 30 days compared to 25 days control','Intratumoral','Induction of apoptosis','Level of IFN beta production does not effected by combination','In clinical trial for various cancer cell line','27503504'),
  ('OV_5386','Maraba virus','MG1','RNA','Rhabdoviridae','None','No','Virus in combination with 2mg/kg micromolar palcitaxel for 48 hours','No','NA','NA','NA','NA','NA','NA','NA','NA','C57/Bl6 mice isograft for 1.0E+6 EO771 cells','No','NA','Reduction in tumor volume to 100 cubic mm compared to control 1200 cubic mm after 30 days and increase in survival time to 70 days compared to 32 days control','Intratumoral','Induction of apoptosis','Level of IFN beta production does not effected by combination','In clinical trial for various cancer cell line','27503504'),
  ('OV_5387','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human rhabdomyosarcoma cell line','RD','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu','40% cell growth inhibition after 72 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5388','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human rhabdomyosarcoma cell line','RD','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, one fold dilution','56.778% cell growth inhibition after 72 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5389','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human rhabdomyosarcoma cell line','RD','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, two fold dilution','60.493% cell growth inhibition after 72 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5390','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human rhabdomyosarcoma cell line','RD','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, three fold dilution','38.616% cell growth inhibition after 72 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5391','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human rhabdomyosarcoma cell line','RD','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, four fold dilution','31.039% cell growth inhibition after 72 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5392','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human rhabdomyosarcoma cell line','RD','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, five fold dilution','19.801% cell growth inhibition after 72 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5393','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human rhabdomyosarcoma cell line','RD','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, one fold dilution','53.110% cell growth inhibition after 120 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5394','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human rhabdomyosarcoma cell line','RD','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, two fold dilution','69.954% cell growth inhibition after 120 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5395','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human rhabdomyosarcoma cell line','RD','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, three fold dilution','53.717% cell growth inhibition after 120 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5396','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human rhabdomyosarcoma cell line','RD','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, four fold dilution','31.714% cell growth inhibition after 120 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5397','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human rhabdomyosarcoma cell line','RD','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, five fold dilution','15.174% cell growth inhibition after 120 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5398','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human rhabdomyosarcoma cell line','RD','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, six fold dilution','5.918% cell growth inhibition after 120 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5399','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human glioblastoma cell line','ANGM5','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu','46.047% cell growth inhibition after 72 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5400','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human glioblastoma cell line','ANGM5','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, one fold dilution','46.047% cell growth inhibition after 72 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5401','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human glioblastoma cell line','ANGM5','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, two fold dilution','73.183% cell growth inhibition after 72 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5402','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human glioblastoma cell line','ANGM5','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, three fold dilution','58.012% cell growth inhibition after 72 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5403','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human glioblastoma cell line','ANGM5','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, four fold dilution','27.350% cell growth inhibition after 72 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5404','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human glioblastoma cell line','ANGM5','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, five fold dilution','19.658% cell growth inhibition after 72 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5405','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human glioblastoma cell line','ANGM5','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, six fold dilution','14.529% cell growth inhibition after 72 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5406','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human glioblastoma cell line','ANGM5','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, one fold dilution','87.81% cell growth inhibition after 120 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5407','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human glioblastoma cell line','ANGM5','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, two fold dilution','90.101% cell growth inhibition after 120 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5408','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human glioblastoma cell line','ANGM5','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, three fold dilution','74.746% cell growth inhibition after 120 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5409','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human glioblastoma cell line','ANGM5','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, four fold dilution','48.477% cell growth inhibition after 120 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5410','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human glioblastoma cell line','ANGM5','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, five fold dilution','36.421% cell growth inhibition after 120 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5411','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human glioblastoma cell line','ANGM5','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu, six fold dilution','23.477% cell growth inhibition after 120 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5412','Measles virus','Schwarz vaccine stain','RNA','Paramyxoviridae','None','Yes','No','No','ICCMGR cell bank unit, Iraq','Human glioblastoma cell line','ANGM5','7.0E+3 cells per well','NA','MTT assay','3.4 × 10⁵ pfu','35.279% cell growth inhibition after 120 hours','No','No','NA','No response','NA','Induction of apoptosis as measured by mitochondrial permeability apoptosis assay','NA','NA','27512663'),
  ('OV_5413','Vaccinia virus','LIVP-GFP','DNA','Poxviridae','Deletion mutant for tk gene','Yes','No','No','Russian academy of science','Murine lymphosarcoma cell line','RLS','80% confluence','NA','MTT assay','1 MOI','90% cell viability after 24 hours','No','No','NA','No response','NA','NA','NA','NA','27538520'),
  ('OV_5414','Vaccinia virus','LIVP-GFP','DNA','Poxviridae','Deletion mutant for tk gene','Yes','No','No','Russian academy of science','Murine lymphosarcoma cell line','RLS','80% confluence','NA','MTT assay','1 MOI','80% cell viability after 48 hours','No','No','NA','No response','NA','Reduction production of IL-6 indicating tumor inhibition','NA','NA','27538520'),
  ('OV_5415','Vaccinia virus','LIVP-GFP','DNA','Poxviridae','Deletion mutant for tk gene','Yes','No','No','Russian academy of science','Murine lymphosarcoma cell line','RLS','80% confluence','NA','MTT assay','1 MOI','50% cell viability after 72 hours','No','No','NA','No response','NA','Reduction production of IL-6 indicating tumor inhibition','NA','NA','27538520'),
  ('OV_5416','Vaccinia virus','LIVP-GFP','DNA','Poxviridae','Deletion mutant for tk gene','Yes','No','No','Russian academy of science','Murine lymphosarcoma cell line','RLS-40','80% confluence','NA','MTT assay','1 MOI','90% cell viability after 24 hours','No','No','NA','No response','NA','Reduction production of IL-6 indicating tumor inhibition','NA','NA','27538520'),
  ('OV_5417','Vaccinia virus','LIVP-GFP','DNA','Poxviridae','Deletion mutant for tk gene','Yes','No','No','Russian academy of science','Murine lymphosarcoma cell line','RLS-40','80% confluence','NA','MTT assay','1 MOI','90% cell viability after 48 hours','No','No','NA','No response','NA','Reduction production of IL-6 indicating tumor inhibition','NA','NA','27538520'),
  ('OV_5418','Vaccinia virus','LIVP-GFP','DNA','Poxviridae','Deletion mutant for tk gene','Yes','No','No','Russian academy of science','Murine lymphosarcoma cell line','RLS-40','80% confluence','NA','MTT assay','1 MOI','80% cell viability after 72 hours','No','No','NA','No response','NA','Reduction production of IL-6 indicating tumor inhibition','NA','NA','27538520'),
  ('OV_5419','Vaccinia virus','LIVP-GFP','DNA','Poxviridae','Deletion mutant for tk gene','Yes','No','No','Russian academy of science','Murine melanoma','B16','3.0E+3 cells per well','NA','MTT assay','1 MOI','57% cell viability after 24 hours','No','No','NA','No response','NA','Reduction production of IL-6 indicating tumor inhibition','NA','NA','27538520'),
  ('OV_5420','Vaccinia virus','LIVP-GFP','DNA','Poxviridae','Deletion mutant for tk gene','Yes','No','No','Russian academy of science','Murine melanoma','B16','3.0E+3 cells per well','NA','MTT assay','1 MOI','42% cell viability after 48 hours','No','No','NA','No response','NA','Reduction production of IL-6 indicating tumor inhibition','NA','NA','27538520'),
  ('OV_5421','Vaccinia virus','LIVP-GFP','DNA','Poxviridae','Deletion mutant for tk gene','Yes','No','No','Russian academy of science','Murine melanoma','B16','3.0E+3 cells per well','NA','MTT assay','1 MOI','22% cell viability after 72 hours','No','No','NA','No response','NA','Reduction production of IL-6 indicating tumor inhibition','NA','NA','27538520'),
  ('OV_5422','Vaccinia virus','LIVP-GFP','DNA','Poxviridae','Deletion mutant for tk gene','Yes','No','No','Russian academy of science','Human cervical carcinoma','KB-3-1','9.0E+3 cells per well','NA','MTT assay','1 MOI','64% cell viability after 24 hours','No','No','NA','No response','NA','Reduction production of IL-6 indicating tumor inhibition','NA','NA','27538520'),
  ('OV_5423','Vaccinia virus','LIVP-GFP','DNA','Poxviridae','Deletion mutant for tk gene','Yes','No','No','Russian academy of science','Human cervical carcinoma','KB-3-1','9.0E+3 cells per well','NA','MTT assay','1 MOI','40% cell viability after 48 hours','No','No','NA','No response','NA','Reduction production of IL-6 indicating tumor inhibition','NA','NA','27538520'),
  ('OV_5424','Vaccinia virus','LIVP-GFP','DNA','Poxviridae','Deletion mutant for tk gene','Yes','No','No','Russian academy of science','Human cervical carcinoma','KB-3-1','9.0E+3 cells per well','NA','MTT assay','1 MOI','17% cell viability after 72 hours','No','No','NA','No response','NA','Reduction production of IL-6 indicating tumor inhibition','NA','NA','27538520'),
  ('OV_5425','Vaccinia virus','LIVP-GFP','DNA','Poxviridae','Deletion mutant for tk gene','Yes','No','No','Russian academy of science','Human cervical carcinoma','KB-8-5','9.0E+3 cells per well','NA','MTT assay','1 MOI','70% cell viability after 24 hours','No','No','NA','No response','NA','Reduction production of IL-6 indicating tumor inhibition','NA','NA','27538520'),
  ('OV_5426','Vaccinia virus','LIVP-GFP','DNA','Poxviridae','Deletion mutant for tk gene','Yes','No','No','Russian academy of science','Human cervical carcinoma','KB-8-5','9.0E+3 cells per well','NA','MTT assay','1 MOI','60% cell viability after 48 hours','No','No','NA','No response','NA','Reduction production of IL-6 indicating tumor inhibition','NA','NA','27538520'),
  ('OV_5427','Vaccinia virus','LIVP-GFP','DNA','Poxviridae','Deletion mutant for tk gene','Yes','No','No','Russian academy of science','Human cervical carcinoma','KB-8-5','9.0E+3 cells per well','NA','MTT assay','1 MOI','35% cell viability after 72 hours','No','No','NA','No response','NA','Reduction production of IL-6 indicating tumor inhibition','NA','NA','27538520'),
  ('OV_5428','Vaccinia virus','LIVP-GFP','DNA','Poxviridae','Deletion mutant for tk gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','C57Bl6 mice subcutaneous injected for 1.0E+5 B16 cells','5.0E+7 pfu','NA','Reduction in tumor volume to below 0.3 cubic cm compared to control 1.2 cubic cm after 20 days','Intratumoral','Reduction production of IL-6 indicating tumor inhibition','NA','NA','27538520'),
  ('OV_5429','Vaccinia virus','LIVP-GFP','DNA','Poxviridae','Deletion mutant for tk gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','CBA mice sintramuscularly injected for 5.0E+7 RLS-40 cells','5.0E+7 pfu','NA','Reduction in tumor volume to below 0.2 cubic cm compared to control 0.8 cubic cm after 15 days','Intratumoral','Reduction production of IL-6 indicating tumor inhibition','NA','NA','27538520'),
  ('OV_5430','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','KLM1','NA','NA','WST-1 assay','1 MOI','60% cell viable after day 2','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5431','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','KLM1','NA','NA','WST-1 assay','1 MOI','10% cell viable after day 4','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5432','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','KLM1','NA','NA','WST-1 assay','1 MOI','100% cell killing after day 6','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5433','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','KLM1','NA','NA','WST-1 assay','1 MOI','100% cell killing after day 8','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5434','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','KLM1','NA','NA','WST-1 assay','1 MOI','100% cell killing after day 10','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5435','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','Capan-2','NA','NA','WST-1 assay','1 MOI','100% cell viable after day 2','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5436','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','Capan-2','NA','NA','WST-1 assay','1 MOI','80% cell viable after day 4','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5437','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','Capan-2','NA','NA','WST-1 assay','1 MOI','70% cell viable after day 6','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5438','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','Capan-2','NA','NA','WST-1 assay','1 MOI','50% cell viable after day 8','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5439','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','Capan-2','NA','NA','WST-1 assay','1 MOI','40% cell viable after day 10','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5440','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','PSN1','NA','NA','WST-1 assay','1 MOI','100% cell viable after day 2','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5441','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','PSN1','NA','NA','WST-1 assay','1 MOI','100% cell viable after day 4','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5442','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','PSN1','NA','NA','WST-1 assay','1 MOI','100% cell viable after day 6','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5443','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','PSN1','NA','NA','WST-1 assay','1 MOI','90% cell viable after day 8','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5444','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','PSN1','NA','NA','WST-1 assay','1 MOI','100% cell viable after day 10','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5445','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','PK1','NA','NA','WST-1 assay','1 MOI','100% cell viable after day 2','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5446','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','PK1','NA','NA','WST-1 assay','1 MOI','90% cell viable after day 4','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5447','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','PK1','NA','NA','WST-1 assay','1 MOI','100% cell viable after day 6','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5448','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','PK1','NA','NA','WST-1 assay','1 MOI','80% cell viable after day 8','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5449','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','PK1','NA','NA','WST-1 assay','1 MOI','60% cell viable after day 10','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5450','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','PK9','NA','NA','WST-1 assay','1 MOI','90% cell viable after day 2','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5451','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','PK9','NA','NA','WST-1 assay','1 MOI','90% cell viable after day 4','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5452','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','PK9','NA','NA','WST-1 assay','1 MOI','70% cell viable after day 6','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5453','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','PK9','NA','NA','WST-1 assay','1 MOI','60% cell viable after day 8','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5454','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Tohuku university Japan','Human pancreatic cancer cell line','PK9','NA','NA','WST-1 assay','1 MOI','60% cell viable after day 10','No','No','NA','No response','NA','NA','NA','NA','27561180'),
  ('OV_5455','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','SCID mice xenograft for KLM','1.0E+6 TCID50','NA','Reduction in tumor volume to below 600 cubic mm after 90 days compared to control 2500 cubic mm','Intratumoral','NA','NA','NA','27561180'),
  ('OV_5456','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','SCID mice xenograft for Capan2','1.0E+6 TCID50','NA','Reduction in tumor volume to below 100 cubic mm after 45 days compared to control 1600 cubic mm','Intratumoral','NA','NA','NA','27561180'),
  ('OV_5457','Vaccinia virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Balb/c mice injected with tumor','1.0E+4 pfu','NA','Mice failed to develop cancer','Subcutaneous','NA','NA','NA','US41098983'),
  ('OV_5458','Vaccinia virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Balb/c mice injected with tumor','1.0E+5 pfu','NA','Mice failed to develop cancer','Subcutaneous','NA','NA','NA','US41098983'),
  ('OV_5459','Vaccinia virus','wild type','DNA','Poxviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Balb/c mice injected with tumor','1.0E+6 pfu','NA','Mice failed to develop cancer','Subcutaneous','NA','NA','NA','US41098983'),
  ('OV_5460','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','60% cell survival after day 1','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5461','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','30% cell survival after day 2','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5462','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','5% cell survival after day 3','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5463','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 4','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5464','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 5','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5465','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 6','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5466','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','100% cell survival after day 1','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5467','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','75% cell survival after day 2','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5468','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','60% cell survival after day 3','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5469','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','30% cell survival after day 4','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5470','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','10% cell survival after day 5','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5471','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','100% cell death after day 6','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5472','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','35% cell survival after day 1','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5473','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','20% cell survival after day 2','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5474','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 3','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5475','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 4','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5476','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 5','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5477','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 6','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5478','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','90% cell survival after day 1','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5479','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','58% cell survival after day 2','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5480','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','50% cell survival after day 3','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5481','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','20% cell survival after day 4','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5482','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','5% cell survival after day 5','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5483','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','100% cell death after day 6','No','No','NA','No response','NA','NA','NA','NA','US5585096'),
  ('OV_5484','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','NA','NA','NA','Balb/c mice xenograft for U-87MG','5.0E+7 pfu','NA','Reduction in tumor growth below 2%','Intraneoplastic','NA','NA','NA','US5585096'),
  ('OV_5485','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5 and ICP6 gene','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','NA','NA','NA','Balb/c mice xenograft for U-87MG','5.0E+7 pfu','NA','Reduction in tumor growth below 5%','Intraneoplastic','NA','NA','NA','US5585096'),
  ('OV_5486','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','60% cell survival after day 1','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5487','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','30% cell survival after day 2','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5488','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','5% cell survival after day 3','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5489','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 4','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5490','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 5','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5491','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 6','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5492','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','100% cell survival after day 1','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5493','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','75% cell survival after day 2','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5494','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','60% cell survival after day 3','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5495','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','30% cell survival after day 4','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5496','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','10% cell survival after day 5','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5497','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','100% cell death after day 6','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5498','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','35% cell survival after day 1','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5499','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','20% cell survival after day 2','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5500','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 3','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5501','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 4','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5502','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 5','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5503','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 6','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5504','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','90% cell survival after day 1','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5505','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','58% cell survival after day 2','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5506','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','50% cell survival after day 3','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5507','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','20% cell survival after day 4','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5508','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','5% cell survival after day 5','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5509','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','100% cell death after day 6','No','No','NA','No response','NA','NA','NA','NA','US5728379'),
  ('OV_5510','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','NA','NA','NA','Balb/c mice xenograft for U-87MG','5.0E+7 pfu','NA','Reduction in tumor growth below 2%','Intraneoplastic','NA','NA','NA','US5728379'),
  ('OV_5511','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP4 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','NA','NA','NA','Balb/c mice xenograft for U-87MG','5.0E+7 pfu','NA','Reduction in tumor growth below 5%','Intraneoplastic','NA','NA','NA','US5728379'),
  ('OV_5512','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','60% cell survival after day 1','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5513','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','30% cell survival after day 2','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5514','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','5% cell survival after day 3','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5515','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 4','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5516','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 5','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5517','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 6','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5518','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','100% cell survival after day 1','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5519','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','75% cell survival after day 2','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5520','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','60% cell survival after day 3','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5521','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','30% cell survival after day 4','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5522','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','10% cell survival after day 5','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5523','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','100% cell death after day 6','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5524','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','35% cell survival after day 1','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5525','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','20% cell survival after day 2','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5526','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 3','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5527','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 4','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5528','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 5','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5529','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','1 MOI','100% cell death after day 6','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5530','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','90% cell survival after day 1','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5531','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','58% cell survival after day 2','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5532','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','50% cell survival after day 3','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5533','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','20% cell survival after day 4','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5534','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','5% cell survival after day 5','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5535','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','Trypan blue cell exclusion assay','0.01 MOI','100% cell death after day 6','No','No','NA','No response','NA','NA','NA','NA','US6139834'),
  ('OV_5536','Herpes simplex virus','G207-1','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','NA','NA','NA','Balb/c mice xenograft for U-87MG','5.0E+7 pfu','NA','Reduction in tumor growth below 2%','Intraneoplastic','NA','NA','NA','US6139834'),
  ('OV_5537','Herpes simplex virus','G207-2','DNA','Herpesviridae','Deletion mutant for gamma 34.5, ICP6 gene and ibonucleotide reductase','Yes','No','No','ATCC','Human glioma cell line','U-87 MG','NA','NA','NA','NA','NA','Balb/c mice xenograft for U-87MG','5.0E+7 pfu','NA','Reduction in tumor growth below 5%','Intraneoplastic','NA','NA','NA','US6139834'),
  ('OV_5538','Herpes simplex virus','1716','DNA','Herpesviridae','Double deletion mutant in ICP34.5 gene','No','Virus in combination with mitomycin drug','No','ATCC','Human large cell carcinoma cell line H460','H460','NA','NA','NA','NA','NA','Mouse model xenograft for H460 cell line','4.0E+6 pfu','NA','Reduction in tumor volume to 0.793 +/- 0.047','Intravenously','NA','NA','NA','US6428968'),
  ('OV_5539','Herpes simplex virus','1716','DNA','Herpesviridae','Double deletion mutant in ICP34.5 gene','Yes','No','No','ATCC','Human large cell carcinoma cell line H460','H460','NA','NA','NA','NA','NA','Mouse model xenograft for H460 cell line','4.0E+6 pfu','NA','Reduction in tumor volume to 1.127 +/- 0.139','Intravenously','NA','NA','NA','US6428968'),
  ('OV_5540','Herpes simplex virus','Mutant','DNA','Herpesviridae','Deletion mutatnt in TK gene and UL 24 gene','Yes','No','No','ATCC','Human medulloblastoma cell line','D283','NA','NA','NA','10 MOI','All cells was dead after 4 days','No','No','NA','No response','NA','NA','NA','NA','US6770274'),
  ('OV_5541','Herpes simplex virus','Mutant','DNA','Herpesviridae','Deletion mutatnt in TK gene and UL 24 gene','Yes','No','No','ATCC','Human medulloblastoma cell line','D283','NA','NA','NA','1 MOI','All cells was dead after 14 days','No','No','NA','No response','NA','NA','NA','NA','US6770274'),
  ('OV_5542','Herpes simplex virus','Mutant','DNA','Herpesviridae','Deletion mutatnt in TK gene and UL 24 gene','Yes','No','No','ATCC','Human medulloblastoma cell line','SNB40','NA','NA','NA','0.001 MOI','All cells was dead after 4 days','No','No','NA','No response','NA','NA','NA','NA','US6770274'),
  ('OV_5543','Herpes simplex virus','Mutant','DNA','Herpesviridae','Deletion mutatnt in TK gene and UL 24 gene','Yes','No','No','ATCC','Human medulloblastoma cell line','SNB40','NA','NA','NA','0.1 MOI','All cells was dead after 4 days','No','No','NA','No response','NA','NA','NA','NA','US6770274'),
  ('OV_5544','Herpes simplex virus','Mutant','DNA','Herpesviridae','Deletion mutatnt in TK gene and UL 24 gene','Yes','No','No','ATCC','Human malignant cell line','U87','NA','NA','NA','NA','NA','Fisher male mice xenograft subcutaneous for U86 (3.0E+6)','5.0E+6 pfu','NA','Tumor size was significantly smaller in treated mice compared to control','Intravenously','NA','NA','NA','US6770274'),
  ('OV_5545','Herpes simplex virus','Mutant','DNA','Herpesviridae','Deletion mutatnt in TK gene and UL 24 gene','Yes','No','No','ATCC','Human malignant cell line','U87','NA','NA','NA','NA','NA','Fisher male mice xenograft subrenal for U86 (3.0E+6)','5.0E+6 pfu','NA','Tumor size was significantly smaller in treated mice compared to control','Intravenously','NA','NA','NA','US6770274'),
  ('OV_5546','Herpes simplex virus','Mutant','DNA','Herpesviridae','Deletion mutatnt in TK gene and UL 24 gene','Yes','No','No','ATCC','Human malignant cell line','U87','NA','NA','NA','NA','NA','Fisher male mice xenograft intracerebral for U86 (1.6E+5)','1.0E+3 pfu','NA','Three of seven mice survived after 7 week','Intravenously','NA','NA','NA','US6770274'),
  ('OV_5547','Herpes simplex virus','Mutant','DNA','Herpesviridae','Deletion mutatnt in TK gene and UL 24 gene','Yes','No','No','ATCC','Human malignant cell line','U87','NA','NA','NA','NA','NA','Fisher male mice xenograft intracerebral for U86 (1.6E+5)','1.0E+5 pfu','NA','Four of seven mice survived after 7 week','Intravenously','NA','NA','NA','US6770274'),
  ('OV_5548','Herpes simplex virus','Mutant','DNA','Herpesviridae','Deletion mutatnt in TK gene and UL 24 gene','Yes','No','No','ATCC','Human malignant cell line','U87','NA','NA','NA','NA','NA','Fisher male mice xenograft intracerebral for U86 (1.6E+5)','1.0E+3 pfu','NA','All mice was dead after week 14','Intravenously','NA','NA','NA','US6770274'),
  ('OV_5549','Herpes simplex virus','Mutant','DNA','Herpesviridae','Deletion mutatnt in TK gene and UL 24 gene','Yes','No','No','ATCC','Human malignant cell line','U87','NA','NA','NA','NA','NA','Fisher male mice xenograft intracerebral for U86 (1.6E+5)','1.0E+5 pfu','NA','Two of seven mice survived after 14 week','Intravenously','NA','NA','NA','US6770274'),
  ('OV_5550','Adenovirus','wild type','DNA','Adenoviridae','None','No','Virus in combination with Gancliovar (100mg/kg) after 80 hours','No','NA','Human adenocortical cell cell line','SW13','NA','NA','NA','NA','NA','Nude mice xenograft for SW13 (10E+6)','2.0E+9 pfu','NA','80% of animal survived after day 50','Intraperitoneal','NA','NA','NA','US6875610'),
  ('OV_5551','Adenovirus','wild type','DNA','Adenoviridae','None','No','Virus in combination with Gancliovar (100mg/kg) after 30 hours','No','NA','Human adenocortical cell cell line','SW13','NA','NA','NA','NA','NA','Nude mice xenograft for SW13 (10E+6)','2.0E+9 pfu','NA','70% of animal survived after day 50','Intraperitoneal','NA','NA','NA','US6875610'),
  ('OV_5552','Reovirus','Reovirus serotype 3','RNA','Reoviridae','None','Yes','No','No','ATCC','Human breast cancer cell line','MCF-7','60% confluency','NA','NA','40 MOI','Cell viability drops from 93 to 16% after 72 hours','No','No','NA','No response','NA','Induction of apoptosis by virus infection','NA','NA','US6994858'),
  ('OV_5553','Reovirus','Reovirus serotype 3','RNA','Reoviridae','None','Yes','No','No','ATCC','Human breast cancer cell line','SKBR3','60% confluency','NA','NA','40 MOI','Cell viability drops from 93 to 16% after 72 hours','No','No','NA','No response','NA','Induction of apoptosis by virus infection','NA','NA','US6994858'),
  ('OV_5554','Reovirus','Reovirus serotype 3','RNA','Reoviridae','None','Yes','No','No','ATCC','Human breast cancer cell line','MDA-MB-468','60% confluency','NA','NA','40 MOI','Cell viability drops to 12.7% after 24 hours','No','No','NA','No response','NA','Induction of apoptosis by virus infection','NA','NA','US6994858'),
  ('OV_5555','Reovirus','Reovirus serotype 3','RNA','Reoviridae','None','Yes','No','No','ATCC','Human breast cancer cell line','MDA-MB-468','60% confluency','NA','NA','40 MOI','Cell viability drops to 8.8% after 48 hours','No','No','NA','No response','NA','Induction of apoptosis by virus infection','NA','NA','US6994858'),
  ('OV_5556','Reovirus','Reovirus serotype 3','RNA','Reoviridae','None','Yes','No','No','ATCC','Human breast cancer cell line','MDA-MB-468','60% confluency','NA','NA','40 MOI','Cell viability drops to 3.6% after 72 hours','No','No','NA','No response','NA','Induction of apoptosis by virus infection','NA','NA','US6994858'),
  ('OV_5557','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','Human keratinocytes','EN60','1.0E+5 cells per well','NA','NA','1 MOI','Significant death of cancer cell line after 72 hours','No','No','NA','No response','NA','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5558','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','Human pancreatic cell line','SUIT-2','1.0E+5 cells per well','NA','NA','1 MOI','Significant death of cancer cell line after 72 hours','No','No','NA','No response','NA','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5559','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','Human pancreatic cell line','BxPC-3','1.0E+5 cells per well','NA','NA','1 MOI','Significant death of cancer cell line after 72 hours','No','No','NA','No response','NA','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5560','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','Human pancreatic cell line','PANC-1','1.0E+5 cells per well','NA','NA','1 MOI','Significant death of cancer cell line after 72 hours','No','No','NA','No response','NA','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5561','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','Human pancreatic cell line','MIAPaCa-2','1.0E+5 cells per well','NA','NA','1 MOI','Significant death of cancer cell line after 72 hours','No','No','NA','No response','NA','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5562','Reovirus','wild type','RNA','Reoviridae','None','Yes','No','No','NA','Human keratinocytes','EN60','1.0E+5 cells per well','NA','NA','1 MOI','Significant death of cancer cell line after 72 hours','No','No','NA','No response','NA','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5563','Reovirus','wild type','RNA','Reoviridae','None','Yes','No','No','NA','Human pancreatic cell line','SUIT-2','1.0E+5 cells per well','NA','NA','1 MOI','Significant death of cancer cell line after 72 hours','No','No','NA','No response','NA','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5564','Reovirus','wild type','RNA','Reoviridae','None','Yes','No','No','NA','Human pancreatic cell line','BxPC-3','1.0E+5 cells per well','NA','NA','1 MOI','Significant death of cancer cell line after 72 hours','No','No','NA','No response','NA','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5565','Reovirus','wild type','RNA','Reoviridae','None','Yes','No','No','NA','Human pancreatic cell line','PANC-1','1.0E+5 cells per well','NA','NA','1 MOI','Significant death of cancer cell line after 72 hours','No','No','NA','No response','NA','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5566','Reovirus','wild type','RNA','Reoviridae','None','Yes','No','No','NA','Human pancreatic cell line','MIAPaCa-2','1.0E+5 cells per well','NA','NA','1 MOI','Significant death of cancer cell line after 72 hours','No','No','NA','No response','NA','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5567','Sindbis virus','AR339','RNA','Togaviridae','None','No','Sindbis virus in combination with Reovirus','No','NA','Human keratinocytes','EN60','1.0E+5 cells per well','NA','NA','1 MOI','Enhancer cytolytic effect in combination after 72 hours','No','No','NA','No response','NA','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5568','Sindbis virus','AR339','RNA','Togaviridae','None','No','Sindbis virus in combination with Reovirus','No','NA','Human pancreatic cell line','SUIT-2','1.0E+5 cells per well','NA','NA','1 MOI','Enhancer cytolytic effect in combination after 72 hours','No','No','NA','No response','NA','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5569','Sindbis virus','AR339','RNA','Togaviridae','None','No','Sindbis virus in combination with Reovirus','No','NA','Human pancreatic cell line','BxPC-3','1.0E+5 cells per well','NA','NA','1 MOI','Enhancer cytolytic effect in combination after 72 hours','No','No','NA','No response','NA','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5570','Sindbis virus','AR339','RNA','Togaviridae','None','No','Sindbis virus in combination with Reovirus','No','NA','Human pancreatic cell line','PANC-1','1.0E+5 cells per well','NA','NA','1 MOI','Enhancer cytolytic effect in combination after 72 hours','No','No','NA','No response','NA','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5571','Sindbis virus','AR339','RNA','Togaviridae','None','No','Sindbis virus in combination with Reovirus','No','NA','Human pancreatic cell line','MIAPaCa-2','1.0E+5 cells per well','NA','NA','1 MOI','Enhancer cytolytic effect in combination after 72 hours','No','No','NA','No response','NA','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5572','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','Human pancreatic cell line','SUIT-2','NA','NA','NA','NA','NA','Nude mice xenografted subcutaneously for SUIT-2','1.0E+6 pfu','NA','Tumor volume reduced to below 3.0 cm after 10 weeks','Intratumoral','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5573','Reovirus','wild type','RNA','Reoviridae','None','Yes','No','No','NA','Human pancreatic cell line','SUIT-2','NA','NA','NA','NA','NA','Nude mice xenografted subcutaneously for SUIT-2','1.0E+6 pfu','NA','Tumor volume reduced to below 1.0 cm after 10 weeks','Intratumoral','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5574','Sindbis virus','AR339','RNA','Togaviridae','None','No','Sindbis virus in combination with Reovirus','No','NA','Human pancreatic cell line','SUIT-2','NA','NA','NA','NA','NA','Nude mice xenografted subcutaneously for SUIT-2','1.0E+6 pfu','NA','Tumor volume reduced to below 0.5 cm after 10 weeks','Intratumoral','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5575','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','Human pancreatic cell line','BxPC-3','NA','NA','NA','NA','NA','Nude mice xenografted subcutaneously for BxPC3','1.0E+6 pfu','NA','Tumor volume reduced to below 2.0 cm after 10 weeks','Intratumoral','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5576','Reovirus','wild type','RNA','Reoviridae','None','Yes','No','No','NA','Human pancreatic cell line','BxPC-3','NA','NA','NA','NA','NA','Nude mice xenografted subcutaneously for BxPC3','1.0E+6 pfu','NA','Tumor volume reduced to below 3.0 cm after 10 weeks','Intratumoral','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5577','Sindbis virus','AR339','RNA','Togaviridae','None','No','Sindbis virus in combination with Reovirus','No','NA','Human pancreatic cell line','BxPC-3','NA','NA','NA','NA','NA','Nude mice xenografted subcutaneously for BxPC3','1.0E+6 pfu','NA','Complete reduction in tumor volume after 10 weeks','Intratumoral','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5578','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','Human pancreatic cell line','BxPC-3','NA','NA','NA','NA','NA','Nude mice xenografted subcutaneously for MIAPaCa-2','1.0E+6 pfu','NA','Tumor volume reduced to below 5.0 cm after 12 weeks','Intratumoral','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5579','Reovirus','wild type','RNA','Reoviridae','None','Yes','No','No','NA','Human pancreatic cell line','BxPC-3','NA','NA','NA','NA','NA','Nude mice xenografted subcutaneously for MIAPaCa-2','1.0E+6 pfu','NA','Tumor volume reduced to below 4.0 cm after 12 weeks','Intratumoral','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5580','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','Human eosophageal cancer cell line','YES-6','NA','NA','NA','NA','NA','Mice xenografted for eosophageal cancer cell line YES-6','1.0E+6 pfu','NA','Complete reduction in tumor volume after 28 weeks','Intratumoral','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5581','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','Human eosophageal cancer cell line','YES-6','NA','NA','NA','NA','NA','Mice xenografted for eosophageal cancer cell line YES-6','1.0E+6 pfu','NA','Complete reduction in tumor volume after 28 weeks','Intraperitoneal','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5582','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','Human eosophageal cancer cell line','TTn','NA','NA','NA','NA','NA','Mice xenografted for eosophageal cancer cell line TTn','1.0E+6 pfu','NA','Tumor volume reduced to below 500mm after 32 weeks','Intratumoral','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5583','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','Human eosophageal cancer cell line','TTn','NA','NA','NA','NA','NA','Mice xenografted for eosophageal cancer cell line TTn','1.0E+6 pfu','NA','Tumor volume reduced to below 500mm after 32 weeks','Intraperitoneal','Induction of apoptosis by virus infection','NA','NA','US7270812B2'),
  ('OV_5584','Reovirus','Reovirus strain T3D','RNA','Reoviridae','None','Yes','No','No','NA','Murine fibroblast cell line','THC-11','NA','NA','NA','NA','NA','SCID mice isograft for THC-11 (2.3E+5)','1.0E+7 pfu','NA','Reduction in tumor volume 284mg compared to control 602 mg after 3 weeks','Intratumoral','NA','NA','NA','US7374752'),
  ('OV_5585','Reovirus','Reovirus strain T3D','RNA','Reoviridae','None','Yes','No','No','NA','Murine fibroblast cell line','THC-11','NA','NA','NA','NA','NA','SCID mice isograft for THC-11 (4.8E+5)','1.0E+7 pfu','NA','Reduction in tumor volume 228mg compared to control 1523 mg after 3 weeks','Intratumoral','NA','NA','NA','US7374752'),
  ('OV_5586','Reovirus','Reovirus strain T3D','RNA','Reoviridae','None','Yes','No','No','NA','Murine fibroblast cell line','3T3','NA','NA','NA','NA','NA','SCID mice isograft for 3T3 (2.3E+5)','1.0E+7 pfu','NA','Reduction in tumor volume below 1 cm after 12 days','Intratumoral','NA','NA','NA','US7374752'),
  ('OV_5587','Reovirus','Reovirus strain T3D','RNA','Reoviridae','None','Yes','No','No','NA','Murine fibroblast cell line','3T3','NA','NA','NA','NA','NA','SCID mice isograft for 3T3 (4.8E+5)','1.0E+7 pfu','NA','Reduction in tumor volume below 1 cm after 12 days','Intratumoral','NA','NA','NA','US7374752'),
  ('OV_5588','Reovirus','Reovirus strain T3D','RNA','Reoviridae','None','Yes','No','No','NA','Human breast carcinoma cell line','MDA-MB-468','NA','NA','NA','NA','NA','SCID mice xenograft for MDA-MB468 (1.0E+5)','1.0E+7 pfu','NA','Reduction in tumor volume to 38.33gm compared to control 128.54 after 4 weeks','Intratumoral','NA','NA','NA','US7374752'),
  ('OV_5589','Measles virus','Measles virus edmon strain (MV-Edm)','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human myeloma cell line','ARH-77','NA','NA','NA','NA','NA','SCID mice xenograft for ARH-77','1.0E+7 pfu','NA','Complete reduction in tumor volume after 30 days when injected 1 dose','Intravenously','NA','NA','NA','US7393527'),
  ('OV_5590','Measles virus','Measles virus edmon strain (MV-Edm)','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human myeloma cell line','ARH-77','NA','NA','NA','NA','NA','SCID mice xenograft for ARH-77','1.0E+7 pfu','NA','Complete reduction in tumor volume after 30 days when injected 7 dose alternative days','Intravenously','NA','NA','NA','US7393527'),
  ('OV_5591','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human fibrosarcoma cell line','HT1080','80% confluency','NA','MTT assay','2 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5592','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human pancreatic carcinoma cell line','PANC-1','80% confluency','NA','MTT assay','3 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5593','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human renal carcinoma cell line','CAKI-1','80% confluency','NA','MTT assay','8 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5594','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human renal carcinoma cell line','CAKI-1','80% confluency','NA','MTT assay','11 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5595','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human renal carcinoma cell line','A498','80% confluency','NA','MTT assay','15 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5596','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human lung carcinoma cell line','H-1299','80% confluency','NA','MTT assay','26 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5597','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human lung carcinoma cell line','A427','80% confluency','NA','MTT assay','2 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5598','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human lung carcinoma cell line','A549','80% confluency','NA','MTT assay','13 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5599','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human melanoma cell line','SK-MEL-2','80% confluency','NA','MTT assay','8 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5600','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human melanoma cell line','SKMEL-3','80% confluency','NA','MTT assay','2 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5601','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human melanoma cell line','SKMEL-5','80% confluency','NA','MTT assay','4 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5602','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human melanoma cell line','A375','80% confluency','NA','MTT assay','37 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5603','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human melanoma cell line','MALME-3M','80% confluency','NA','MTT assay','778 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5604','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human melanoma cell line','HT144','80% confluency','NA','MTT assay','28 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5605','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human breast carcinoma cell line','SKNR3','80% confluency','NA','MTT assay','10 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5606','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human breast carcinoma cell line','MDA-MB-468','80% confluency','NA','MTT assay','44 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5607','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human breast carcinoma cell line','ZR75-1','80% confluency','NA','MTT assay','78 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5608','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human ovarian sarcoma cell line','SW626','80% confluency','NA','MTT assay','4 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5609','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human ovarian sarcoma cell line','PA-1','80% confluency','NA','MTT assay','4 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5610','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human ovarian sarcoma cell line','ES-2','80% confluency','NA','MTT assay','13 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5611','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human ovarian sarcoma cell line','SKOV3','80% confluency','NA','MTT assay','24 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5612','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human ovarian sarcoma cell line','OVCAR3','80% confluency','NA','MTT assay','34 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5613','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human glioblastoma cell line','U-87 MG','80% confluency','NA','MTT assay','25 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5614','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human glioblastoma cell line','U373MG','80% confluency','NA','MTT assay','765 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5615','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human glioblastoma cell line','U138','80% confluency','NA','MTT assay','38 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5616','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human glioblastoma cell line','A172','80% confluency','NA','MTT assay','207 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5617','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human bladder carcinoma','HT1197','80% confluency','NA','MTT assay','3 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5618','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human bladder carcinoma','UM-UC-3','80% confluency','NA','MTT assay','54 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5619','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human bladder carcinoma','HT1367','80% confluency','NA','MTT assay','422 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5620','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human neuroblastoma cell line','IMR-32','80% confluency','NA','MTT assay','41 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5621','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human cervical carcinoma cell line','HeLa','80% confluency','NA','MTT assay','4 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5622','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human prostate cancer cell line','Du145','80% confluency','NA','MTT assay','31 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5623','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human prostate cancer cell line','PC-3','80% confluency','NA','MTT assay','3×10³ pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5624','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human colon carcinoma cell line','SW620','80% confluency','NA','MTT assay','55 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5625','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human colon carcinoma cell line','HT-29','80% confluency','NA','MTT assay','1 ×10⁶ pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5626','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human head and neck carcinoma cell line','KB','80% confluency','NA','MTT assay','4 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5627','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human carcinoma cell line','A253','80% confluency','NA','MTT assay','2.7 ×10³ pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5628','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human carcinoma cell line','FaDu','80% confluency','NA','MTT assay','2.9 ×10³ pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5629','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human carcinoma cell line','Hep-2','80% confluency','NA','MTT assay','1.5 ×10⁴ pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5630','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human neuroepithelioma cell line','SK-N-MC','80% confluency','NA','MTT assay','20 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5631','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human small cell lung carcinoma cell line','DMS-114','80% confluency','NA','MTT assay','48 pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5632','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human small cell lung carcinoma cell line','DMS-153','80% confluency','NA','MTT assay','1.1 ×10⁵ pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5633','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human small cell lung carcinoma cell line','NCI-H345','80% confluency','NA','MTT assay','1.2 ×10⁶ pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5634','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human prostate small cell carcinoma','NCI-H660','80% confluency','NA','MTT assay','1.0 ×10⁵ pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5635','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human leukemia cell line','K562','80% confluency','NA','MTT assay','5.4 ×10⁴ pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5636','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human lymphoma cell line','Ramos','80% confluency','NA','MTT assay','1 ×10⁶ pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5637','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human lymphoma cell line','Daudi','80% confluency','NA','MTT assay','1 ×10⁶ pfu','50% of cancer cell death occurs','No','No','NA','No response','NA','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5638','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for human fibroblast HT1080 (10 million)','3.0E+8 pfu','NA','Complete regrression in tumor in 11 mice from complete 12 (tumor volume <10mm and >5 mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5639','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for human fibroblast HT1080 (10 million)','3.0E+8 pfu','NA','Complete regrression in tumor in 8 mice from complete 9 (tumor volume <10mm and >5 mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5640','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for human fibroblast HT1080 (10 million)','3.0E+8 pfu','NA','Complete regrression in tumor in all mice (tumor volume <10mm and >5 mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5641','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for human ovarian carcinoma PA-1 (10 million)','3.0E+8 pfu','NA','Complete regrression in tumor in all mice (tumor volume <10mm and >5 mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5642','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for human oral carcinoma KB (10 million)','3.0E+8 pfu','NA','Complete reduction in tumor in 7 mice from all 12 treated (tumor volume <10mm and >5 mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5643','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for human fmelanoma SKMEL (10 million)','3.0E+8 pfu','NA','Complete reduction in tumor in 5 mice from all 8 treated (tumor volume <10mm and >5 mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5644','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for human lung carcinoma A375 (10 million)','3.0E+8 pfu','NA','Complete reduction in tumor in 5 mice from all 8 treated (tumor volume <10mm and >5 mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5645','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for human lung carcinoma A375 (10 million)','3.0E+8 pfu','NA','Complete regrression in tumor in all mice (tumor volume <10mm and >5 mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5646','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for humanglioblastoma U87MG (10 million)','3.0E+8 pfu','NA','Complete reduction in tumor in 1 mice from all 9 treated (tumor volume <10mm and >5 mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5647','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for human fibroblast HT1080 (10 million)','1.0E+9 pfu','NA','Complete regression in all tumor bearing mice (tumor volume <8.5 mm and > 5.5)','Intravenously','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5648','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for human fibroblast HT1080 (10 million)','3.0E+8 pfu','NA','Complete regression in all tumor bearing mice (tumor volume <8.5 mm and > 5.5)','Intravenously','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5649','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for human fibroblast HT1080 (10 million)','6.0E+7 pfu','NA','Complete regression in tumor volume in 10 mice out of 11 (tumor volume <8.5 mm and > 5.5)','Intravenously','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5650','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for human fibroblast HT1080 (10 million)','2.0E+7 pfu','NA','Complete regression in tumor volume in 5 mice out of 11 (tumor volume <8.5 mm and > 5.5)','Intravenously','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5651','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for human fibroblast HT1080 (10 million)','2.0E+7 pfu','NA','Complete regression in tumor volume in 5 mice out of 7 (tumor volume <8.5 mm and > 5.5)','Intravenously','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5652','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','1.5E+9 pfu','NA','Complete regression in tumor in 2 mice from total 8 tretated (tumor dimension 8 - 9.5mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5653','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','9.0E+8 pfu','NA','Complete regression in tumor in 7 mice from total 8 tretated (tumor dimension 8 - 9.5mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5654','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+8 pfu','NA','Complete regression in tumor in 3 mice from total 8 tretated (tumor dimension 8 - 9.5mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5655','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','1.5E+9 pfu','NA','Complete regression in tumor in 2 mice from total 6 tretated (tumor volume <300mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5656','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','9.0E+8 pfu','NA','Complete regression in tumor in 3 mice from total 4 tretated (tumor dimension <300mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5657','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+8 pfu','NA','Complete regression in tumor in 2 mice from total 6 tretated (tumor volume <300mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5658','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+8 pfu','NA','Complete regression in tumor in 3 mice from total 5 tretated (tumor volume >300mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5659','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+8 pfu','NA','Complete regression in tumor in all mice(tumor volume >300mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5660','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+8 pfu','NA','Complete regression in tumor in 4 mice from total 5 tretated (tumor volume>300mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5661','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','1.5E+9 pfu','NA','Complete regression in tumor in all mice (tumor dimension 10 - 11.5 mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5662','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+8 pfu','NA','Complete regression in tumor in 6 mice from 7 (tumor dimension 10 - 11.5 mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5663','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+7 pfu','NA','Complete regression in tumor in 5 mice from 7 (tumor dimension 10 - 11.5 mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5664','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+6 pfu','NA','Complete regression in tumor in 5 mice from 7 (tumor dimension 10 - 11.5 mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5665','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','1.5E+9 pfu','NA','Complete regression in tumor in all mice (tumor volume >300mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5666','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+8 pfu','NA','Complete reduction in tumor in 6 mice from 7 (tumor volume >300mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5667','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+7 pfu','NA','Complete reduction in tumor in 4 mice from 6 (tumor volume >300mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5668','Newcastle disease virus','NDV-MK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+6 pfu','NA','Complete reduction in tumor in 4 mice from 6 (tumor volume >300mm)','Intratumoral','Induction of apoptosis by virus infection','Induction of IFN-Gamma production','NA','US7470426'),
  ('OV_5669','Adenovirus','OV802','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human hepatocellular carcinoma cell line','Hep3B','NA','NA','MTT assay','0.01 MOI','Complete cancer cell death','No','No','NA','No response','NA','NA','Induction of IFN-Gamma, IL6 and other immunostimulatory cytokines production','NA','US7473418'),
  ('OV_5670','Adenovirus','OV802','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human hepatocellular carcinoma cell line','Hep3B','NA','NA','MTT assay','1 MOI','Complete cancer cell death after day 5','No','No','NA','No response','NA','NA','Induction of IFN-Gamma, IL6 and other immunostimulatory cytokines production','NA','US7473418'),
  ('OV_5671','Adenovirus','OV802','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human renal epithelia cancer cell line','HRE','NA','NA','MTT assay','0.01 MOI','Complete cancer cell death','No','No','NA','No response','NA','NA','Induction of IFN-Gamma, IL6 and other immunostimulatory cytokines production','NA','US7473418'),
  ('OV_5672','Adenovirus','OV802','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human renal epithelia cancer cell line','HRE','NA','NA','MTT assay','1 MOI','Complete cancer cell death after day 8','No','No','NA','No response','NA','NA','Induction of IFN-Gamma, IL6 and other immunostimulatory cytokines production','NA','US7473418'),
  ('OV_5673','Adenovirus','OV802','DNA','Adenoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Balb/c mice xenograft for A549 (5.0E+6 )','4.0E+8 pfu','NA','Reduction in tumor volume to below 300 after 80 days','NA','NA','Induction of IFN-Gamma, IL6 and other immunostimulatory cytokines production','NA','US7473418'),
  ('OV_5674','Herpes simplex virus','HSV-G47-delta','DNA','Herpesviridae','Deletion mutatnt for Gamma 34.5, ICP6 and ICP47 gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','A/J mice isograft for Neuro2a cell line (5.0E+6)','1.0E+6 pfu','NA','Reduction in tumor volume to 2500mm after 17 days','Intratumoral','NA','Induction of IL-12 and IFn-gamma production','NA','US7655459'),
  ('OV_5675','Herpes simplex virus','HSV-G47-delta','DNA','Herpesviridae','Deletion mutatnt for Gamma 34.5, ICP6 and ICP47 gene','No','Virus in combination with IL-18','No','NA','NA','NA','NA','NA','NA','NA','NA','A/J mice isograft for Neuro2a cell line (5.0E+6)','1.0E+6 pfu','NA','Reduction in tumor volume below 500mm after 17 days','Intratumoral','NA','Induction of IL-12 and IFn-gamma production','NA','US7655459'),
  ('OV_5676','Herpes simplex virus','HSV-G47-delta','DNA','Herpesviridae','Deletion mutatnt for Gamma 34.5, ICP6 and ICP47 gene','No','Virus in combination with IL-18 (1microgram/day)','No','NA','NA','NA','NA','NA','NA','NA','NA','A/J mice isograft for Neuro2a cell line (5.0E+6)','2.0E+6 pfu','NA','Reduction in tumor volume to 700mm after 15 days compared to control 2200mm','Intratumoral','NA','Induction of IL-12 and IFn-gamma production','NA','US7655459'),
  ('OV_5677','Herpes simplex virus','HSV-R8306','DNA','Herpesviridae','Deletion mutant for Gamma 34.5 gene and addition of IL-4 gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','C57BL/6 mice xenograft for GL-261 (1.0E+5)','1.0E+6 pfu','NA','Increase in survival of mice up to 28 day','Intratumoral','NA','NA','NA','US7744899'),
  ('OV_5678','Herpes simplex virus','HSV-R8306','DNA','Herpesviridae','Deletion mutant for Gamma 34.5 gene and addition of IL-10 gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','C57BL/6 mice xenograft for GL-261 (1.0E+5)','1.0E+6 pfu','NA','Increase in survival of mice up to 26 day','Intratumoral','NA','NA','NA','US7744899'),
  ('OV_5679','Reovirus','Reovirus strain T3D','RNA','Reoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','SCID mice xenograft for MDA-MB468 (1.0E+5)','1.0E+7 pfu','NA','Reduction in tumor volume to 38.33gm compared to control 128.54 after 4 weeks','Intratumoral','NA','NA','NA','US7815914'),
  ('OV_5680','Reovirus','Reovirus strain T3D','RNA','Reoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','C3H mice xenografted for ras transformed C3H cell line (1.0E+6)','5.0E+8 pfu','NA','Reduction in tumor volume to 60mm after 24 days','Intravenously','NA','NA','NA','US7964187'),
  ('OV_5681','Reovirus','Reovirus strain T3D','RNA','Reoviridae','None','No','Virus strain in combination with cisplatin (2.5 mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','C3H mice xenografted for ras transformed C3H cell line (1.0E+6)','5.0E+8 pfu','NA','Reduction in tumor volume to 22mm after 24 days','Intravenously','NA','NA','NA','US7964187'),
  ('OV_5682','Vaccinia virus','GLV-1h22','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 261.8mm compared to control 240.8 mm after 33 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5683','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 248.4mm compared to control 240.8 mm after 33 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5684','Vaccinia virus','GLV-1h70','DNA','Poxviridae','Insertion of Ruc-GFP, LacZ gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 216.8mm compared to control 240.8 mm after 33 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5685','Vaccinia virus','GLV-1h71','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus respectively using P11k vector','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 208.8mm compared to control 240.8 mm after 33 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5686','Vaccinia virus','GLV-1h72','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA and LacZ at F14.5L gene locus and TK and HA gene locus respectively using P11k vector','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 157.2mm compared to control 240.8 mm after 33 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5687','Vaccinia virus','GLV-1h73','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, LacZ gene at TK gene, noncoding DNA into HA locus','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 280.3mm compared to control 240.8 mm after 33 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5688','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 301.9mm compared to control 240.8 mm after 33 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5689','Vaccinia virus','GLV-1h22','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 273.5mm compared to control 263.6 mm after 36 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5690','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 243.8mm compared to control 263.6 mm after 36 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5691','Vaccinia virus','GLV-1h70','DNA','Poxviridae','Insertion of Ruc-GFP, LacZ gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 286mm compared to control 263.6 mm after 36 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5692','Vaccinia virus','GLV-1h71','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus respectively using P11k vector','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 267.1mm compared to control 263.6 mm after 36 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5693','Vaccinia virus','GLV-1h72','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA and LacZ at F14.5L gene locus and TK and HA gene locus respectively using P11k vector','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 155.6mm compared to control 263.6 mm after 36 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5694','Vaccinia virus','GLV-1h73','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, LacZ gene at TK gene, noncoding DNA into HA locus','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 310.9mm compared to control 263.6 mm after 36 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5695','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 416.9mm compared to control 263.6 mm after 36 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5696','Vaccinia virus','GLV-1h22','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 536.1mm compared to control 579.1 mm after 43 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5697','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 5550.4mm compared to control 579.1 mm after 43 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5698','Vaccinia virus','GLV-1h70','DNA','Poxviridae','Insertion of Ruc-GFP, LacZ gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 463.4mm compared to control 579.1 mm after 43 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5699','Vaccinia virus','GLV-1h71','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus respectively using P11k vector','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 543.3mm compared to control 579.1 mm after 43 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5700','Vaccinia virus','GLV-1h72','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA and LacZ at F14.5L gene locus and TK and HA gene locus respectively using P11k vector','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 320.1mm compared to control 579.1 mm after 43 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5701','Vaccinia virus','GLV-1h73','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, LacZ gene at TK gene, noncoding DNA into HA locus','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 679mm compared to control 579.1 mm after 43 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5702','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 660mm compared to control 579.1 mm after 43 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5703','Vaccinia virus','GLV-1h22','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 701.4mm compared to control 636.4 mm after 50 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5704','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 761.3mm compared to control 636.4 mm after 50 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5705','Vaccinia virus','GLV-1h70','DNA','Poxviridae','Insertion of Ruc-GFP, LacZ gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 706.6mm compared to control 636.4 mm after 50 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5706','Vaccinia virus','GLV-1h71','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus respectively using P11k vector','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 721.3mm compared to control 636.4 mm after 50 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5707','Vaccinia virus','GLV-1h72','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA and LacZ at F14.5L gene locus and TK and HA gene locus respectively using P11k vector','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 476.3mm compared to control 636.4 mm after 50 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5708','Vaccinia virus','GLV-1h73','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, LacZ gene at TK gene, noncoding DNA into HA locus','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 864.1mm compared to control 636.4 mm after 50 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5709','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 828.6mm compared to control 636.4 mm after 50 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5710','Vaccinia virus','GLV-1h22','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 978.4mm compared to control 671.6 mm after 57 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5711','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 852mm compared to control 671.6 mm after 57 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5712','Vaccinia virus','GLV-1h70','DNA','Poxviridae','Insertion of Ruc-GFP, LacZ gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 985.5mm compared to control 671.6 mm after 57 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5713','Vaccinia virus','GLV-1h71','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus respectively using P11k vector','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 936.1mm compared to control 671.6 mm after 57 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5714','Vaccinia virus','GLV-1h72','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA and LacZ at F14.5L gene locus and TK and HA gene locus respectively using P11k vector','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 695mm compared to control 671.6 mm after 57 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5715','Vaccinia virus','GLV-1h73','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, LacZ gene at TK gene, noncoding DNA into HA locus','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 1179.9mm compared to control 671.6 mm after 57 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5716','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 897.4mm compared to control 671.6 mm after 57 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5717','Vaccinia virus','GLV-1h22','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 1485mm compared to control 2715 mm after 92 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5718','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 1053mm compared to control 2715 mm after 92 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5719','Vaccinia virus','GLV-1h70','DNA','Poxviridae','Insertion of Ruc-GFP, LacZ gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 852mm compared to control 2715 mm after 92 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5720','Vaccinia virus','GLV-1h71','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus respectively using P11k vector','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 606mm compared to control 2715 mm after 92 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5721','Vaccinia virus','GLV-1h72','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA and LacZ at F14.5L gene locus and TK and HA gene locus respectively using P11k vector','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 751mm compared to control 2715 mm after 92 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5722','Vaccinia virus','GLV-1h73','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, LacZ gene at TK gene, noncoding DNA into HA locus','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 166.7mm compared to control 2715 mm after 92 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5723','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Complete regression in tumor volume after 92 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5724','Vaccinia virus','GLV-1h22','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 1536.9mm compared to control 2918.3 mm after 97 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5725','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 962.2mm compared to control 2918.3 mm after 97 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5726','Vaccinia virus','GLV-1h70','DNA','Poxviridae','Insertion of Ruc-GFP, LacZ gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 579.2mm compared to control 2918.3 mm after 97 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5727','Vaccinia virus','GLV-1h71','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus respectively using P11k vector','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 546.9mm compared to control 2918.3 mm after 97 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5728','Vaccinia virus','GLV-1h72','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA and LacZ at F14.5L gene locus and TK and HA gene locus respectively using P11k vector','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 720.1mm compared to control 2918.3 mm after 97 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5729','Vaccinia virus','GLV-1h73','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, LacZ gene at TK gene, noncoding DNA into HA locus','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 117.8mm compared to control 2918.3 mm after 97 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5730','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Complete regression in tumor volume after 97 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5731','Vaccinia virus','GLV-1h22','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 412.9mm after 39 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5732','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 350.2mm after 39 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5733','Vaccinia virus','GLV-1h73','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, LacZ gene at TK gene, noncoding DNA into HA locus','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 341.1mm after 39 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5734','Vaccinia virus','GLV-1h82','DNA','Poxviridae','Insertion of Ruc-GFP gene at place of HA gene under Psel promoter','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 353.4mm after 39 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5735','Vaccinia virus','GLV-1h83','DNA','Poxviridae','Insertion of Ruc-GFP gene at place of HA gene under Psel promoter','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 392.25mm after 39 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5736','Vaccinia virus','GLV-1h84','DNA','Poxviridae','Insertion of Ruc-GFP gene at place of F14.5L gene under Psel promoter','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 305.6mm after 39 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5737','Vaccinia virus','GLV-1h85','DNA','Poxviridae','Insertion of noncoding DNA into F14.5L gene, TK gene at place of LacZ and gusA gene at place of HA gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 350.65mm after 39 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5738','Vaccinia virus','GLV-1h86','DNA','Poxviridae','Insertion of Ruc-GFP into F14.5L gene, noncoding DNA at place of LacZ and HA gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 419.55mm after 39 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5739','Vaccinia virus','GLV-1h22','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 750.4mm after 47 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5740','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 722.3mm after 47 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5741','Vaccinia virus','GLV-1h73','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, LacZ gene at TK gene, noncoding DNA into HA locus','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 819.8mm after 47 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5742','Vaccinia virus','GLV-1h82','DNA','Poxviridae','Insertion of Ruc-GFP gene at place of HA gene under Psel promoter','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 1081.2mm after 47 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5743','Vaccinia virus','GLV-1h83','DNA','Poxviridae','Insertion of Ruc-GFP gene at place of HA gene under Psel promoter','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 1222.25mm after 47 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5744','Vaccinia virus','GLV-1h84','DNA','Poxviridae','Insertion of Ruc-GFP gene at place of F14.5L gene under Psel promoter','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 604.3mm after 47 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5745','Vaccinia virus','GLV-1h85','DNA','Poxviridae','Insertion of noncoding DNA into F14.5L gene, TK gene at place of LacZ and gusA gene at place of HA gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 914mm after 47 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5746','Vaccinia virus','GLV-1h86','DNA','Poxviridae','Insertion of Ruc-GFP into F14.5L gene, noncoding DNA at place of LacZ and HA gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 962.1mm after 47 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5747','Vaccinia virus','GLV-1h22','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 1424.4mm after 62 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5748','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 1390.35mm after 62 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5749','Vaccinia virus','GLV-1h73','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, LacZ gene at TK gene, noncoding DNA into HA locus','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 983.2mm after 62 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5750','Vaccinia virus','GLV-1h82','DNA','Poxviridae','Insertion of Ruc-GFP gene at place of HA gene under Psel promoter','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 1319.2mm after 62 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5751','Vaccinia virus','GLV-1h83','DNA','Poxviridae','Insertion of Ruc-GFP gene at place of HA gene under Psel promoter','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 1686.05mm after 62 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5752','Vaccinia virus','GLV-1h84','DNA','Poxviridae','Insertion of Ruc-GFP gene at place of F14.5L gene under Psel promoter','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 982mm after 62 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5753','Vaccinia virus','GLV-1h85','DNA','Poxviridae','Insertion of noncoding DNA into F14.5L gene, TK gene at place of LacZ and gusA gene at place of HA gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 947.2mm after 62 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5754','Vaccinia virus','GLV-1h86','DNA','Poxviridae','Insertion of Ruc-GFP into F14.5L gene, noncoding DNA at place of LacZ and HA gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 1397.55mm after 62 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5755','Vaccinia virus','GLV-1h22','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 1907.5mm after 75 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5756','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 1528.95mm after 75 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5757','Vaccinia virus','GLV-1h73','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, LacZ gene at TK gene, noncoding DNA into HA locus','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 517.3mm after 75 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5758','Vaccinia virus','GLV-1h82','DNA','Poxviridae','Insertion of Ruc-GFP gene at place of HA gene under Psel promoter','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 1211.8mm after 75 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5759','Vaccinia virus','GLV-1h83','DNA','Poxviridae','Insertion of Ruc-GFP gene at place of HA gene under Psel promoter','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 1856.35mm after 75 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5760','Vaccinia virus','GLV-1h84','DNA','Poxviridae','Insertion of Ruc-GFP gene at place of F14.5L gene under Psel promoter','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 614.25mm after 75 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5761','Vaccinia virus','GLV-1h85','DNA','Poxviridae','Insertion of noncoding DNA into F14.5L gene, TK gene at place of LacZ and gusA gene at place of HA gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 255.25mm after 75 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5762','Vaccinia virus','GLV-1h86','DNA','Poxviridae','Insertion of Ruc-GFP into F14.5L gene, noncoding DNA at place of LacZ and HA gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 689.6mm after 75 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5763','Vaccinia virus','GLV-1h22','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 1887.6mm after 89 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5764','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vectorrespectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 1181.4mm after 89 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5765','Vaccinia virus','GLV-1h73','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, LacZ gene at TK gene, noncoding DNA into HA locus','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 74.4mm after 89 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5766','Vaccinia virus','GLV-1h82','DNA','Poxviridae','Insertion of Ruc-GFP gene at place of HA gene under Psel promoter','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 855.9mm after 89 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5767','Vaccinia virus','GLV-1h83','DNA','Poxviridae','Insertion of Ruc-GFP gene at place of HA gene under Psel promoter','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 1392mm after 89 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5768','Vaccinia virus','GLV-1h86','DNA','Poxviridae','Insertion of Ruc-GFP into F14.5L gene, noncoding DNA at place of LacZ and HA gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes 187.5mm after 89 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5769','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 264.9mm compared to control 204.3 mm after 32 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5770','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 365.7mm compared to control 333.9 mm after 42 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5771','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 155.3mm compared to control 646.6 mm after 50 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5772','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 62mm compared to control 886.4 mm after 56 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5773','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','No','Virus in combination with cidofovir (25mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 291.1mm compared to control 204.3 mm after 32 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5774','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','No','Virus in combination with cidofovir (25mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 314.2mm compared to control 333.9 mm after 42 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5775','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','No','Virus in combination with cidofovir (25mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 238.3mm compared to control 646.6 mm after 50 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5776','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','No','Virus in combination with cidofovir (25mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 117.4mm compared to control 886.4 mm after 56 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5777','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','No','Virus in combination with cidofovir (50mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 279.8mm compared to control 204.3 mm after 32 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5778','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','No','Virus in combination with cidofovir (50mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 395.5mm compared to control 333.9 mm after 42 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5779','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','No','Virus in combination with cidofovir (50mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 206.5mm compared to control 646.6 mm after 50 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5780','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','No','Virus in combination with cidofovir (50mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 61mm compared to control 886.4 mm after 56 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5781','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','No','Virus in combination with cidofovir (100mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 587.1mm compared to control 204.3 mm after 32 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5782','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','No','Virus in combination with cidofovir (100mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 391.1mm compared to control 333.9 mm after 42 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5783','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','No','Virus in combination with cidofovir (100mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 184mm compared to control 646.6 mm after 50 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5784','Vaccinia virus','GLV-1h74','DNA','Poxviridae','Insertion of noncoding DNA at F14.5 locus, noncoding DNA at TK locus and HA gene locus in gusA','No','Virus in combination with cidofovir (100mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for GI-101A human breast carcinoma cells (5.0E+6)','5.0E+6 pfu','NA','Tumor volume become 58mm compared to control 886.4 mm after 56 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5785','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','1.0E+7 pfu','NA','Tumor volume reduced to 176.9 mm compared to control 278.1 after 53 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5786','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','1.0E+7 pfu','NA','Tumor volume reduced to 598.8mm compared to control 755 after 63 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5787','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','1.0E+7 pfu','NA','Tumor volume reduced to 668.4 mm compared to control 1169.9 after 69 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5788','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','1.0E+7 pfu','NA','Tumor volume reduced to 896.6 mm compared to control 2512.7 after 77 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5789','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','2.0E+6 pfu','NA','Tumor volume becomes 298.8 after 41 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5790','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','2.0E+6 pfu','NA','Tumor volume becomes 1448.3 after 55 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5791','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','2.0E+6 pfu','NA','Tumor volume becomes 2512.4 after 64 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5792','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','2.0E+6 pfu','NA','Tumor volume becomes 34.07 after 71 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5793','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','No','Virus in combination with cisplatin (5mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','2.0E+6 pfu','NA','Tumor volume becomes 415.1 after 41 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5794','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','No','Virus in combination with cisplatin (5mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','2.0E+6 pfu','NA','Tumor volume becomes 1403.1 after 55 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5795','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','No','Virus in combination with cisplatin (5mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','2.0E+6 pfu','NA','Tumor volume becomes 1163.7 after 64 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5796','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','No','Virus in combination with cisplatin (5mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','2.0E+6 pfu','NA','Tumor volume becomes 993 after 71 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5797','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','No','Virus in combination with cisplatin (5mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','2.0E+6 pfu','NA','Tumor volume becomes 757.5 after 79 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5798','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','No','Virus in combination with cisplatin (5mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','2.0E+6 pfu','NA','Tumor volume becomes 667 after 87 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5799','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','No','Virus in combination with cisplatin (5mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','2.0E+6 pfu','NA','Tumor volume becomes 547 after 93 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5800','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','No','Virus in combination with cisplatin (5mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','2.0E+6 pfu','NA','Tumor volume becomes 549 after 99 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5801','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','No','Virus in combination with cisplatin (5mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','2.0E+6 pfu','NA','Tumor volume becomes 511 after 106 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5802','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','No','Virus in combination with cisplatin (5mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','2.0E+6 pfu','NA','Tumor volume becomes 465.3 after 113 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5803','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','No','Virus in combination with cisplatin (5mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','2.0E+6 pfu','NA','Tumor volume becomes 441.3 after 119 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5804','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes to 268.4 after 55 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5805','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes to 623.7 after 62 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5806','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes to 1232.5 after 70 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5807','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes to 1277.05 after 75 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5808','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','5.0E+6 pfu','NA','Tumor volume reduced to 1189.55 mm after 81 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5809','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','5.0E+6 pfu','NA','Tumor volume reduced to 744.4mm after 89 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5810','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','No','Virus in combination with cisplatin (5mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes to 402.1 after 55 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5811','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','No','Virus in combination with cisplatin (5mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes to 1128.15 after 62 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5812','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','No','Virus in combination with cisplatin (5mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes to 1485.05 after 70 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5813','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','No','Virus in combination with cisplatin (5mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','5.0E+6 pfu','NA','Tumor volume becomes to 1599.35 after 75 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5814','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','No','Virus in combination with cisplatin (5mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','5.0E+6 pfu','NA','Tumor volume reduced to 1411.4mm after 81 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5815','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','No','Virus in combination with cisplatin (5mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','5.0E+6 pfu','NA','Tumor volume reduced to 1040mm after 89 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5816','Vaccinia virus','GLV-1h68','DNA','Poxviridae','Insertion of Ruc-GFP, non coding DNA at F14.5L gene locus and TK and HA gene locus using psel vector respectively','No','Virus in combination with cisplatin (5mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for OVCAR-3 (5.0E+6)','5.0E+6 pfu','NA','Tumor volume reduced to 906.75 mm after 96 days','Intravenously','Induction of apoptosis','NA','NA','US8052968'),
  ('OV_5817','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human fibrosarcoma cell line','HT1080','80% confluency','NA','NA','2 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5818','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human melanoma cell line','SK-MEL-2','80% confluency','NA','NA','8 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5819','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human melanoma cell line','SKMEL-3','80% confluency','NA','NA','2 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5820','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human melanoma cell line','SKMEL-5','80% confluency','NA','NA','4 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5821','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human melanoma cell line','A375','80% confluency','NA','NA','37 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5822','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human melanoma cell line','MALME-3M','80% confluency','NA','NA','778 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5823','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human melanoma cell line','HT144','80% confluency','NA','NA','28 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5824','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human breast carcinoma cell line','SKBR3','80% confluency','NA','NA','10 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5825','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human breast carcinoma cell line','MDA-MB-468','80% confluency','NA','NA','44 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5826','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human breast carcinoma cell line','ZR75-1','80% confluency','NA','NA','78 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5827','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human ovarian carcinoma cell line','SW26','80% confluency','NA','NA','4 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5828','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human ovarian carcinoma cell line','PA-1','80% confluency','NA','NA','4 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5829','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human ovarian carcinoma cell line','ES-2','80% confluency','NA','NA','13 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5830','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human ovarian carcinoma cell line','SKOV3','80% confluency','NA','NA','24 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5831','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human ovarian carcinoma cell line','OVCAR3','80% confluency','NA','NA','34 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5832','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human lung adenocarcinoma cell line','H-1299','80% confluency','NA','NA','26 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5833','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human glioblastoma cell line','U-87 MG','80% confluency','NA','NA','25 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5834','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human glioblastoma cell line','U373MG','80% confluency','NA','NA','765 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5835','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human glioblastoma cell line','U138','80% confluency','NA','NA','38 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5836','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human glioblastoma cell line','A172','80% confluency','NA','NA','207 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5837','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human bladder carcinoma cell line','HT1197','80% confluency','NA','NA','3 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5838','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human bladder carcinoma cell line','UM-UC-3','80% confluency','NA','NA','54 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5839','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human bladder carcinoma cell line','HT1376','80% confluency','NA','NA','422 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5840','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human neuroblastoma cell line','IMR-32','80% confluency','NA','NA','41 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5841','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human cervical carcinoma cell line','HeLa','80% confluency','NA','NA','4 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5842','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human prostae carcinoma cell line','Du145','80% confluency','NA','NA','31 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5843','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human prostae carcinoma cell line','PC-3','80% confluency','NA','NA','3.1 ×10³ pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5844','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human colon carcinoma cell line','SW620','80% confluency','NA','NA','55 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5845','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human colon carcinoma cell line','HT-29','80% confluency','NA','NA','1 ×10⁶ pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5846','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human head and neck carcinoma cell line','KB','80% confluency','NA','NA','4 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5847','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human head and neck carcinoma cell line','A253','80% confluency','NA','NA','2.7 ×10³ pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5848','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human head and neck carcinoma cell line','FaDu','80% confluency','NA','NA','2.9 ×10³ pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5849','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human head and neck carcinoma cell line','Hep-2','80% confluency','NA','NA','1.5 ×10⁴ pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5850','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human neuroepithelia cancer cell line','SK-N-MC','80% confluency','NA','NA','20 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5851','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human small cell lung carcinoma cell line','DMS-114','80% confluency','NA','NA','48 pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5852','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human small cell lung carcinoma cell line','DMS-153','80% confluency','NA','NA','1.1 ×10⁵ pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5853','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human small cell lung carcinoma cell line','NCI-H345','80% confluency','NA','NA','1.2 ×10⁶ pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5854','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human small cell prostae carcinoma cell line','NCI-H660','80% confluency','NA','NA','1.0 ×10⁵ pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5855','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human leukemia cell line','K562','80% confluency','NA','NA','5.4 ×10⁴ pfu','50% cancer cell death','No','No','NA','No response','NA','NA','NA','NA','US8105578'),
  ('OV_5856','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for HT1080 (10 million)','3.0E+8 pfu','NA','Complete regression in tumor in 11 mouse out of 12','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5857','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for PA-1 (10 million)','3.0E+8 pfu','NA','Complete regression in tumor in 9 mouse out of 9','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5858','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for KB (10 million)','3.0E+8 pfu','NA','Complete regression in tumor in 7 mouse out of 12','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5859','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for SKMEL5 (10 million)','3.0E+8 pfu','NA','Complete regression in tumor in 5 mouse out of 8','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5860','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+8 pfu','NA','Complete regression in tumor in 1 mouse out of 8','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5861','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for U87MG (10 million)','3.0E+8 pfu','NA','Complete regression in tumor in 1 mouse out of 9','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5862','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','1.5E+9 pfu','NA','Complete regression in 2 out of 8 (tumor dimension 8 - 9.5 mm)','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5863','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','9.0E+8 pfu','NA','Complete regression in 7 out of 8 (tumor dimension 8 - 9.5 mm)','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5864','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+8 pfu','NA','Complete regression in 3 out of 8 (tumor dimension 8 - 9.5 mm)','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5865','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+8 pfu','NA','Complete regression in 3 out of 3 (tumor dimension 10 - 11 mm)','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5866','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+8 pfu','NA','Complete regression in 3 out of 3 (tumor dimension 10 - 11 mm)','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5867','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+8 pfu','NA','Complete regression in 3 out of 3 (tumor dimension 10 - 11 mm)','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5868','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','1.5E+9 pfu','NA','Complete regression in tumor volume in 2 out of total 6 (tumor volume <300mm)','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5869','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','9.0E+8 pfu','NA','Complete regression in tumor volume in 3 out of total 4 (tumor volume <300mm)','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5870','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+8 pfu','NA','Complete regression in tumor volume in 2 out of total 6 (tumor volume <300mm)','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5871','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','1.5E+9 pfu','NA','Complete regression in tumor volume in 3 out of total 5 (tumor volume >300mm)','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5872','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','9.0E+8 pfu','NA','Complete regression in tumor volume in 7 out of total 7 (tumor volume >300mm)','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5873','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+10 pfu','NA','Complete regression in tumor volume in 4 out of total 5 (tumor volume >300mm)','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5874','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','1.5E+9 pfu','NA','Complete reduction in tumor 7 out of 7 (tumor dimension 10 - 11.5 mm)','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5875','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+8 pfu','NA','Complete reduction in tumor 6 out of 7 (tumor dimension 10 - 11.5 mm)','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5876','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+7 pfu','NA','Complete reduction in tumor 5 out of 7 (tumor dimension 10 - 11.5 mm)','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5877','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+6 pfu','NA','Complete reduction in tumor 5 out of 7 (tumor dimension 10 - 11.5 mm)','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5878','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','1.5E+9 pfu','NA','Complete reduction in tumor volume 7 out of 7 (Tumor volume >300mm)','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5879','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+8 pfu','NA','Complete reduction in tumor volume 6 out of 7 (Tumor volume >300mm)','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5880','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+7 pfu','NA','Complete reduction in tumor volume 4 out of 6 (Tumor volume >300mm)','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5881','Newcastle disease virus','NDV-PPMK107','RNA','Paramyxoviridae','None','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for A375 (10 million)','3.0E+6 pfu','NA','Complete reduction in tumor volume 4 out of 6 (Tumor volume >300mm)','Intratumoral','NA','NA','NA','US8105578'),
  ('OV_5882','Herpes simplex virus','Mutant','DNA','Herpesviridae','Deletion mutant for Gamma 34.5 gene','Yes','No','Virus expressing vasculostatin peptide','ATCC','NA','NA','NA','NA','NA','NA','NA','Athymic mice xenograft for U87DeltaEGFR','1.0E+5 pfu','NA','Survival time increased','Intratumoral','NA','NA','NA','US8450106'),
  ('OV_5883','Parovirus','Mutant','DNA','Paroviridae','Deletion mutatnt for Gamma 34.5, ICP6 and ICP47 gene','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Balb/c mice xenograft for PANC-1','1 RU per ml','NA','Tumor volume reduced to 500mm after 83 days','Intratumoral','NA','NA','NA','US8916176'),
  ('OV_5884','Parovirus','Mutant','DNA','Paroviridae','Deletion mutatnt for Gamma 34.5, ICP6 and ICP47 gene','Yes','No','Yes','NA','NA','NA','NA','NA','NA','NA','NA','Balb/c mice xenograft for HeLa (2.0E+6)','1 RU per ml','NA','Survival time increased up to 40 days','Intratumoral','NA','NA','NA','US8916176'),
  ('OV_5885','Vaccinia virus','Mutant','DNA','Poxviridae','Mutant in F2L gene','No','Virus in combination with 5FC(100mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Nude mice xenograft for LoVo cell','1.0E+6 pfu','NA','Tumor volume reduced to 1000mm compared to control 2500mm after 40 days','Intratumoral','NA','NA','NA','US9180150'),
  ('OV_5886','Vaccinia virus','Mutant','DNA','Poxviridae','Mutant in F2L gene','No','Virus in combination with 5FC(100mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Nude mice xenograft for HepG2','1.0E+6 pfu','NA','Tumor volume reduced to 1000mm compared to control 2500mm after 40 days','Intratumoral','NA','NA','NA','US9180150'),
  ('OV_5887','Respiratory synctial virus','Mutant','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human RWPE-1 cell line','Human RWPE-1 cell line','NA','NA','MTT assay','2 MOI','Slight reduction in tumor growth','No','No','NA','No response','NA','Induction of apoptosis as measured by TUNEL assay','NA','NA','US9241998'),
  ('OV_5888','Respiratory synctial virus','Mutant','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human prostate cancer cell line','PC-3','NA','NA','MTT assay','2 MOI','20% cell survived after treatment','No','No','NA','No response','NA','Induction of apoptosis as measured by TUNEL assay','NA','NA','US9241998'),
  ('OV_5889','Respiratory synctial virus','Mutant','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic nude mice xenograft for PC-3 (3.0E+6), below ear','1.0E+6 pfu','NA','Tumor volume reduced to 200mm after 38 days compared to control 1200mm','Intratumoral','Induction of apoptosis as measured by TUNEL assay','NA','NA','US9241998'),
  ('OV_5890','Respiratory synctial virus','Mutant','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic nude mice xenograft for PC-3 (3.0E+6), below ear','1.0E+6 pfu','NA','Tumor volume reduced to 300mm after 35 days compared to control 900mm','Intratumoral','Induction of apoptosis as measured by TUNEL assay','NA','NA','US9241998'),
  ('OV_5891','Adenovirus','CGTG-602','DNA','Adenoviridae','Virus E1A promoter is replaced by human E2F1 promoter','Yes','No','No','ATCC','Human lung cancer cell line','A549','NA','NA','MTT assay','1 ×10⁴ pfu','80% of cancer cell death occurs after 100 days','No','No','NA','No response','NA','NA','NA','NA','US9410129'),
  ('OV_5892','Adenovirus','CGTG-602','DNA','Adenoviridae','Virus E1A promoter is replaced by human E2F1 promoter','Yes','No','No','ATCC','Human ovarian carcinoma cell line','SKOV3','NA','NA','MTT assay','1 ×10⁴ pfu','80% of cancer cell death occurs after 100 days','No','No','NA','No response','NA','NA','NA','NA','US9410129'),
  ('OV_5893','Adenovirus','CGTG-602','DNA','Adenoviridae','Virus E1A promoter is replaced by human E2F1 promoter','Yes','No','No','ATCC','Human prostate cancer cell line','PC-3-MM2','NA','NA','MTT assay','1 ×10⁴ pfu','All cell death occurs after 100 days','No','No','NA','No response','NA','NA','NA','NA','US9410129'),
  ('OV_5894','Adenovirus','CGTG-602','DNA','Adenoviridae','Virus E1A promoter is replaced by human E2F1 promoter','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Hamster xenograft for HAPT-1 (7.0E+6)','3.0E+8 pfu','NA','Tumor volume reduced to 300mm after 18 days compared to control 800mm','Intratumoral','NA','NA','NA','US9410129'),
  ('OV_5895','Adenovirus','CGTG-602','DNA','Adenoviridae','Virus E1A promoter is replaced by human E2F1 promoter','No','Virus in combination with cyclosporin','No','NA','NA','NA','NA','NA','NA','NA','NA','Hamster xenograft for HAPT-1 (7.0E+6)','3.0E+8 pfu','NA','Tumor volume reduced to 300mm after 18 days compared to control 800mm','Intratumoral','NA','NA','NA','US9410129'),
  ('OV_5896','Vaccinia virus','VVTK-FCU1','DNA','Poxviridae','Defective in J2R gene, expressing FCU1 gene','Yes','No','No','NA','Human colon tumor cell line','LoVo','3.0E+5 pfu','NA','MTT assay','0.00001 MOI','60% of cancer cell death occurs','No','No','NA','No response','NA','NA','NA','NA','US9687515'),
  ('OV_5897','Vaccinia virus','VVTK-FCU1','DNA','Poxviridae','Defective in J2R gene, expressing FCU1 gene, defective in I4L gene','Yes','No','No','NA','Human colon tumor cell line','LoVo','3.0E+5 pfu','NA','MTT assay','0.00001 MOI','58% of cancer cell death occurs','No','No','NA','No response','NA','NA','NA','NA','US9687515'),
  ('OV_5898','Vaccinia virus','VVTK-FCU1','DNA','Poxviridae','Defective in J2R gene, expressing FCU1 gene, defective in I4L gene','No','Virus in combination with 5FU (100mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Swiss nude mice xenograft for LoVo cell line (5.0E+6)','1.0E+7 pfu','NA','Tumor volume reduced to nearly 1000mm compared to control 2400mm','Intravenously','NA','NA','NA','US9687515'),
  ('OV_5899','Vaccinia virus','VVTK-FCU1','DNA','Poxviridae','Defective in J2R gene, expressing FCU1 gene, defective in F4L gene','No','Virus in combination with 5FU (100mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Swiss nude mice xenograft for LoVo cell line (5.0E+6)','1.0E+7 pfu','NA','Tumor volume reduced to below 1000mm compared to control 2400mm','Intravenously','NA','NA','NA','US9687515'),
  ('OV_5900','Vaccinia virus','VVTK-FCU1','DNA','Poxviridae','Defective in J2R gene, expressing FCU1 gene, defective in I4L gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Swiss nude mice xenograft for U87MG(5.0E+6)','1.0E+7 pfu','NA','Tumor volume reduced to below 500mm comapred to control 3500mm after 60 days','Intravenously','NA','NA','NA','US9687515'),
  ('OV_5901','Vaccinia virus','VVTK-FCU1','DNA','Poxviridae','Defective in J2R gene, expressing FCU1 gene, defective in I4L gene','No','Virus in combination with 5FU (100mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Swiss nude mice xenograft for U87MG(5.0E+6)','1.0E+7 pfu','NA','Tumor volume reduced to below 500mm comapred to control 3500mm after 60 days','Intravenously','NA','NA','NA','US9687515'),
  ('OV_5902','Newcastle disease virus','NDV-B1','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human pancreatic cancer cell line','PANC-1','5E+5 pfu','NA','LDH release assay','0.1 MOI','50% of cancer cell death occurs after 3 days','No','No','NA','No response','NA','NA','Virus induced IFN-gamma production','NA','US10035984'),
  ('OV_5903','Newcastle disease virus','NDV-B1','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human pancreatic cancer cell line','MIA paCa-2','5E+5 pfu','NA','LDH release assay','0.1 MOI','No cell death observed after 3 days','No','No','NA','No response','NA','NA','Virus induced IFN-gamma production','NA','US10035984'),
  ('OV_5904','Newcastle disease virus','NDV-F3aa','RNA','Paramyxoviridae','Virus expressing NS1 protein','Yes','No','No','ATCC','Human pancreatic cancer cell line','PANC-1','5E+5 pfu','NA','LDH release assay','0.1 MOI','100% cell killing observed after 3 days','No','No','NA','No response','NA','NA','Virus induced IFN-gamma production','NA','US10035984'),
  ('OV_5905','Newcastle disease virus','NDV-F3aa','RNA','Paramyxoviridae','Virus expressing NS1 protein','Yes','No','No','ATCC','Human pancreatic cancer cell line','MIA paCa-2','5E+5 pfu','NA','LDH release assay','0.1 MOI','30% cell killing observed after 3 days','No','No','NA','No response','NA','NA','Virus induced IFN-gamma production','NA','US10035984'),
  ('OV_5906','Newcastle disease virus','NDV-B1','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human neck and head carcinoma cell line','SCC','5E+5 pfu','NA','LDH release assay','0.1 MOI','60% cell killing after 3 days','No','No','NA','No response','NA','NA','Virus induced IFN-gamma production','NA','US10035984'),
  ('OV_5907','Newcastle disease virus','NDV-B1','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human neck and head carcinoma cell line','SCC','5E+5 pfu','NA','LDH release assay','0.1 MOI','No cell death observed after 3 days','No','No','NA','No response','NA','NA','Virus induced IFN-gamma production','NA','US10035984'),
  ('OV_5908','Newcastle disease virus','NDV-F3aa','RNA','Paramyxoviridae','Virus expressing NS1 protein','Yes','No','No','ATCC','Human neck and head carcinoma cell line','SCC','5E+5 pfu','NA','LDH release assay','0.1 MOI','100% cell killing observed after 3 days','No','No','NA','No response','NA','NA','Virus induced IFN-gamma production','NA','US10035984'),
  ('OV_5909','Newcastle disease virus','NDV-F3aa','RNA','Paramyxoviridae','Virus expressing NS1 protein','Yes','No','No','ATCC','Human neck and head carcinoma cell line','SCC','5E+5 pfu','NA','LDH release assay','0.1 MOI','70% cell killing after 3 days','No','No','NA','No response','NA','NA','Virus induced IFN-gamma production','NA','US10035984'),
  ('OV_5910','Newcastle disease virus','NDV-B1','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human melanoma cell line','SK MEL-2','5E+5 pfu','NA','LDH release assay','0.1 MOI','100% cell killing observed after 3 days','No','No','NA','','NA','NA','Virus induced IFN-gamma production','NA','US10035984'),
  ('OV_5911','Newcastle disease virus','NDV-B1','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human melanoma cell line','B16-F10','5E+5 pfu','NA','LDH release assay','0.1 MOI','40% cell killing after 3 days','No','No','NA','No response','NA','NA','Virus induced IFN-gamma production','NA','US10035984'),
  ('OV_5912','Newcastle disease virus','NDV-F3aa','RNA','Paramyxoviridae','Virus expressing NS1 protein','Yes','No','No','ATCC','Human melanoma cell line','SK MEL-2','5E+5 pfu','NA','LDH release assay','0.1 MOI','100% cell killing observed after 3 days','No','No','NA','No response','NA','NA','Virus induced IFN-gamma production','NA','US10035984'),
  ('OV_5913','Newcastle disease virus','NDV-F3aa','RNA','Paramyxoviridae','Virus expressing NS1 protein','Yes','No','No','ATCC','Human melanoma cell line','B16-F10','5E+5 pfu','NA','LDH release assay','0.1 MOI','30% cell killing after 3 days','No','No','NA','No response','NA','NA','Virus induced IFN-gamma production','NA','US10035984'),
  ('OV_5914','Newcastle disease virus','NDV-F3aa','RNA','Paramyxoviridae','Virus expressing NS1 protein','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c mice xenograft for B16-F10 (1.0E+5)','5.0E+6 pfu','NA','Complete regression in tumor volume after 25 days','Intratumoral','NA','Virus induced IFN-gamma production','NA','US10035984'),
  ('OV_5915','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','NA','Human lung cancer cell line','ABC-1','NA','NA','WST-1 assay','1 MOI','60% cell killing after 7 days','No','No','NA','No response','NA','NA','NA','NA','US10335481'),
  ('OV_5916','Measles virus','wild type','RNA','Paramyxoviridae','Mutated for SLAM binding','Yes','No','No','NA','Human lung cancer cell line','NCI-H441','NA','NA','WST-1 assay','1 MOI','Complete cell killing after 7 days','No','No','NA','No response','NA','NA','NA','NA','US10335481'),
  ('OV_5917','Measles virus','wild type','RNA','Paramyxoviridae','Mutated for SLAM binding','Yes','No','No','NA','Human lung cancer cell line','NCI-H2170','NA','NA','WST-1 assay','1 MOI','Complete cell killing after 7 days','No','No','NA','No response','NA','NA','NA','NA','US10335481'),
  ('OV_5918','Measles virus','wild type','RNA','Paramyxoviridae','Mutated for SLAM binding','Yes','No','No','NA','Human lung cancer cell line','NCI-H358','NA','NA','WST-1 assay','1 MOI','90% cell killing after 7 days','No','No','NA','No response','NA','NA','NA','NA','US10335481'),
  ('OV_5919','Measles virus','wild type','RNA','Paramyxoviridae','Mutated for SLAM binding','Yes','No','No','NA','Human lung cancer cell line','Calu-3','NA','NA','WST-1 assay','1 MOI','70% cancer cell killing after 7 days','No','No','NA','No response','NA','NA','NA','NA','US10335481'),
  ('OV_5920','Measles virus','wild type','RNA','Paramyxoviridae','Mutated for SLAM binding','Yes','No','No','NA','Human lung cancer cell line','NCI-H1666','NA','NA','WST-1 assay','1 MOI','70% cancer cell killing after 7 days','No','No','NA','No response','NA','NA','NA','NA','US10335481'),
  ('OV_5921','Measles virus','wild type','RNA','Paramyxoviridae','Mutated for SLAM binding','Yes','No','No','NA','Human lung cancer cell line','PC-14','NA','NA','WST-1 assay','1 MOI','20% cell killing after 7 days','No','No','NA','No response','NA','NA','NA','NA','US10335481'),
  ('OV_5922','Measles virus','wild type','RNA','Paramyxoviridae','Mutated for SLAM binding','Yes','No','No','NA','Human lung cancer cell line','A431','NA','NA','WST-1 assay','1 MOI','20% cell killing after 7 days','No','No','NA','No response','NA','NA','NA','NA','US10335481'),
  ('OV_5923','Measles virus','wild type','RNA','Paramyxoviridae','Mutated for SLAM binding','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','SCID mice xenograft for NCI-H441(1.0E+8)','5.0E+7 pfu','NA','Reduction in tumor volume to 200mm compared to control 2500mm after 40 days','Intratumoral','NA','NA','NA','US10335481'),
  ('OV_5924','Measles virus','wild type','RNA','Paramyxoviridae','Mutated for SLAM binding','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','SCID mice xenograft for NCI-H441(1.0E+8)','5.0E+7 pfu','NA','Significant reduction in tumor volume','Intravenously','NA','NA','NA','US10335481'),
  ('OV_5925','Measles virus','wild type','RNA','Paramyxoviridae','Mutated for SLAM binding','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','SCID mice xenograft for DLDI(5.0E+6)','1.0E+6 TCID50','NA','Tumor volume reduced to below 400mm after 20 days','Intratumoral','NA','NA','NA','US10335481'),
  ('OV_5926','Measles virus','wild type','RNA','Paramyxoviridae','Mutated for SLAM binding','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','SCID mice xenograft for HT29(5.0E+6)','1.0E+6 TCID50','NA','Tumor volume reduced to below 400mm after 20 days','Intratumoral','NA','NA','NA','US10335481'),
  ('OV_5927','Measles virus','wild type','RNA','Paramyxoviridae','Mutated for SLAM binding','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','SCID mice xenograft for HCC70(5.0E+6)','1.0E+6 TCID50','NA','Tumor volume reduced to 200mm after 30 days','Intratumoral','NA','NA','NA','US10335481');
